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SUMMARY OF THESIS
Pancreaticoduodenectomy with or without adjuvant chemotherapy remains the
only modality of possible cure in patients with cancer involving the head of the
pancreas and the periampullary region. While mortality rates after
pancreaticoduodenectomy have improved considerably over the course of the last
century, morbidity remains high. Patient selection is of paramount importance in
ensuring that major surgery is offered to individuals who will most benefit from a
pancreaticoduodenectomy. Moreover, identifying preoperative risk factors provides
potential targets for prehabilitation and optimisation of the patient’s physiology
before undertaking surgery. In addition to this, early identification of patients who
are likely to develop postoperative complications allows for better allocation of
critical care resources and more aggressive management high risk patients.
Cardiopulmonary exercise testing is becoming an increasingly popular tool in the
preoperative risk assessment of the surgical patient. However, very little work has
been done to investigate the role of cardiopulmonary exercise testing in predicting
complications after pancreaticoduodenectomy. The impact of jaundice, systemic
inflammation and other preoperative clinicopathological characteristics on
cardiopulmonary exercise physiology has not been studied in detail before in this
cohort of patients.
The overall aim of the thesis was to examine the relationships between
preoperative clinico-pathological characteristics including cardiopulmonary exercise
physiology, obstructive jaundice, body composition and systemic inflammation and
complications and the post-surgical systemic inflammatory response in patients
undergoing pancreaticoduodenectomy.
Chapter 1 reviews the existing literature on preoperative cardiopulmonary
exercise testing, the impact of obstructive jaundice, perioperative systemic
inflammation and the importance of body composition in determining outcomes in
patients undergoing major surgery with particular reference to pancreatic surgery.
Chapter 2 reports on the role of cardiopulmonary exercise testing in predicting
postoperative complications after pancreaticoduodenectomy. The results
demonstrate that patients with V˙O2AT less than 10 ml/kg/min are more likely to
develop a postoperative pancreatic fistula, stay longer in hospital and less likely to
receive adjuvant therapy. These results emphasise the importance of aerobic fitness
to recover from the operative stress of major surgery without significant morbidity.
Cardiopulmonary exercise testing may prove useful in selecting patients for
intensive prehabilitation programmes as well as for other optimisation measures to
prepare them for major surgery.
Chapter 3 evaluates the relationship between cardiopulmonary exercise
physiology and other clinicopathological characteristics of the patient. A detailed
analysis of cardiopulmonary exercise test parameters in jaundiced versus
non-jaundiced patients demonstrates that obstructive jaundice does not impair
cardiopulmonary exercise physiology. This further supports emerging evidence in
contemporary literature that jaundiced patients can proceed directly to surgery
without preoperative biliary drainage. The results of this study also show an
interesting inverse relationship between body mass index and anaerobic threshold
which is analysed in more detail in Chapter 4.
Chapter 4 examines the relationship between preoperative cardiopulmonary
exercise physiology and body composition in depth. All parameters measured at
cardiopulmonary exercise test are compared against body composition and body
mass index. The results of this chapter report that the current method of
reporting V˙O2 , both at peak exercise and anaerobic threshold, is biased against
obese subjects and advises caution in the interpretation of cardiopulmonary
exercise test results in patients with a high BMI. This is particularly important as
current evidence in literature suggests that postoperative outcomes in obese
subjects are comparable to non-obese subjects while cardiopulmonary exercise test
results are also abnormally low in this very same cohort of patients.
Chapter 5 analyses the relationship between preoperative clinico-pathological
characteristics including systemic inflammation and the magnitude of the
postoperative systemic inflammatory response. Obstructive jaundice appears to
have an immunosuppressive effect while elevated preoperative CRP and
hypoalbuminemia appear to have opposite effects with hypoalbuminemia resulting
in a lower response while elevated CRP in the absence of hypoalbuminemia
resulted in a greater postoperative systemic inflammatory response.
Chapter 6 evaluates the role of the early postoperative systemic inflammatory
response in predicting complications after pancreaticoduodenectomy and aims to
establish clinically relevant thresholds for C-Reactive Protein for the prediction of
complications. The results of this chapter demonstrate that CRP levels as early as
the second postoperative day are associated with complications. While
post-operative CRP was useful in the prediction of infective complications, this
was the case only in patients who did not develop a post-operative pancreatic
fistula. The predictive ability of inflammatory markers for infectious complications
was blunted in patients with a pancreatic fistula.
Chapter 7 summarises the findings of this thesis, their place in current literature
and future directions. The results of this thesis add to the current knowledge
regarding the complex pathophysiological abnormalities in patients undergoing
pancreaticoduodenectomy, with specific emphasis on the interaction between
cardiopulmonary exercise physiology, obstructive jaundice, systemic inflammation
and postoperative outcomes.
The work presented in this thesis lays the foundations for further studies aimed at
improving outcomes after pancreaticoduodenectomy through the development of
individualised, goal-directed therapies that are initiated well before this morbid yet
necessary operation is performed.
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1.1 Pancreatic neoplasia
1.1.1 Epidemiology of pancreatic cancer
Tumours involving the head of the pancreas and the periampullary region account
for a small proportion of gastrointestinal tumours. They may be broadly classified
as benign and malignant. Most pancreatic neoplasia are malignant [Li et al. 2004].
Pancreatic ductal adenocarcinoma arising from the ductal epithelium of the
exocrine part of the pancreas is the most common cancer of the pancreas.
However, the head of the pancreas is anatomically related to several other
epithelium lined structures that can also give rise to cancers. These include the
distal common bile duct (cholangiocarcinoma), the duodenum (duodenal
adenocarcinoma) and the ampulla (ampullary adenocarcinoma). Neuroendocrine
tumours (NET) are a collection of a variety of neoplasia that originate from the
endocrine portion of the pancreas. Other neoplasia such as intra-ductal papillary
neoplasms (IPMN) as well as rare stromal tumours may also occur in this region.
Occasionally, chronic pancreatitis may present with features similar to pancreatic
cancer and can be morphologically, radiologically and histologically difficult to
differentiate from cancer.
Pancreatic cancer is the tenth most common cancer in the UK but the fifth most
common cause of cancer death. Only 21% survive beyond the first year and 5-year
survival is 3% [CancerResearchUK 2011]. The majority of patients (80-85%) with
pancreatic cancer present with inoperable disease [CancerResearchUK 2011; Sener
et al. 1999].
In patients with resectable disease, surgery [Sener et al. 1999; Sohn et al. 2000;
Geer et al. 1993] followed by adjuvant chemotherapy in selected patients
[Neoptolemos et al. 2004; Neoptolemos et al. 2009] offers the only chance of a cure.
However, major pancreatic surgery places significant physiological stresses on
multiple organ systems. The ability of the cardiac and respiratory systems in
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particular, to cope with the increased physiological demand placed by general
anaesthesia and major pancreatic surgery plays an important role in determining
outcome after surgery.
1.1.2 Aetiology of pancreatic cancer
Several factors have been identified as being associated with an increased risk of
pancreatic cancer. The most important risk factor associated with increased
incidence of pancreatic cancer is tobacco. Tobacco smoking has been reported to
be associated with at least a 2-fold increased risk of pancreatic cancer and this risk
increases to 5-fold in patients with over 40 pack-years of smoking [Raimondi et al.
2007; Iodice et al. 2008]. This increased risk persists for at least 10 years after
cessation of smoking [Iodice et al. 2008].
The association between alcohol consumption and pancreatic cancer is less clear.
While alcohol consumption on its own has not been shown to result in an increased
risk of pancreatic cancer, the incidence of pancreatic cancer in heavy drinkers is
greater than in the general population. This may be due to the confounding effect
of cigarette smoking in this cohort of patients [Jiao et al. 2009; Rohrmann et al.
2009].
Obesity and high caloric intake have also been reported to be associated with
increased risk of pancreatic cancer although the underlying mechanisms and the
effects of confounding factors are poorly understood [Berrington de Gonzalez et al.
2003; Larsson et al. 2007; Li et al. 2009].
Other possible risk factors include increasing age, diet high in saturated fats,
chronic pancreatitis, family history of pancreatic cancer and genetic abnormalities
resulting in cancer syndromes [Raimondi et al. 2009; Maisonneuve et al. 2010]. It
is of note that some of the important risk factors such as smoking, obesity, poor
diet and increasing age may also be associated with other medical comorbidities
including cardiorespiratory diseases that may have a significant impact on patient
Chapter 1. Introduction 4
fitness.
1.1.3 Clinical presentation
The anatomical location of the pancreas, deep within the retroperitoneum,
surrounded by numerous vital blood vessels including the coeliac trunk and its
branches, the superior mesenteric artery, portal vein and superior mesenteric vein
as well as proximity to other viscera such as the stomach, duodenum, transverse
colon results in early involvement of these structures even by relatively small
tumours [Li et al. 2004]. Moreover, symptoms are often absent in the early stages
and when present are too non-specific to help with diagnosis. Obstructive jaundice
is the most common presenting symptom and painless, obstructive jaundice in an
elderly patient should always raise the suspicion of a neoplastic process in the head
of the pancreas or the periampullary region. Other non-specific symptoms include
weight loss, early satiety, vomiting, fatigue and pain in the epigastrium or the
back. Occasionally, the first presentation of a pancreatic neoplasm may be in the
form of an episode of acute pancreatitis.
1.1.4 Diagnosis and staging
Initial assessment includes a thorough history, clinical examination and blood tests
including full blood count, renal function tests, liver function tests and tumour
markers, especially CA 19-9. However, definitive diagnosis requires cross-sectional
imaging in the form of a contrast-enhanced computerised tomogram (CECT) of
the abdomen using a pancreas-specific protocol (a modified form of the
portal-venous phase). CECT of the pancreas when combined with CT Thorax also
provides accurate information on staging of the disease with regards to metastasis
and this can be supplemented by further imaging such as Positron Emission
Tomography (PET-CT) or contrast-enhanced Magnetic Resonance Imaging (MRI)
of the liver in specific cases. CECT-pancreas is also useful for assessing local
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resectability with accurate information regarding vascular involvement. Endoscopic
Ultrasound (EUS) is used in selected patients to assess vascular involvement and
for obtaining tissue samples for histological examination. In jaundiced patients,
endoscopic retrograde cholangio pancreatography (ERCP) may play a role in the
alleviation of jaundice in patients with cholangitis by placing stents across the
obstructed bile duct, obtaining accurate visualisation of the biliary anatomy as
well as obtaining brushings from within the bile duct for cytological examination.
However, the role routine preoperative biliary drainage is controversial and is
discussed in more detail in Section 1.9.4.
1.1.5 Treatment of pancreatic cancer
Pancreaticoduodenectomy (followed by adjuvant chemotherapy in some cancers)
offers the only chance of cure in patients with resectable pancreatic cancer who are
fit enough to undergo surgery [Li et al. 2004] In patients with unresectable disease
or who are not fit to undergo surgery, palliative chemotherapy plays a limited role
in prolonging survival. Assessment of resectability of lesions of the head of the
pancreas is discussed in the next section while the assessment of physiological
fitness and the impact of comorbidity are discussed in detail in section 1.4 on page
15.
1.2 Surgical treatment of pancreatic cancer
Pancreaticoduodenectomy remains a technically challenging and complex surgical
procedure. Excision of cancer of the head of the pancreas was first described as a
two-stage operation by a German surgeon, Walther Kausch in 1909 at
Augusta-Viktoria-Krankenhaus in Berlin-Scho¨neberg [Kausch 1912]. The operation
was further popularised initially as a two-stage procedure by Allen Whipple
[Whipple et al. 1935], an American surgeon, before evolving into the current single
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stage operation by the 1950s [Whipple 1941; Whipple 1950].
1.2.1 Resectability criteria
Resectable pancreatic cancer is defined as a tumour that does not involve the
coeliac axis or the superior mesenteric artery and is not associated with distant
metastatic disease [Li et al. 2004]. Tumours involving the portal vein or superior
mesenteric vein are considered borderline resectable and can still be resected
completely with en-bloc venous resection in selected cases [Fuhrman et al. 1996].
Neoadjuvant therapies such as chemotherapy with or without local radiotherapy
[Gillen et al. 2010; Evans et al. 2008] and newer treatment modalities such as
electroporation [Bower et al. 2011] and intra-peritoneal chemotherapy [Kamath
et al. 2009] are the subject of ongoing clinical research. There is increasing
evidence that some of these patients may be able to undergo potentially curative
surgery after neo-adjuvant treatment [Gillen et al. 2010].
1.2.2 Operative technique
Pancreaticoduodenectomy is considered one of the most technically challenging
operations on the gastrointestinal tract. While the procedure is carried out in a
broadly similar fashion in all major centres, there remain some variations in
perioperative care as well as some operative steps. The following is a description of
the procedure as performed at the West of Scotland Pancreatic Unit.
A comprehensive preoperative evaluation was performed including staging of the
disease for local resectability and absence of metastatic disease, assessment of
patient fitness and anaesthetic review. All patients with suspected cancer were
discussed at the pancreato-biliary multidisciplinary team meeting. Fully informed
consent was obtained after discussion regarding treatment options, the details of a
pancreaticoduodenectomy, expected perioperative course, potential risks and
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follow-up care.
Patients received thrombo-prophylaxis on the night before surgery which was
continued until discharge from hospital. General anaesthesia with complete muscle
relaxation was used in all patients. Epidural analgesia was used routinely in
patients during the early part of the study period while all patients in the later
half of the study period received spinal diamorphine. Prophylactic antibiotics were
administered at induction. The use of Octreotide, a somatostatin analogue, to
reduce the incidence of postoperative pancreatic fistula is still under debate
[Halloran et al. 2002; Li et al. 2004] . However, it was routinely used in all patients
at our centre. Octreotide was administered intra-operatively (200 micrograms by
subcutaneous injection at induction and repeated after 4 hours) and was continued
for 5 days postoperatively (200 micrograms by subcutaneous injection
administered three times a day).
A roof-top incision was made to enter the abdominal cavity. After assessing the
peritoneal cavity and liver for absence of metastatic disease, an early assessment
was made for local resectability. This involved complete Kocherisation of the
duodenum to assess the retroperitoneum. Both the superior mesenteric artery and
coeliac axis were assessed early for tumour involvement (‘artery-first’ approach)
[Weitz et al. 2010]. The gastrocolic omentum was divided to enter the lesser sac.
The superior mesenteric vein was identified and a retro-pancreatic tunnel was
created between the pancreatic neck and the portal vein. If less than half the
circumference of the superior mesenteric vein or portal vein was involved, an
en-bloc resection was performed with vein repair at the same time. The
hepatoduodenal ligament was dissected after a fundus-first cholecystectomy to
isolate the common bile duct which was transected after ascertaining the hepatic
artery anatomy. The gastro-duodenal artery was divided leaving a short segment
on the common hepatic artery. This was done to facilitate mesenteric angiography
and embolisation of this vessel in case of post-pancreatectomy haemorrhage. The
stomach (classical Whipple) or the first part of the duodenum (pylorus-preserving
pancreaticoduodenectomy) were divided using a stapling device. The pancreatic
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neck was transected using Harmonic scalpel, diathermy or cold blade depending
on surgeon’s preference. The jejunum was divided at the first jejunal arcade and
the jejunal mesentery was divided using the Harmonic ultrasonic scalpel. The
retroportal lamina was divided preserving the superior mesenteric artery.
Reconstruction was performed as follows: either a pancreatico-jejunostomy was
fashioned using 4-0 Biosyn sutures in a two-layer duct-to-mucosa technique or a
pancreatico-gastrostomy was created using 3/0 Biosyn sutures placed in a similar
manner. Hepatico-jejunostomy was performed using interrupted 4/0 Biosyn
sutures. Gastro-jejunostomy or duodenojejunostomy (in pylorus-preserving
pancreaticoduodenectomy) was performed using continuous 3/0 Polydioxanone
(PDS) sutures in 2-layers. One or two surgical drains were placed and the
abdomen was closed after ensuring haemostasis.
1.2.3 Postoperative care
All patients were routinely admitted to the Surgical High Dependency Unit unless
intra-operative events necessitated admission to the Intensive Care Unit. A
standardised regimen of intravenous fluids, naso-jejunal feeding, mobilisation and
physiotherapy was implemented in all patients. Standard physiological parameters
including haemodynamic measurements, renal function and arterial blood gases
were used to monitor adequate end organ perfusion. All patients received proton
pump inhibitors and Octreotide. Patients were discharged to the general surgical
ward as early as possible. Amylase content in the drain fluid was measured on the
third post-operative day to aid in the diagnosis of post-operative pancreatic fistula.
Surgical drains and naso-gastric/naso-jejunal tubes were removed at the surgeon’s
discretion. Patients were discharged when medically fit.
Histopathology reports were discussed at the multi-disciplinary team meeting for
cancer patients and suitable patients were referred for adjuvant chemotherapy.
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1.2.4 Complications
The incidence of complications after pancreaticoduodenectomy remains high in
spite of a steady decline in postoperative mortality from over 40% in the 1950s to
less than 5% in most large volume centres around the world [DeOliveira et al.
2006; Emick et al. 2006; Yeo et al. 1997; Winter et al. 2006; Teh et al. 2009;
Gouma et al. 2000]. Accurate definitions and clinical severity grading are useful in
comparing outcomes between centres as well as for research, audit and quality
improvement purposes. The consensus definitions of the International Study
Group for Pancreatic Surgery (ISGPS) and the Clavien-Dindo classification
systems were used during the course of the studies reported here.
1.2.4.1 Postoperative pancreatic fistula
Postoperative pancreatic fistula is one of the most dreaded complications after a
pancreaticoduodenectomy and can be associated with significant short-term
morbidity as well as long-term disability. The reported incidence of postoperative
pancreatic fistula varies from 2% to 30% after pancreaticoduodenectomy [Yeo et al.
1997; DeOliveira et al. 2006; Bassi et al. 2005a; Winter et al. 2007; Pratt et al.
2008a]. The variation in reported incidence has been largely due to lack of clear
definition of what constituted a postoperative pancreatic fistula. It can be the
result of breakdown or poor healing at the pancreatico-jejunostomy/
pancreatico-gastrostomy or may be the result of direct parenchymal leak unrelated
to the anastomosis.
It is now generally accepted that 1 in 4 patients will develop a pancreatic fistula as
defined by the International Study Group for Pancreatic Fistula (ISGPF) which
has published a consensus statement on the definition and grading of postoperative
pancreatic fistula [Bassi et al. 2005a]. A postoperative pancreatic fistula is defined
as drain output of any measurable quantity after the third postoperative day with
amylase content greater than three times the upper limit of the normal serum
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amylase value at the laboratory used for testing.
Three grades of postoperative pancreatic fistula have been defined based on clinical
severity as described in Table 1.1 on page 10. Grade B and C fistulae are
considered to be clinically significant as they alter patient management and are
often associated with other secondary complications such as intra-abdominal
sepsis, post-pancreatectomy haemorrhage or delayed gastric emptying. They may
require further intervention (either radiological or operative) or prolonged critical
care support.
1.2.4.2 Post-pancreatectomy haemorrhage
Post-pancreatectomy haemorrhage is reported to occur in 1 to 8% of patients
undergoing pancreaticoduodenectomy. However, it accounts for 11% to 38% of
mortality after pancreaticoduodenectomy [Wente et al. 2007]. Post-pancreatectomy
haemorrhage may either be intra-luminal into the gastrointestinal tract or
intra-abdominal into the peritoneal/retro-peritoneal space. Post-pancreatectomy
haemorrhage may be from a number of potential sources although bleeding from
the stump of the gastroduodenal artery is the most common cause. Other
potential sources include suture lines at the anastomoses, gastric/duodenal ulcers
or diffuse gastritis, pseudoaneurysms of the gastro-duodenal, splenic or rarely the
hepatic artery or rarely, haemobilia.
Haemorrhage is often secondary to non-healing of the pancreatico-jejunal
anastomosis leading to leakage of amylase-rich pancreatic juices into the
retroperitoneum or secondary to intra-abdominal sepsis or bile leak [Tien et al.
2005; Koukoutsis et al. 2006; Choi et al. 2004; Balladur et al. 1996]. This can then
lead to erosion of ligated blood vessels, most commonly the stump of the
gastro-duodenal artery. Post-pancreatectomy haemorrhage is usually managed
with angiographic embolisation of the bleeding vessel and surgical intervention is
only rarely required. The grading of severity of post-pancreatectomy haemorrhage
as described by the International Study Group of Pancreatic Surgery [Wente et al.
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2007] is shown in Table 1.2 on page 10.
1.2.4.3 Clavien-Dindo classification of complications
A number of other adverse events may occur following pancreaticoduodenectomy
including cardiopulmonary complications such as myocardial infarction, cardiac
arrhythmias, pneumonia and pleural effusions, wound complications such as wound
sepsis and dehiscence, intra-abdominal problems including intra-abdominal sepsis,
leakage from the hepatico-jejunostomy or the gastro-jejunostomy, infected fluid
collections, renal dysfunction, deep vein thrombosis, pulmonary embolism, etc.
The Clavien-Dindo system grades the severity of complications based on the
impact of the complication on the management of the patient and has been
validated in large numbers of surgical patients [Clavien et al. 2009; Dindo et al.
2004]. The classification is summarised in Table 1.3 on page 13. and was used to
grade complications in this thesis. Complications of grade 3 or greater are
considered clinically significant as they require further procedures either under
local or general anaesthesia, single or multiple organ support or result in death.
However, grades 1 and 2 are managed with ward-based care including antibiotics,
wound management, supplemental enteral or parenteral nutrition and similar
interventions.
1.3 Adjuvant and neoadjuvant treatment
While surgery is the primary modality of curative treatment in patients with
resectable pancreatic cancer, there is clear evidence that adjuvant chemotherapy
improves survival and is now the standard of care for patients with pancreatic
ductal adenocarcinoma.
Early randomised trials reported improved survival in patients with inoperable
pancreatic cancer [Mallinson et al. 1980] as well as in patients who had undergone
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potentially curative surgery [Bakkevold et al. 1993b].
The European Study Group for Pancreatic Cancer (ESPAC) has conducted some
of the largest randomised controlled trials of adjuvant chemotherapy and
chemoradiotherapy versus observation after potentially curative surgery. They
have reported that chemotherapy after surgery prolonged survival while
chemoradiotherapy had a harmful effect [Neoptolemos et al. 2001; Neoptolemos
et al. 2004; Neoptolemos et al. 2009; Neoptolemos et al. 2010].
The ESPAC-1 trial compared the use of chemotherapy with Fluorouracil and
Folinic acid or chemoradiotherapy with 20Gy radiotherapy and 5-Fluorouracil
(5-FU) versus observation only in patients who underwent potentially curative
surgery for pancreatic ductal adenocarcinoma [Neoptolemos et al. 2004]. The
5-year survival rate in patients who received chemotherapy was 20% while it was
8% in patients who did not receive chemotherapy, demonstrating a clear survival
benefit for adjuvant chemotherapy. However, adjuvant chemoradiotherapy resulted
in 5-year survival dropping from 20% to 10% and has largely been abandoned in
the adjuvant setting. The ESPAC-3 trial compared the efficacy of 5-FU and Folinic
acid with Gemcitabine and reported that Gemcitabine was not superior to
5-FU/Folinic acid [Neoptolemos et al. 2010].
Oettle and co-workers reported on the results of a European multi-center,
randomised controlled phase 3 trial comparing the results of surgery versus surgery
and adjuvant chemotherapy with 6 cycles of gemcitabine in patients with
pancreatic ductal adenocarcinoma [Oettle et al. 2007]. The median disease free
survival in patient who received gemcitabine chemotherapy was 13.4 months while
it was only 6.9 months in the surgery-only group. However, there was no difference
in overall survival.
However, 25% to 50% of patients who undergo surgery for pancreatic ductal
adenocarcinoma either do not receive or do not complete a full course of adjuvant
chemotherapy [Sohn et al. 2000; Neoptolemos et al. 2004; Oettle et al. 2007]. A
number of factors have been identified for the non-receipt of adjuvant therapy
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including comorbidity, postoperative complications and favourable pathological
features [Spitz et al. 1997; Aloia et al. 2007; Oettle et al. 2007; Merchant et al.
2009; Russ et al. 2009].
Increasingly, neo-adjuvant therapies are being used in patients with initially
unresectable or ’borderline-resectable’ cancers in an attempt to improve
resectability. In a meta-analysis of 111 studies, Gillen and co-workers reported that
approximately one-third of initially unresectable patients can be expected to have
resectable tumours after neo-adjuvant treatment [Gillen et al. 2010]. The authors
recommended that such patients should be actively included in neo-adjuvant
protocols and re-staged for resection after treatment.
1.4 Preoperative risk stratification
Selection of patients suitable for potentially curative surgery not only depends on
the resectability criteria that were discussed in section 1.2.1 but also on
physiological fitness [Bilimoria et al. 2007; Sandroussi et al. 2010]. Major
pancreatic surgery is associated with significant morbidity. Subjecting patients
with poor physiological reserve to a pancreaticoduodenectomy is fraught with risk.
High risk patients undergoing surgery are more likely to develop postoperative
complications resulting in prolonged hospitalisation and poor quality of life with
little difference in survival when compared to palliative treatment only. The risk of
post-operative mortality is also increased.
1.4.1 Comorbidity
Comorbidity is defined as the presence of or the effect of other diseases that a
patient has in addition to the primary disease of interest. Major pancreatic surgery
requires the patient to have adequate reserve to cope not only with the increased
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perioperative physiological demand but also with any adverse events that may
occur.
The presence of comorbid conditions is associated with increased incidence of
adverse outcomes in patients undergoing treatment for pancreatic cancer [Mann
et al. 2010]. It can also limit the therapeutic options available due to the
associated complications or side effects of surgery or adjuvant treatment
[Sandroussi et al. 2010]. Patients with multiple comorbidities are more likely to
have higher readmission rates, morbidity and mortality following discharge after
pancreaticoduodenectomy [Teh et al. 2009].
DeOliveira and co-workers reported that cardiovascular disease was a risk factor
not only for overall morbidity but also for severity of complications after
pancreaticoduodenectomy [DeOliveira et al. 2006]. Obesity is known to be
associated with greater incidence and severity of postoperative complications
[Benns et al. 2009]. However, existing methods of measuring the impact of
comorbidity on physiological fitness are limited and do not adequately predict
outcomes after major pancreatic surgery [Castro et al. 2009].
1.4.2 Risk stratification
Physiological fitness or reserve may be defined as the ability of the patient’s organ
systems to respond appropriately and adequately to the stress of surgery. Major
surgery has a significant physiological impact on multiple organ systems, especially
the cardiorespiratory system. The ability of the cardiorespiratory system as well as
other organ systems including renal, gastrointestinal, hepatic, coagulatory and
immunological systems to cope with major surgery and its sequelae plays a major
role in determining postoperative outcomes. Therefore, accurate assessment of
physiological fitness is important in patient selection, individualised risk prediction
and consent, preoperative optimisation as well as perioperative management. A
thorough clinical history of co-existing illnesses, general examination and review of
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patient’s medications is followed by more specialist testing to assess fitness.
Numerous methods including individual tests and composite scores derived from
physiological and biochemical variables have been used for risk assessment.
The Physiological and Operative Severity Score for the enumeration of Mortality
and Morbidity (POSSUM) is one of the most used scores for risk-prediction in
general surgery [Copeland et al. 1991]. It was devised by Copeland and co-workers
as a method of predicting risk-adjusted mortality and morbidity rates for
comparative audit between different surgical departments [Copeland et al. 1993]
and individual surgeons [Copeland et al. 1995]. While some authors have reported
it to be useful in predicting postoperative outcomes after pancreatic surgery [Pratt
et al. 2008b] others have found that POSSUM was not a good risk prediction
model in this group of patients [Khan et al. 2003; Kocher et al. 2005; Tamijmarane
et al. 2008; Castro et al. 2009].
The physiology component of the POSSUM score (POSSUM Physiology Score,
PPS) which takes into account comorbidities and specific preoperative biochemical
parameters was used as an objective static measure of comorbidity in this thesis.
The POSSUM Physiology Score has been reported to be associated with
preoperative systemic inflammation and cancer-specific survival in patients who
underwent potentially curative surgery for colorectal cancer [Richards et al. 2010].
The variables used in the calculation of the POSSUM Physiology Score are shown
in Table 1.4 on page 18.
More recently, elevated preoperative systemic inflammation as measured by the
modified Glasgow Prognostic Score (mGPS) has been reported to be associated
with increased incidence of infective complications after colorectal surgery [Moyes
et al. 2009] as well as oesophageal resections [Vashist et al. 2010].
POSSUM and other similar composite scores such as the APACHE II (Acute
Physiology and Chronic Health Evaluation II) [Knaus et al. 1985] and Estimation
of Physiologic Ability and Surgical Stress (E-PASS) [Haga et al. 1999; Hashimoto
et al. 2010] have not found widespread use for risk prediction in pancreatic surgery.
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Table 1.4: Variables used in the calculation of the POSSUM Physiology Score.
Score
Variable 1 2 4 8
Age <61 61-70 >70
Cardiac Signs No failure Diuretic, digoxin,
antianginal, an-
tiHT therapy
Peripheral
oedema, war-
farin, borderline
cardiomegaly
Raised JVP, car-
diomegaly
Respiratory No dyspnoea Dyspnoea on ex-
ertion
Limiting dysp-
noea (one flight),
moderate COAD
Dyspnoea at rest
(rate>30/min),
fibrosis or consol-
idation
ECG Normal AF
rate 60-90
Other abnorm.
rhythm,
>4/min ectopics,
Q-waves, ST/T-
changes
Systolic-BP
(mm Hg)
110 - 130 100 - 109
131 - 170
>170,
90 - 99
< 90
Pulse rate 50 - 80 40 - 49
81 -100
101 - 120 <40
> 120
Haemoglobin
(g/dl)
13 - 16 11.5 - 12.9
16.1 - 17
10 - 11.4
17.1 - 18
<10
>18
White cell count
(x106/l)
4 - 10 10.1 - 20
3.1 - 4
>20
<3
Urea (mmol/l) <7.6 7.6 - 10 10.1 - 15 >15
Sodium
(mmol/l)
>135 131 - 135 126 - 130 <126
Potassium
(mmol/l)
3.5 - 5 3.2 - 3.4
5.1 - 5.3
2.9 - 3.1
5.4 - 5.9
<2.9
>5.9
Glasgow Coma
Scale
15 12 - 14 9 - 11 <9
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While these scores are either useful for comparative audit between patient
populations or in the case of APACHE II, for monitoring response to therapy in
intensive care, they are of limited value when applied to individual patients.
1.4.3 Static versus dynamic testing
Conventional tests of cardiac and respiratory function assess either performance at
rest or only one component of the cardiorespiratory system. These tests include
electrocardiography, echocardiography, exercise tolerance testing, myocardial
perfusion scan, pulmonary function tests including spirometry. However, none of
these tests adequately measure the ability of the cardiopulmonary and circulatory
systems to deliver oxygen to the tissues at times of increased demand. Patients
with sub-clinical cardiopulmonary dysfunction or limitation cannot be identified on
these tests alone. It is this group of patients who are most likely to be at greater
risk of complications and who will most benefit from targeted prehabilitation.
Moreover, composite score such as POSSUM do not provide information on the
ability of the patient to cope with physiological stress or on how their risk may be
mitigated before surgery. Cardiopulmonary exercise testing overcomes the
limitations of the conventional static tests by providing a global assessment of the
patient’s oxygen delivery mechanisms at times of increased physiological demand.
1.4.4 Pancreas-specific risk factors
In addition to all of the above risk factors, post pancreatectomy complications are
significantly associated with factors unique to pancreatic disease. Postoperative
pancreatic fistula is one of the most dreaded complications after a
pancreaticoduodenectomy and is discussed in more detail in Section 1.2.4.1. Soft
pancreas texture, narrow pancreatic duct, pathology that does not obstruct the
pancreatic duct such as ampullary or duodenal cancers are independent risk factors
for pancreatic fistula [Pratt et al. 2008a]. These organ-specific risk factors are
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independent of comorbidity and patient fitness [DeOliveira et al. 2006]. Lin and
co-workers reported that in a study of 1891 patients undergoing
pancreaticoduodenectomy, only soft pancreatic gland texture and coronary disease
were related to postoperative pancreatic fistula on multivariate analysis [Lin et al.
2004].
Several studies have attempted to evaluate various surgical strategies in improving
perioperative outcomes after pancreaticoduodenectomy. A prospective,
multi-center, randomised controlled trial of 170 patients undergoing
pancreaticoduodenectomy did not demonstrate any significant difference between a
Whipple’s classical pancreaticoduodenectomy and pylorus preserving
pancreaticoduodenectomy [Tran et al. 2004]. A Cochrane review in 2008 reported
on 7 randomised controlled trials comparing classical pancreaticoduodenectomy
with pylorus-preserving pancreaticoduodenectomy and found no difference in
morbidity, mortality or survival [Diener et al. 2008].
A prospective randomised trial comparing pancreaticogastrostomy versus
pancreaticojejunostomy in patients undergoing pancreaticoduodenectomy reported
that there was no difference in the incidence of overall complications or pancreatic
fistula. However, patients who had a pancreaticogastrostomy had a significantly
lower rate of biliary fistula, postoperative collections, delayed gastric emptying as
well as lower incidence of multiple surgical complications [Bassi et al. 2005b]. A
meta-analysis of eleven studies (one randomised trial, 2 non-randomised
prospective trials and eight observational studies) appeared to show improved
outcomes in patients undergoing pancreaticogastrostomy rather than a
pancreaticojejunostomy [McKay et al. 2006]. However, an earlier trial by Yeo and
co-workers failed to demonstrate any difference in outcomes between either
technique [Yeo et al. 1995].
In spite of a lack of any clear evidence of efficacy, octreotide continues to be used
in many centres including ours to reduce the incidence of postoperative pancreatic
fistula. While some early randomised trials reported the benefits of octreotide in
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decreasing the risk of postoperative pancreatic fistula [Montorsi et al. 1995;
Nakatsuka et al. 2000], other more recent trials have not reproduced these results
[Lowy et al. 1997; Yeo et al. 2000; Kollmar et al. 2008].
Surgical drains after pancreaticoduodenectomy have been a subject of considerable
debate. A prospective randomised controlled trial of 179 patients in 2001 reported
that intra-abdominal drains placed at the time of surgery did not reduce the
incidence of complications [Conlon et al. 2001].
Two randomised trials comparing early versus delayed drain removal in patients
with low risk of pancreatic fistula after pancreaticoduodenectomy reported that
early drain removal was associated with lower incidence of pancreatic fistula,
abdominal complications and pulmonary complications [Kawai et al. 2006; Bassi
et al. 2010].
However, these pancreas-specific risk factors are not modifiable before surgery,
have been studied extensively before and are not the subject of this thesis.
1.5 Cardiopulmonary exercise testing
1.5.1 Origins of preoperative cardiopulmonary exercise
testing
The idea of measuring V˙O2 (oxygen consumption) and vV˙CO2 (expired
carbon-dioxide) as a measure of cardiopulmonary response to exercise was
described in the early twentieth century. In 1924, Hill and co-workers reported on
adaptations made to an existing apparatus to allow measurement of oxygen
consumption during exercise [Hill et al. 1924]. Their method involved the subject
running while connected to a large bag slung on their back to collect expired gases.
The subjects then returned to the laboratory where they were connected to a fairly
large apparatus involving several more large bags and other equipment that filled
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the most part of a large room. But the premise of their method remains
unchanged to this date; to examine the response of the cardiopulmonary system to
exercise. Such methods were refined by other physiologists to reduce the chance of
errors and to devise more practical methods suitable for medical use [KATZ LN
et al. 1934; Sutton et al. 1940].
One of the earliest attempts to apply these dynamic tests in surgical patients was
reported by Starr and co-workers in 1945 [Starr et al. 1945]. They tried to devise a
test that could assess respiratory function and oxygen utilisation in surgical
patients before, immediately after and a week after surgery. They reported on the
difficulties in obtaining reproducible results but suggested that a slow return to
baseline of heart rate, respiratory rate and oxygen utilisation after surgery could
identify patients who are slow to recover.
However, cardiopulmonary exercise testing in its current form where
breath-by-breath analysis of gas exchange is combined with real-time
electrocardiography during incremental exercise was devised and popularised by
Karlman Wasserman and his team of physiologists. Wassermann and his team
reported on the ventilatory response to exercise and how it may be used to identify
cardiorespiratory disease in 1964 [Naimark et al. 1964]. The pioneering work on
the detection of anaerobic threshold was also done by his team and applied in the
assessment of patients with cardiac disease [Wasserman et al. 1964; Wasserman
1967; Wasserma.k et al. 1973].
The use of cardiopulmonary exercise testing as part of preoperative assessment was
first reported by Older and co-workers. They conducted a prospective study of 187
patients over the age of 60 undergoing major abdominal surgery [Older et al. 1993].
All patients underwent a symptom-limited exercise test on a cycle ergometer with
real-time 12-lead ECG monitoring. The average V˙O2 across all patients was 12.4
ml/min/kg. There were a total of 11 deaths related to cardiovascular causes
(5.9%) and 3 deaths due to non-cardiovascular causes. They reported that 10 out
of the 11 deaths due to cardiovascular causes occurred in patients with
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V˙O2AT < 11ml/kg/min (n=55). Only one patient in the group with
V˙O2AT ≥ 11ml/kg/min (n=132) died of cardiovascular complications (18% vs
0.8%, p<0.001). Eight out of the 10 patients in the low V˙O2AT group who died
also had evidence of myocardial ischaemia (p<0.01).
1.5.2 Cardiopulmonary exercise test methodology
Figure 1.1: ZAN-600 Cycle Erogmeter and CPET suite.
(Image from www.nspirehealth.com)
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Cardiopulmonary exercise tests were performed in the Department of Respiratory
Medicine at the Glasgow Royal Infirmary using the ZAN-600 CPET suite (nSpire
Health, Longmont, CO 80501, USA). All tests were performed by specialised
respiratory physiologists. Suitable equipment for cardiopulmonary resuscitation
were available in the department in case of unexpected problems. The department
was situated within the main hospital premises and therefore was easily accessible
to the hospital cardiac arrest team. All patients were fully informed of the steps
involved in the procedure, the reasons for performing the test as well as the risks
involved.
Spirometry was performed in all patients prior to cardiopulmonary exercise testing.
Capillary blood gases were measured in all patients after the test. The gas and
flow analysis equipment were calibrated prior to every test. An electronically
braked cycle ergometer was used to increase resistance to pedalling in preset
increments. A tight-fitting face mask was placed on the patient covering the nose
and the mouth. Breath-by-breath gas analysis and 12-lead electrocardiography
were displayed in real-time to the investigator allowing measurement of several
cardiac and respiratory parameters as they changed during exercise.
The test started with an initial 3-minute rest period to allow measurement of
baseline parameters. This was followed by an incremental work-load test that
involved the patient pedalling at approximately 60 revolutions per minute while
the resistance to pedalling was gradually increased in preset increments. The test
was terminated when patients reached volitional fatigue (maximal exercise
tolerance), significant ischaemic changes on ECG or for other safety reasons.
The oxygen consumption at this point (considered ‘peak’ exercise capacity) is
called V˙O2Peak. This is different from V˙O2Max which is identified by the plateauing
of the increasing V˙O2 when the physiological limits of oxygen consumption are met
in an individual. V˙O2Max is only observed in very fit individuals or well-trained
athletes. This seldom happens in surgical patients and V˙O2Peak is used as a
surrogate for V˙O2Max.
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The list of parameters measured is provided in Tables 1.5 and 1.6 on page 29. A
detailed description of these parameters is provided in Section 1.6.
1.5.3 Measuring the anaerobic threshold
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Figure 1.2: 9-panel view of trending parameters during cardiopulmonary exer-
cise.
The anaerobic threshold (variously described as the lactate threshold or ventilatory
threshold) is the point during exercise when oxygen demand by exercising skeletal
muscle outstrips supply. Therefore, muscle tissues use anaerobic respiration to
supplement aerobic respiration to continue generation of ATP. The resulting
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metabolic lactic acidosis is almost immediately compensated by the bicarbonate
buffer as below:
H+ +HCO3− ⇐⇒ H2CO3 ⇐⇒ H2O + CO2 (1.1)
The resulting excess CO2 is exhaled and is one of many parameters measured
during cardiopulmonary exercise testing. This transition from aerobic to anaerobic
respiration may be determined using the V-slope method [Sue et al. 1988] or the
ventilatory equivalents method [Beaver et al. 1986]. Most centres, like ours, use
both methods supplemented by information from a variety of other parameters to
enable accurate determination of the anaerobic threshold. This approach is also
recommended by the American Thoracic Society/American College of Chest
Physicians Statement on cardiopulmonary exercise testing [“ATS/ACCP
Statement on Cardiopulmonary Exercise Testing” 2003].
The software presents a standard 9-panel view of trending plots of various
parameters measured during incremental exercise. All of these trends are taken
into consideration rather than any one particular parameter value in determining
the overall outcome of the test. A sample 9-panel view derived from parameters
belonging to one of the patients studied is shown in Figure 1.2. The data used to
generate these plots is included in Appendix C.
1.5.3.1 V-slope method
During aerobic phase of exercise, V˙O2 and V˙CO2 share a linear relationship as shown
in the left half of Figure 1.3 on page 27. However, as anaerobic respiration starts to
supplement aerobic respiration, V˙CO2 increases disproportionate to V˙O2 as a direct
result of the respiratory buffer described in equation 1.1 on page 26. This results in
a distinct difference in the slope of the relationship between V˙O2 and V˙CO2 during
aerobic exercise (Line A) versus during anaerobic exercise (Line B). The point at
which the two slopes intersect is the anaerobic threshold and the V˙O2 at this point
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Figure 1.3: Determination of V˙O2AT by the V-slope method.
in exercise is commonly referred to as the anaerobic threshold or V˙O2AT.
1.5.3.2 Ventilatory equivalents method
The ventilatory equivalents method of determining V˙O2AT involves plotting
V˙E/V˙O2 and V˙E/V˙CO2 against time, exercise load or V˙O2 . The point at which
V˙E/V˙O2 increases while V˙E/V˙CO2 stays the same or decreases is the anaerobic
threshold and this can be seen in Fig. 1.2F. Most respiratory physiologists
including those at our centre use both methods as well as other trends during
exercise to determine the anaerobic threshold as well as its validity.
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1.6 Description of CPET parameters
1.6.1 Exercise load
The most common form of cardiopulmonary exercise testing for clinical use
involves a cycle ergometer with steadily increasing resistance delivered through
electric braking. This allows accurate measurement of work load in Watts. The
relationship between V˙O2 and work rate is usually linear and the slope of this
relationship is independent of sex, age or height. An abnormality in this
relationship is usually due to cardiopulmonary or circulatory causes.
1.6.2 Minute ventilation, V˙E
Minute ventilation or respiratory minute volume (V˙E) is the volume of air that is
inhaled/expired in a minute.
V˙E = V˙T ×Bf (1.2)
where V˙T = Tidal Volume and Bf = Breathing Frequency.
Increasing V˙E is one of the main mechanisms involved in increasing oxygen delivery
during exercise. It is also an important factor in clearing CO2 from the blood.
1.6.3 Oxygen Uptake, V˙O2
V˙O2 or oxygen uptake is measured breath-by-breath using digital analysis of the
inspired and expired gases. This is then averaged, usually over time, to smooth-out
any significant breath-by-breath variation. V˙O2 increases with increasing work load
and is influenced by several factors that have a role in the transport and utilisation
of oxygen. These may be broadly classified as cardiac, pulmonary, circulatory and
tissue factors. Some of the factors are encompassed in the following formula for
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Table 1.5: Parameters measured at spirometry.
Parameter Units Description
FVC litres Forced Vital Capacity
FEV1 litres Forced Expiratory Volume in 1 second
FEV1/FVC % Tiffeneau-Pinelli index
Table 1.6: Common parameters measured at cardiopulmonary exercise testing.
Parameter Units Description
Load Watts Exercise Workload
V˙E litres/min Ventilatory Equivalent
Vt litres Tidal volume
V˙O2 litres/min Absolute Oxygen uptake/consumption
V˙O2/kg ml//kg/min Corrected Oxygen uptake/consumption
V˙E/V˙O2 Ventilatory Equivalent for O2
V˙CO2 litres/min Carbon-dioxide output
V˙E/V˙CO2 Ventilatory Equivalent for CO2
RER Respiratory Exchange Ratio
PETO2 mmHg End Tidal O2
PETCO2 mmHg End Tidal CO2
O2Pulse ml/beat Oxygen pulse
HR beats/min Heart Rate
Bf resps/min Breathing Frequency
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V˙O2 .
V˙O2 = CaO2 × Cardiac Output (1.3)
where CaO2 is O2 content per ml of blood and is defined by,
CaO2 = Haemoglobin× 1.34× SaO2 (1.4)
and cardiac output, the primary cardiac factor that influences V˙O2 , is:
Cardiac Output = Stroke V olume×Heart Rate (1.5)
Stroke volume is in turn influenced by ventricular function and end-diastolic
volumes. The heart rate response to exercise is discussed in section 1.6.8 on page
32.
Pulmonary gas exchange plays an important role in the oxygenation of blood and
removal of CO2 and is influenced by numerous factors, the detailed discussion of
which is beyond the scope of this chapter. However, ventilation, pulmonary blood
flow, gas-exchange across the alveolar membrane and ventilation-perfusion
mismatches (V/Q mismatch) all play an important role in determining the
response of the lungs to exercise.
The quality of the peripheral circulation, both anatomical and its physiologic
response to exercise which involves redistribution of blood flow to exercising
muscle, has an important role in increasing availability of oxygen. The oxygen
carrying capacity of blood determined by haemoglobin concentration, its
saturation and the O2 dissociation curve as well as the ability of tissues to extract
and utilise oxygen are equally important factors that influence V˙O2 .
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1.6.4 Oxygen pulse, O2Pulse
O2Pulse is defined as the oxygen uptake per heart beat.
O2Pulse =
V˙O2
Heart rate
(1.6)
While some authors have suggested that oxygen pulse may be a surrogate for
stroke volume others disagree. The clinical application of oxygen pulse in surgical
patients remains unclear.
1.6.5 Respiratory Exchange Ratio, RER
The ratio of V˙CO2/V˙O2 is called the Respiratory Exchange Ratio. An RER greater
that 1.0 may be caused either by lactic acidosis or due to hyperventilation. The
RER is also a marker of the fuel being used for metabolism with RER less than 1.0
indicating mixed fuel source in the form of carbohydrate and fat while an RER of
1.0 or greater indicates a primarily carbohydrate source.
1.6.6 Ventilatory Equivalent for O2 and CO2, V˙E/V˙O2,
V˙E/V˙CO2
The changes in V˙E/V˙O2 and V˙E/V˙CO2 during exercise provide valuable information
regarding the ventilatory response to exercise. Both V˙E/V˙O2 and V˙E/V˙CO2 tend to
decrease initially during exercise. However, as the anaerobic threshold is passed,
V˙E/V˙O2 starts increasing before V˙E/V˙CO2 . This change in direction is yet another
method to confirm the anaerobic threshold. V˙E/V˙CO2 eventually starts increasing
as respiratory compensation of metabolic acidosis results in increased V˙E.
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1.6.7 End-tidal O2 and CO2, PETO2 , PETCO2
PETO2 and PETCO2 are the partial pressures of O2 and CO2 at the end of an
exhaled breath and are closely related to PaO2 and PaCO2 respectively. PETCO2 is
dependent on pulmonary gas-exchange which is in turn influenced by the right
ventricular output, pulmonary blood flow and alveolar gas exchange. The changes
in PETO2 and PETCO2 during exercise help identify ventilation-perfusion mismatch
as well as hyperventilation.
1.6.8 Heart Rate, HR
The heart rate response during exercise in healthy individuals is a linear function
of V˙O2 increasing linearly with increasing work load and increasing V˙O2 . The
difference between the predicted peak heart rate and the observed peak heart rate
is called the Heart Rate Reserve or HRR. Failure to achieve the predicted peak
heart rate or a wide HRR may be due to cardiac disease or due to medication used
to treat cardiovascular disorders such as beta-blockers or calcium-channel blockers.
This information in conjunction with 12-lead ECG evidence of ischaemia provides
undeniable evidence of primary cardiac dysfunction.
1.6.9 Breathing frequency, Bf
In healthy individuals, breathing frequency is one of the most important
respiratory responses to exercise in order to increase oxygen uptake. However, a
variety of respiratory disorders including chronic obstructive pulmonary disease or
restrictive disorders such as interstitial lung disease can impair this response.
Morbidly obese patients may also have additional restrictions on respiratory
response due to their body habitus. On the other hand, hyperventilation in an
otherwise healthy patient may make interpretation of the results difficult although
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the analysis of trends in other parameters such as PETO2 and PETCO2 aids in the
diagnosis of hyperventilation versus true respiratory problems.
1.7 Role of CPET in preoperative assessment
1.7.1 General Surgery
Several studies over the past 2 decades have established the value of
cardiopulmonary exercise testing in patients, especially elderly, undergoing major
abdominal surgery. Older and co-workers conducted a prospective study of 187
patients over the age of 60 undergoing major abdominal surgery. All patients
underwent a symptom-limited exercise test on a cycle ergometer with real-time
12-lead ECG monitoring. The average V˙O2 across all patients was 12.4 ml/min/kg.
There were a total of 11 deaths related to cardiovascular causes (5.9%) and 3
deaths due to non-cardiovascular causes. They reported that 10 out of the 11
deaths due to cardiovascular causes occurred in patients with
V˙O2AT < 11ml/kg/min (n=55) while only one patient in the group with
V˙O2AT ≥ 11ml/kg/min (n=132) died of cardiovascular complications (18% vs
0.8%, p < 0.001). Eight out of the 10 patients in the low V˙O2AT group who died
also had evidence of myocardial ischaemia (p < 0.01) [Older et al. 1993].
In a later, larger prospective study of 548 patients who underwent major
abdominal surgery including colorectal and abdominal aneurysm surgery, they
used a risk stratification system that combined V˙O2AT < 11ml/kg/min,
V˙E/V˙CO2 > 35 and evidence of myocardial ischaemia during exercise. High risk
patients (V˙O2AT < 11ml/kg/min, n=153) were admitted to intensive care after
surgery and had a mortality due to cardiovascular causes of 4.6%. Moderate risk
group (V˙O2AT > 11ml/kg/min and either V˙E/V˙CO2 > 35 or evidence of myocardial
ischaemia, n=115) was managed in the high dependency unit after surgery and
had a cardiovascular mortality of 1.7%. Low risk patients (with none of the risk
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factors mentioned above, n=280) were managed on the general surgical ward with
no cardiovascular mortality [Older et al. 1999]. Subsequent literature reviews by
Older and co-workers have emphasised the value of cardiopulmonary exercise
testing in risk assessment as well as optimising perioperative care in the high-risk
surgical patient [Older et al. 2000; Older et al. 2004; Older et al. 2005].
These findings have since been replicated in several other studies although the
threshold value of V˙O2AT as well as the inclusion of other CPET parameters to
attribute risk differ in these studies. Hightower and co-workers studied 32 patients
over the age of 18 undergoing a variety of major elective abdominal surgery. In
this heterogeneous cohort, they reported that the percent predicted anaerobic
threshold achieved < 75%, heart rate at the anaerobic threshold and the heart rate
response from rest to anaerobic threshold were all independently associated with
postoperative morbidity. While it is difficult to extrapolate results from this small
heterogeneous cohort to the general surgical population, it would appear that
other cardiopulmonary exercise test parameters may have a role in predicting risk
in these patients [Hightower et al. 2010].
Snowden and co-workers reported in a study of 171 patients of who 123 underwent
surgery, that V˙O2AT < 10.1 ml/kg/min was associated with not only
cardiovascular complications but also with other complications including
pulmonary, renal, gastrointestinal, infective and haematological complications.
One of the strengths of this study was the fact that clinicians were blinded to the
results of preoperative cardiopulmonary exercise testing, thus avoiding
management bias. They also included other cardiopulmonary exercise test
parameters such as V˙O2Peak and V˙E/V˙CO2 at the anaerobic threshold in addition to
V˙O2AT in their analysis and showed that V˙O2AT was more predictive of
postoperative morbidity than POSSUM derived morbidity, cardiac risk scoring
index or a validated activity questionnaire. However, this study also included a
heterogeneous cohort of diseases including vascular, pancreatic and hepatobiliary
disorders and sarcomas [Snowden et al. 2010].
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In a study of 847 patients undergoing elective abdominal surgery for colorectal
disease, bladder or renal cancer, Wilson and co-workers found that V˙O2AT < 11
ml/kg/min in the absence of documented cardiac risk factors was associated with a
relative risk of mortality of 10.0 (95% CI 1.7-61.9) [Wilson et al. 2010]. This
emphasises the value of cardiopulmonary exercise testing in diagnosing sub-clinical
or previously undiagnosed (and untreated) cardiovascular and respiratory disease.
Moreover, 90-day survival was also better in patients with better aerobic capacity
(V˙O2AT > 11 ml/kg/min and V˙E/V˙CO2 < 34) and in patients without ischaemic
heart disease. This appears to suggest that aerobic capacity influenced not only
postoperative outcomes but also medium-term survival after patients left hospital.
1.7.2 Oesophago-gastric and bariatric surgery
In a retrospective study involving 91 patients who underwent curative
oesophagectomy with 3-field lymphadenectomy via a right thoracotomy for
squamous cell carcinoma of the thoracic oesophagus between 1991 and 1995,
Nagamatsu and co-workers reported that V˙O2max/m
2 < 800ml/min/m2 predicted
cardiopulmonary complications [Nagamatsu et al. 2001]. They also reported that
V˙O2AT/m
2 and routine spirometry did not predict cardiopulmonary complications.
They recommended that in patients with V˙O2 .max/m
2 < 800ml/min/m2, surgical
treatment be modified either into a 2-stage procedure or a trans-hiatal procedure
avoiding a thoracotomy where possible.
Cardiopulmonary exercise testing has also been useful in predicting short-term
complications after bariatric surgery. McCullough and co-workers defined a
composite primary outcome measure that included myocardial infarction, unstable
angina, deep vein thrombosis, pulmonary embolism, renal failure, stroke and death
and applied this in a cohort of 109 consecutive patients who underwent Roux-en-Y
gastric bypass surgery. This composite adverse outcome was more likely in patients
with high BMI (>45) and low V˙O2Peak (<15.9 ml/kg/min). Patients in whom
both these risk factors were absent did not develop postoperative complications.
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They also observed a significant negative relationship between BMI and V˙O2
(p<0.0001) and age(p<0.0001). Poor aerobic capacity was also associated with the
presence of diabetes and hypertension suggesting further evidence of the metabolic
cost of obesity in these patients [McCullough 2006].
However, Forshaw and co-workers reported that cardiopulmonary exercise testing
was of limited use in predicting complications after oesophagectomy [Forshaw et al.
2008]. They studied 78 patients undergoing either trans-hiatal (n=39) or
trans-thoracic (n=39) oesophagectomy. They evaluated several thresholds for both
V˙O2Peak and V˙O2AT and found no useful correlation with cardiopulmonary
complications, non-cardiopulmonary complications, length of stay in critical care
or in hospital. While V˙O2Peak was significantly lower in patients who developed
postoperative cardiopulmonary complications, receiver-operator characteristics
(ROC) analysis did not identify a clinically useful threshold that would stratify
patients into different risk groups. Post-oesophagectomy complications such as
anastomotic leak or sepsis often happen within the thorax and are not necessarily
due to cardiopulmonary dysfunction. They postulated that this may have reduced
the predictive ability of preoperative cardiopulmonary exercise testing. Older and
Hall, the pioneers of cardiopulmonary exercise testing in surgical patients, also
raise this issue in their letter to the authors of the above study [Hall et al. 2009].
1.7.3 Vascular surgery
The earliest report of the application of cardiopulmonary exercise test in elective
abdominal aortic aneurysm surgery was by Nugent and co-workers in 1998. They
reported on cardiopulmonary exercise testing using a treadmill in 36 patients
undergoing elective abdominal aortic aneurysm surgery. They found no difference
in the V˙O2Peak in patients who developed complications versus those who did not
(18.6 vs 2.8 ml/kg/min, p>0.05). However, they reported that in the 4 patients
who were denied surgery as they were deemed medically unfit, V˙O2Peak was less
than 20 ml/kg/min. However, this threshold did not discriminate patients who
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developed complications and the authors concluded that cardiopulmonary exercise
testing should not be used on its own to guide clinical management of these
patients [Nugent et al. 1998].
However, cardiopulmonary exercise testing has been reported to predict 2-year
survival in patients undergoing elective aortic aneurysm surgery. Carlisle and Swart
reported that a Revised Cardiac Risk Index (RCRI) score > 1 in combination with
a V˙E/V˙CO2 > 42 was associated with a 2-year survival rate of 55% while the 2-year
survival rate was 97% if neither risk factor was present. V˙O2AT was not a predictor
of survival in multi-variate analysis in this study [Carlisle et al. 2007].
While studies have reported that repeated cardiopulmonary exercise testing
provides reproducible results in patients with abdominal aortic aneurysm and
preoperative exercise regimens are safe and effective at increasing aerobic capacity
in patients awaiting surgery, there is no published literature on the association
between cardiopulmonary exercise testing and postoperative complications in
patients undergoing vascular surgery. There are several papers post 2010.
1.7.4 Liver transplantation
Peak V˙O2 < 60% predicted and V˙O2AT < 50% predicted have been reported to be
associated with increased 100-day mortality in patients undergoing liver
transplantation. In patients with cirrhosis awaiting hepatic transplantation,
reduced aerobic capacity may not only be due to primary cardiorespiratory
insufficiency but may also be due to the secondary effects of hepatic dysfunction
itself. These include cirrhotic cardiomyopathy, hepatopulmonary syndrome and
decreased peripheral oxygen utilisation due to cirrhotic myopathy [Epstein et al.
2004]. This is further supported by the fact that patients who undergo liver
transplantation have been shown to have improved aerobic capacity a year after
surgery [Iscar et al. 2009]. However, there is very little other evidence of the
application of cardiopulmonary exercise testing in patients undergoing major
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hepato-pancreato-biliary surgery or liver transplantation.
1.7.5 Thoracic surgery
The role of cardiopulmonary exercise testing in patient undergoing non-cardiac
thoracic surgery has been well established for over a decade. In a recent
meta-analysis of 14 studies, Benzo and co-workers reported on 955 patients who
underwent cardiopulmonary exercise tests as part of their preoperative work-up
before lung resection for cancer. V˙O2Max (ml/kg/min), V˙O2Max (% predicted),
maximum exercise load achieved (Watts) and FEV1 (% predicted) were all
significantly higher in patients who recovered with no postoperative complications.
They also found that the mean V˙O2Max in patients who did not develop
complications was approximately 20 ml/kg/min and the mean V˙O2Max in patients
who developed complications was 15 ml/kg/min across all studies. This would
suggest that cardiopulmonary exercise testing can offer clinically useful thresholds
across different populations that can be used to risk stratify patients [Benzo et al.
2007].
The 2nd edition of the American College of Chest Physicians’ Evidence-Based
Clinical Practice Guidelines for the ’Physiologic evaluation of the patient with lung
cancer being considered for resectional surgery’ recommends that patients with a
low V˙O2Max (<10 ml/kg/min) or with low V˙O2Max (<15 ml/kg/min) associated
with other risk factors on spirometry and cardiopulmonary exercise testing should
be counselled about non-operative treatment options and non-standard surgery as
the risk of perioperative death and cardiopulmonary complications was very high.
The 1C grading of this recommendation not only represents the observational
nature of most of the studies it is based on but also that such observational
evidence is sufficiently consistent [Benzo et al. 2007] to make a strong
recommendation [Colice et al. 2007].
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1.8 Systemic inflammation and outcome
The host inflammatory response to cancer, comorbidity and surgical trauma has
been known to influence both short-term and long-term outcomes after major
cancer surgery [McMillan et al. 2001; Read et al. 2004; Roxburgh et al. 2010].
Moreover, postoperative complications have been reported to be associated with
poorer oncologic outcomes and cancer-specific survival in patients undergoing
potentially curative surgery for cancer [McArdle et al. 2005]. The complex
interactions between pro-inflammatory cytokines and anti-inflammatory cytokines
at different phases during the perioperative period further impact upon the
incidence of complications as well as survival.
1.8.1 Measuring systemic inflammation
Numerous tests are available to not only measure systemic inflammation in general
but also to quantify the various components of the inflammatory response. The
most commonly employed measures in the clinical setting are the serum levels of
C-reactive protein (CRP)and the differential leucocyte count.
One of the earliest reports on the use of CRP to predict cancer-specific survival
was by McMillan and co-workers in 1995 when they reported that an elevated CRP
4 months after curative resection for colorectal cancer was associated with earlier
recurrence [McMillan et al. 1995]. The modified Glasgow Prognostic Score (mGPS)
[Elahi et al. 2004] is based on a combination of C-reactive protein and serum
albumin and is outlined in Table 1.7. Since its introduction, mGPS has been
validated in over a hundred studies looking at several thousand patients with a
wide-range of cancers and an increasing score is associated with poorer long-term
survival in patients with operable as well as inoperable cancers.
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Table 1.7: The modified Glasgow Prognostic Score
mGPS CRP (mg/l) Albumin (g/l)
0 ≤ 10 ≥ 35
1 > 10 ≥ 35
2 > 10 < 35
1.8.2 Inflammation and long-term survival
Elevated preoperative systemic inflammation is associated with poorer survival in
patients undergoing potentially curative surgery for pancreatic cancer [Jamieson
et al. 2005; Clark et al. 2007; Bhatti et al. 2010] as well as in patients with
advanced pancreatic cancer [Glen et al. 2006]. Patients with pancreatic ductal
adenocarcinoma undergoing potentially curative resection survived for a median of
21.5 months if their CRP was ≤ 10 mg/dl a month after their surgery but only 8.4
months if their CRP remained persistently elevated over 10 mg/dl approximately a
month after their operation [Jamieson et al. 2005].
Similar findings have been reported in cancers involving other organs using both
the modified Glasgow Prognostic Score and other scores such as the
neutrophil-lymphocyte ratio (NLR). The modified Glasgow Prognostic Score was
associated with survival independent of tumour stage in patients with colorectal
[McMillan et al. 2007; Leitch et al. 2007], breast [Al Murri et al. 2006; Al Murri
et al. 2007], lung [Forrest et al. 2004], oesophago-gastric [Crumley et al. 2006],
bladder [Hilmy et al. 2006] and prostate [McArdle et al. 2006] cancer.
1.8.3 Inflammation and postoperative complications
Abnormalities of systemic inflammatory processes present as a continuum that
starts in the preoperative phase possibly as a consequence of underlying comorbid
illnesses, presence of cancer, an abnormality of the immune system or due to a
combination of all of these factors. Surgical trauma in such ’primed’ patients
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results in a cascade of events that trigger several inflammatory pathways that have
now shown to have a direct impact not only on the incidence of postoperative
complications but also on cancer recurrence and long-term survival.
1.8.3.1 Preoperative systemic inflammation
Elevated levels of interleukin-6, α-1 antitrypsin and CRP and decreased levels of
albumin and prealbumin before surgery have been reported to be associated with a
more exaggerated postoperative systemic inflammatory response and infectious
complications after major abdominal surgery [Haupt et al. 1997].
Preoperative systemic inflammation has been reported to be associated with
infectious complications in patients undergoing potentially curative surgery for
colorectal cancer [Moyes et al. 2009]. In a study of 455 patients, Moyes and
co-workers reported that an elevated preoperative modified Glasgow Prognostic
Score (1.7) was associated with increased incidence of infectious complications in
patients undergoing elective as well emergency colorectal cancer surgery. They
postulated that several mechanisms may play a role including dysregulation of
cell-mediated immunity, impaired T-lymphocyte response, disorders in the
complement pathway and possibly due to loss of lean tissue and protein as a
consequence of systemic inflammation. Preoperative mGPS was also associated
with increased incidence of postoperative complications in patients undergoing
oesophageal resection for cancer [Vashist et al. 2010].
1.8.3.2 Postoperative systemic inflammation
An exaggerated and persistent systemic inflammatory response in the early
postoperative period is associated with an increased incidence of complications.
One of the earliest studies comparing several ’acute-phase proteins’ and their role
in predicting postoperative complications reported that in patients who developed
surgical inflammatory complications, CRP remained significantly elevated after the
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third postoperative day [Fischer et al. 1976]. But, other acute-phase proteins such
as ceruloplasmin and α-1 antitrypsin where not useful in monitoring the
postoperative course.
Further studies have established the value of monitoring trends in serum CRP
levels in predicting complications after both elective and emergency surgery
[Mustard et al. 1987].
In a study of 383 patients undergoing elective rectal cancer surgery with primary
anastomosis, Welsch and co-workers reported that persistently raised CRP level
over 140 mg/L after the third/fourth postoperative day was associated with
anastomotic leak [Welsch et al. 2007]. They also reported in a separate study of
688 patients undergoing pancreatic resection with pancreatico-jejunostomy for
neoplastic disease or chronic pancreatitis, that persistently elevated CRP greater
than 140 mg/L on the fourth postoperative day was associated with increased
incidence of complications.
Similar findings have been reported after elective colorectal surgery
[Ortega-Deballon et al. 2010; Woeste et al. 2010], oesophago-gastric surgery [Dutta
et al. 2011], spinal surgery [Meyer et al. 1995; Mok et al. 2008], neurosurgery
[Al-Jabi et al. 2010], simultaneous pancreas-kidney transplantation [Wullstein
et al. 2004], stem-cell transplantation [McNeer et al. 2010] and paediatric
surgery[Laporta Baez et al. 2011].
While CRP level between the third and fifth postoperative day has been reported
to be most predictive of complications, the clinical signs do not become apparent
until later in the postoperative course, often after the fifth day. This has led some
authors to postulate that elevated CRP may in fact be due to an abnormally
modulated postoperative inflammatory response resulting in an initial exaggerated
systemic inflammatory response syndrome (SIRS) followed by a compensatory
anti-inflammatory response syndrome (CARS).
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1.8.3.3 Compensatory anti-inflammatory response
The compensatory anti-inflammatory response syndrome (CARS) is characterised
by several features including reduction in lymphocyte numbers by apoptosis,
decreased responsiveness of monocytes to cytokines, reduced number of human
leukocyte antigen presenting receptors on monocytes, expression of cytokines that
suppress Tumour Necrosis Factor (TNF) and clonal anergy.
In their seminal work on the role of SIRS and CARS in the pathogenesis of sepsis
and organ dysfunction, Bone and co-workers described a state of ‘immunologic
dissonance’ where a ‘pre-primed’ immune system may result in an inappropriate,
out-of-balance massive pro-inflammatory response which is followed by a
proportionately large compensatory anti-inflammatory response that leaves the
patient immunosuppressed and prone to further organ dysfunction, infections and
death [Bone et al. 1997; Bone 1996]. It is very likely that similar mechanisms are
involved in surgical patients except that the initial stressor in this case is surgical
trauma rather than a bacterial infection as in sepsis.
This form of ‘immunoparalysis’ was first described in patients after major trauma
with tissue damage [Abraham et al. 1985; Bandyopadhyay et al. 2007] or after
haemorrhage on its own without associated tissue trauma [Stephan et al. 1987]. In
a detailed review of the mechanisms underlying the compensatory
anti-inflammatory response syndrome, Ward and co-workers describe SIRS and
CARS to be mirror images suggesting that a disproportionately high SIRS is
followed by a period of immunosuppression that leaves the patient prone to further
complications [Ward et al. 2008].
Patients who developed infectious complications after major cancer surgery had
higher levels of interleukin-10 (IL-10), an anti-inflammatory cytokine and marker
of the compensatory anti-inflammatory process [Mokart et al. 2002]. Major surgery
and the associated surgical trauma is associated with elevated levels of IL-10 which
in turn is associated with increase in lymphocyte apoptosis [Delogu et al. 2001],
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reduced monocyte expression of HLA-DR antigens [Klava et al. 1997] and a blunted
response to endotoxins [Ogata et al. 2000; Kawasaki et al. 2001]. , all considered to
be key features of a compensatory anti-inflammatory response syndrome.
Yamaguchi and co-workers compared the levels of pro- and anti-inflammatory
cytokines in patients undergoing cholecystectomy versus patients undergoing
trans-thoracic oesophagectomy. They reported that the initial inflammatory phase
was followed by an immunosuppressive phase that started around the seventh
postoperative day in patients undergoing oesophagectomy. However, patient who
underwent an open cholecystectomy did not experience this immunosuppressive
phase, leading them to postulate that the degree of immunosuppression was
directly proportional to the initial pro-inflammatory process. This in turn was
related to the greater degree of surgical stress and tissue trauma that occurs with a
trans-thoracic oesophagectomy. They also reported that in a randomised cohort
that received an infusion of lymphokine-activated natural killer cells immediately
after oesophagectomy, there was a trend towards fewer infectious complications
[Yamaguchi et al. 2006].
1.8.4 Postoperative complications and long-term survival
There has been increasing evidence that postoperative complications not only have
an impact on the short-term outcomes but also on long-term survival after major
cancer surgery. A recent meta-analysis of 21 studies including 21,902 patients
found that anastomotic leakage was associated with earlier local recurrence after
rectal cancer surgery, a trend towards early local recurrence in other colonic cancer
surgery and a significant reduction in overall survival [Mirnezami et al. 2011]. The
reviewers suggested that several mechanisms may be involved in early recurrence
including local spillage of cancer cells from within the bowel lumen. However, the
role of the local inflammatory processes that occur as a consequence of
anastomotic leakage may play a more important role. This inflammatory process
with the attendant milieu of pro-inflammatory cytokines and angiogenic factors
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may provide a fertile ground for tumour seeding and proliferation.
McArdle and co-workers reported in their study of 2235 patients undergoing
colorectal cancer surgery that anastomotic leakage was associated with early local
recurrence and reduced survival. They suggested that the ’double-hit’ of surgery
followed by anastomotic leak may result in an inflammatory response that is
greater and more protracted and that this may explain the poorer cancer outcomes
in these patients [McArdle et al. 2005].
In a study of 207 patients undergoing surgery for Duke’s B colorectal cancer,
Katoh and co-workers reported that anastomotic leakage and persistently elevated
CRP two weeks after surgery were independent risk factors for systemic
recurrence, further emphasising the important role of inflammation in cancer
recurrence as a consequence of complications [Katoh et al. 2011]. Wound infections
and intra-abdominal infections have also been associated with poorer survival in
colorectal cancer patients [Nespoli et al. 2006]. Similar findings have been reported
after curative surgery for advanced gastric cancer with patients who develop an
anastomotic leak surviving for 30.5 months while patients who did not have a leak
survived for a median of 96.2 months (p<0.001) [Yoo et al. 2011].
Patients who develop severe postoperative complications after
pancreaticoduodenectomy for cancer had significantly shortened survival in a study
involving 428 patients (16.5 vs. 12.4 months, p=0.002) and this was independent
of other recognised risk factors such as tumour grade and lymph node status
[Kamphues et al. 2012]. Similar finding were reported by Raut and co-workers in
their study of 360 patients who underwent pancreaticoduodenectomy for
pancreatic ductal adenocarcinoma [Raut et al. 2007]. and by Kang and co-workers
in their report on 103 patients undergoing R0 resections for cancer of the
pancreatic head [Kang et al. 2009].
These reports in conjunction with the studies on preoperative inflammation, sepsis,
SIRS and CARS emphasise the important role of perioperative systemic
inflammation as a causative factor in postoperative complications and the impact
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of the ’second-hit’ of postoperative complications on long-term survival after
curative cancer surgery.
1.9 The jaundiced patient
Obstructive jaundice is the most common presenting symptom in patients with
pancreatic cancer involving the head of the pancreas and the periampullary region
due to the anatomical location of the distal bile duct. Obstructive jaundice is
known to have a wide range of effects on multiple organ systems including the
cardiovascular system, immune system, coagulation cascade, as well as hepatic
function.
Until recently, major surgery in jaundiced patients has been considered to be more
prone to adverse postoperative events. While this concept has been recently
challenged, surgeons remain wary of operating on the severely jaundiced patient.
In fact, pancreaticoduodenectomy was initially described by Whipple as a
two-stage procedure where the first stage involved a biliary bypass aimed at
relieving obstructive jaundice before the second stage of resection was carried out
[Whipple et al. 1935].
1.9.1 Impact of jaundice on cardiovascular physiology
The detrimental effects of jaundice on the heart and the circulatory system has
been recognised for over 150 years now. King and co-workers reported that the
intravenous injection of bile caused bradycardia, hypotension and eventually death
in dogs [King et al. 1909]. The concept of a ’jaundiced heart’ was fist put forth by
Green and co-workers in 1986 [Green et al. 1986]. They performed
choledocho-caval anastomoses in 5 dogs and studied cardiac function before and 2
weeks after this procedure. They reported that ’cholemia’ was associated with
impaired left ventricular function and blunted response to sympathomimetic
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agents. Similar findings have been reported by other authors in animal studies
[Binah et al. 1985; Bomzon et al. 1986].
The role of atrial natriuretic peptide (ANP) has also been investigated.
Obstructive jaundice was associated with increased levels of ANP as a result of
increased cardiac endocrine activity in bile duct ligated rabbits [Pereira et al.
1994]. Similar findings have been reported in humans as well [Gallardo et al. 1998;
Mart´ınez-Ro´denas et al. 1998].
Moreover, relief of obstructive jaundice is associated with improvement in
endocrine markers of fluid homeostasis as well as cardiac function [Padillo et al.
2001b; Gallardo et al. 1998]. Padillo and co-workers reported that there was a
negative correlation between serum bilirubin levels and left ventricular systolic
work and this was associated with elevated ANP and BNP (brain natriuretic
peptide) levels. However, both ANP and BNP levels decreased after biliary
drainage and there was a significant improvement in cardiac output, cardiac index,
systolic volume and left ventricular systolic work [Padillo et al. 2001b].
More recently, TNFα levels have been reported to mediate cardiac dysfunction in
animal studies and treatment with an anti-TNFα agent restored myocardial
contractility [Yang et al. 2010]. Obstructive jaundice was also associated with
systemic hypotension and there is increasing evidence that some of this may be
mediated by bile acid receptors on the vascular tree [Green et al. 1995; Lefebvre
et al. 2009]. Bile acids can cause vasodilation by decreasing arterial tone and this
may partly explain some of the haemodynamic adverse events that occur after
surgery in jaundiced patients.
1.9.2 Impact of jaundice on renal function
Several studies have reported that obstructive jaundice is associated with
significant abnormalities in fluid homeostasis. Obstructive jaundice is associated
with reduction in the interstitial volume as well as the circulating plasma volume
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[Sitges-Serra et al. 1992; Padillo et al. 1999]. In a study of 63 patients with
obstructive jaundice, Padillo and co-workers reported that severity of jaundice, age
of patient and reduced urinary sodium excretion were independently related to
postoperative renal dysfunction. They also reported that these variables were
related to abnormalities in the levels of hormones responsible for sodium and water
homeostasis including atrial natriuretic peptide [Padillo et al. 2005a]. Endotoxemia
consequent to lack of bile salts in the gut has also been postulated as a possible
mechanism for renal dysfunction in patients with severe jaundice [Bailey 1976].
Jaundice is one of the leading causes of acute renal failure in tertiary-care hospitals
[Liano et al. 1996].
While expansion of the intravascular volume and avoiding dehydration by the
judicious use of intravenous fluids has been recommended in avoiding renal
dysfunction in jaundiced patients [Parks et al. 1994], others have reported that
relief of obstructive jaundice by restoring bile flow improves renal function
independent of fluid therapy [Padillo et al. 2005b]. Perioperative fluid
management, avoidance of hypotension and sepsis control is important in the
prevention of renal failure in jaundiced patients.
1.9.3 Impact of jaundice on the immune system
Obstructive jaundice is associated with a wide range of deleterious effects on the
immune system. The absence of bile in the gut increases the proliferation of gram
negative bacteria. The absence of bile in the gut of bile duct ligated mice was
associated with intestinal bacterial overgrowth and bacterial translocation [Deitch
et al. 1990].
This in association with increased bacterial translocation, increased gut mucosal
permeability and reduced endotoxin elimination by Kuppfer cells within the liver
can predispose the jaundiced patient to septic complications [Nehe´z et al. 2002].
Intestinal permeability is normalised within a few weeks of restoring biliary
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drainage.
Increased serum bilirubin and bile salts directly affect lymphocyte function as well
as the response to pro-inflammatory cytokines [Scott-Conner et al. 1994]. Bile salts
in higher than normal concentrations also induce apoptosis in hepatocytes. Biliary
obstruction is also associated with significant alterations in hepatic macro and
micro-circulation. This in turn can affect the phagocyte clearing function of the
liver. Obstructive jaundice is also associated with abnormal cytokine homeostasis
predisposing the patient to impaired wound healing, sepsis and increased risk of
peri-operative mortality. For instance, concentrations of TNF-α and IL-6 are
significantly elevated in jaundiced patients while the concentrations of IL-1 and
IL-2 are decreased [Padillo et al. 2001a].
However, unlike in animal models, relief of obstructive jaundice by endoscopic
biliary drainage is not associated with an improvement in immune function. On
the contrary, it results in colonisation of the biliary tree by gut bacteria in nearly
all instances of biliary stenting [Kimmings et al. 2000].
1.9.4 Role of preoperative biliary drainage
The increased incidence of adverse events after surgery in patients with obstructive
jaundice resulted in routine preoperative biliary drainage becoming the standard
practice in patients undergoing major pancreatic surgery. Moreover, while
significant improvements in perioperative care has resulted in reduction in
postoperative mortality, morbidity rates have remained high. Obstructive jaundice
has provided a potential target for preoperative optimisation in an attempt to
improve postoperative outcomes.
Early observational studies of small cohorts of patients challenged this paradigm
reporting that surgery in jaundiced patients was not associated with greater risk
and in fact preoperative biliary drainage increased hospitalisation costs [Snellen
et al. 1985; Bakkevold et al. 1993a; Pitt et al. 1985]. Hatfield and co-workers
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reported in one of the earliest randomised controlled trial comparing
pancreaticoduodenectomy with or without preoperative biliary drainage in 57
patients that there was no difference in postoperative complications or mortality
but increased biliary drainage associated complications [Hatfield et al. 1982].
Similar findings have been reported by other authors as well [Lai et al. 1994; Lai
et al. 1994; Jagannath et al. 2005]. However, some authors have recommended that
expandable metal stents were associated with fewer stent related complications
than plastic stents and may be considered in jaundiced patients where surgery is
delayed for other reasons [Wasan et al. 2005; Mullen et al. 2005].
A recent randomised controlled trial of 202 patients reported that there was no
significant difference in post-operative morbidity (47% vs 37%, p=0.14), mortality
or length of stay between the group that underwent preoperative biliary drainage
and the group that underwent early surgery [Gaag et al. 2010]. There was a high
incidence of procedure related complications in the drainage group (46%). The
high incidence of procedure related complications, the use of plastic stents, the 25%
failure to drain at first attempt and exclusion of patients with serum bilirubin >
250 µmol/L were significant limitations of the study. However, the study does show
that early surgery in the jaundiced patient with serum bilirubin < 250 µmol/L is
safe and not associated with increased morbidity or mortality as was once feared.
Mezhir and co-workers also reported a high (23%) stent related complication rate
in their retrospective study of 340 patients where 96% of 201 patients in the biliary
drainage group had plastic stents placed. However, they also reported a greater
incidence of wound infections (7% vs 20%, p=0.01) and intra-abdominal abscesses
(3% vs 12%, p=0.03) in patients who underwent biliary drainage [Mezhir et al.
2009].
The paucity of good quality evidence on the role of preoperative biliary drainage
before pancreatic resection [Wang et al. 2008] and the limitations in our
understanding of the complex pathophysiological effects of jaundice on multiple
organ systems has resulted in persistent wide variation in the perioperative
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management of jaundiced patients across different centres.
The historical indication was biliary drainage was to minimise the haemodynamic
and renal adverse effects of obstructive jaundice. The above mentioned studies
show that surgery in the jaundiced patient is safe and feasible. However, the effect
of obstructive jaundice on cardiopulmonary exercise testing in patients with
pancreatic disease has not been reported previously. Chapter 3 is an investigation
into the relationship between obstructive jaundice and preoperative
cardiopulmonary exercise testing.
1.10 Body composition, obesity and outcomes
1.10.1 Body mass index
The Body Mass Index (BMI) is a measure of a person’s weight relative to their
height and corresponds well with their body composition, especially with the
proportion that is body fat. It is the most widely accepted measure of body
composition, especially of body fat in spite of criticisms that it may not apply to
all populations.
BMI was first devised by Adolphe Quetelet and was formerly known as the
Quetelet index [Eknoyan 2008]. Quetelet was a Belgian sociologist and
mathematician who played a major role in the application of statistical methods to
the social sciences. In his attempts to describe the characteristics of ’normal man’,
Quetelet found that weight increased nearly as the square of the height except at
times of growth spurts in the new born and during puberty [Quetelet et al. 1842].
The calculation of body mass index is simple and as follows:
Body Mass Index =
Weight in Kilograms
(Height in Metres)2
(1.7)
Chapter 1. Introduction 52
The World Health Organisation uses thresholds to categorise adult populations
based on body mass index. These thresholds are independent of age, gender and
race. However, there has been increasing criticism of these thresholds and the
World Health Organisation is undertaking a further review to assess the validity of
these thresholds in different populations. For instance, there is increasing evidence
in Asians, the risk of diabetes and cardiovascular disease is greater at BMI levels
lower than the current WHO cut-off for being overweight. Nonetheless, the
thresholds shown in Table 1.8 are currently in universal use and have been used in
this thesis.
Table 1.8: The WHO classification of Body Mass Index
BMI Category
Below 18.5 Underweight
18.5 – 24.9 Normal range
25.0 – 29.9 Overweight or Pre-obesity
30.0 - 34.9 Obesity class 1
35.0 - 39.9 Obesity class 2
Above 40 Obesity class 3
Obesity is an increasing problem in all developed nations with the proportion of
obese patients undergoing surgery increasing every year. Among the European
Member States, the proportion of adults considered overweight or obese varied in
2008 between 37.0% and 56.7% for women and 51.0% and 69.3% for men. The
United Kingdom had the highest proportion of obese women (23.9%) and the
second highest proportion of obese men (22.1%). A greater proportion of men than
women were obese and there was a marked increase in BMI with increasing age.
There was also an inverse relationship between education level and incidence of
obesity [WHO 2000].
Obesity, especially morbid obesity, is associated with a wide range of secondary
disease states such as ischaemic heart disease, diabetes mellitus, hypertension and
increased incidence of cancers.
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Obesity presents unique problems in surgical patients for several reasons. Surgery
and anaesthesia in the morbidly obese patients can be technically challenging. The
comorbidities associated with morbid obesity require evaluation and management
in the perioperative period. Postoperative physiotherapy and mobilisation require
particular attention in the morbidly obese patients.
1.10.2 Obesity and postoperative complications
The impact of obesity on the rate of postoperative complications remains
controversial. It has been a commonly held belief that obese patients had greater
incidence of complications. Some of the adverse outcomes such as wound
complications and respiratory dysfunction where considered to be the direct result
of the increased body mass index while other complications where related to the
associated comorbidities such as cardiovascular disease, obstructive sleep apnoea or
diabetes mellitus.
Several studies have reported increased incidence of postoperative complications in
obese patients after cardiac, transplant, urologic and gynaecological surgery [Prem
et al. 1965; Holley et al. 1990; Fasol et al. 1992; Gruberg et al. 2002; Lee et al.
2004]. Visceral obesity rather than body mass index has been reported to be
associated with greater incidence of wound complications, overall complication rate
and prolonged hospital stay in patients undergoing laparascopic sigmoid colectomy
for cancer [Tsujinaka et al. 2008].
However, in a prospective, multi-institutional, risk-adjusted cohort study of 2258
patients including 699 patients who underwent pancreatectomy for cancer, Mullen
and co-workers reported that obesity on its own was not a predictor of major
postoperative complications or mortality. However, obesity was an independent
predictor of minor complications including wound infections. However, they noted
that underweight patients had a five-fold increased risk of postoperative mortality
[Mullen et al. 2008].
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Dindo and co-workers studied the impact of obesity on postoperative outcomes in
a prospective study of 6336 patients undergoing elective general surgery. They
reported that obesity was not an independent risk factor for morbidity or
mortality. There was no difference in the median operating time, blood
transfusions or length of hospital stay between obese and non-obese patients. The
type and severity of complications were similar between obese and non-obese
patients [Dindo et al. 2003]. In a more recent prospective, multi-institutional,
risk-adjusted cohort study of 118,707 patients undergoing non-bariatric general
surgery, Mullen and co-workers reported that the risk of mortality was lowest in
the overweight (BMI 25 - 30) and moderately obese (BMI 30 - 35) patients and
highest in the underweight and morbidly obese patients. This appears to confirm
the existence of an ’obesity paradox’ in surgical patients [Mullen et al. 2009].
In a study of 356 consecutive patients undergoing pancreaticoduodenectomy at the
Memorial Sloan-Kettering Cancer Center between 2000 and 2005, House and
co-workers used preoperative cross-sectional imaging of the abdomen (computer
tomography and/or magnetic resonance imaging) to measure a variety of indices of
body composition including abdominal wall fat thickness, hip girdle fat thickness,
retro-renal visceral fat and pancreatic duct diameter [House et al. 2008]. The
incidence of wound infection was greater in obese patients with the risk increasing
linearly with BMI. But, BMI was not associated with any other complications.
They also reported that the thickness of retro-renal fat, a surrogate for visceral
adipose tissue, was a significant risk factor for pancreatic fistula as well as wound
infection. However, there was no correlation between complications and abdominal
wall thickness or hip girdle fat.
The importance of visceral fat in the incidence and severity of postoperative
complications is further emphasised by the finding that excess visceral fat is
associated with the the occurrence of pancreatic fistula after radical total
gastrectomy for gastric cancer. Benns and co-workers reported greater blood loss
and increased incidence and severity of postoperative complications in obese
patients undergoing surgery compared to non-obese patients. However, there was
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no difference in operative time or length of stay in hospital [Benns et al. 2009].
On the contrary, other authors have reported that obesity is not associated with
increased complications after pancreatic surgery. Khan and co-workers reported
that while obesity was associated with increased incidence of intra-operative
bleeding, there was no increase in complications [Khan et al. 2010]. Length of stay
in hospital, overall morbidity and in-hospital mortality were not affected by BMI
after pancreaticoduodenectomy [Tsai et al. 2010] while neither BMI nor
intra-abdominal visceral fat affected postoperative outcomes in another study of
patients undergoing pancreaticoduodenectomy [Balentine et al. 2011].
In a recent meta-analysis of 17 studies, including some of those discussed above,
Ramsey and co-workers reported that BMI was not associated with length of
hospital stay, in-hospital mortality or survival after pancreaticoduodenectomy for
cancer. Obesity was associated with postoperative pancreatic fistula. However, the
authors concluded that with aggressive perioperative care, postoperative morbidity
in obese patients could be mitigated. They also noted several limitations to
making meaningful comparisons between studies due to the lack of clear definitions
for complications after pancreaticoduodenectomy [Ramsey et al. 2011].
1.10.3 Obesity and cancer survival
The effect of obesity and adipose tissue content on cancer-specific survival in
patients with pancreatic cancer is not entirely clear. In a study involving 586
patients who underwent pancreaticoduodenectomy for pancreatic adenocarcinoma,
Khan and co-workers reported that obesity was not associated with overall or
disease-free survival [Khan et al. 2010]. These are similar to the findings reported
by Benns and co-workers who found no difference in overall survival in 306 patients
undergoing resections for pancreatic adenocarcinoma [Benns et al. 2009]. Obesity
during early adulthood is associated with increased risk of pancreatic cancer while
obesity at an older age is associated with reduced overall survival in both resected
Chapter 1. Introduction 56
and unresected patients [Li et al. 2009]. Morbidly obese patients (BMI > 35) were
found to be at 12-fold increased risk of lymph node metastases and associated
decreased survival [Fleming et al. 2009].
Tsai and co-workers reported that while obese patients had similar tumour
characteristics to non-obese patients and comparable perioperative outcomes,
long-term survival was better in obese subjects [Tsai et al. 2010]. This study of
795 patients undergoing potentially curative surgery for pancreatic
adenocarcinoma at the Johns Hopkins Medical Institutions in the United States is
in contrast to other similar studies. The role of obesity on long-term survival after
pancreaticoduodenectomy for pancreatic cancer is less clear with more recent
studies suggesting that there was no link between body mass index and survival
[Dandona et al. 2011; Benns et al. 2009].
While sarcopenia or loss of skeletal muscle mass is associated with poor outcome in
patients with pancreatic cancer, the association between adipose tissue (especially,
visceral fat) and long-term outcomes is less clear. Sarcopenic-obesity where
concurrent sarcopenia and high fat mass are present is associated with significantly
worse survival when compared to sarcopenia or high adiposity on their own [Tan
et al. 2009]. It is clear that body mass index on its own is a poor predictor of
outcome and body composition changes over time play a more important role in
determining cancer survival. While obesity appears to have a protective role in a
wide range of chronic disease states [Kalantar-Zadeh et al. 2007; Amundson et al.
2010; Myers et al. 2011], sarcopenic-obesity has a negative impact on survival [Tan
et al. 2009].
1.10.4 Measuring body composition
While it is possible to estimate the amount of most tissue types, the ones that are
of clinical interest and are related to surgical and cancer outcomes are adipose
tissue and skeletal muscle. Numerous methods have been described for estimation
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of both absolute and proportional amount of these tissues with varying degrees of
complexity and accuracy. Some of the simpler methods include measurement of
subcutaneous fat using calipers or bioelectrical impedance, estimation of skeletal
muscle from mid-arm circumference or creatinine height ratio. Such methods are
valuable to public health and epidemiological studies of malnutrition.
The gold-standard method for assessment of body composition is Dual Energy
X-ray Absorptiometry (DEXA) [Haarbo et al. 1991]. While primarily designed for
assessment of bone mineral density, DEXA scans have been adapted to measure
fat, muscle and water content of subjects accurately and are used widely both in
research and clinical settings. Other techniques such as whole body water or air
displacement plethysmography are relatively cumbersome for routine clinical use.
More recently, cross-sectional imaging including computed tomography (CT) and
magnetic resonance imaging (MRI) have become widely available. Nearly all
patients with gastrointestinal cancer undergo either CT or MRI or both before
commencing treatment. Accurate measurements of subcutaneous adipose tissue,
visceral adipose tissue and skeletal muscle can be made relatively easy either from
the entire series of images or estimates can be made from measurements made at
certain predetermined anatomical levels. Both specialised software or readily
available generic image analysis tools have been used to make these measurements.
The proportion of the total cross-sectional area that is made of adipose tissue or
skeletal muscle at the level of the 3rd or the 4th lumbar vertebra is commonly used
as a surrogate for total body measurements. Thickness of retro-renal visceral fat at
the level of the renal vein has also been reported to be usable as a surrogate for
total visceral adiposity. Studies have also reported on the association between
intra-pancreatic fat content and postoperative complications.
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1.11 Aims of the thesis
The overall aim of the thesis was to examine the inter-relationships between
preoperative clinico-pathological characteristics including cardiopulmonary exercise
physiology, obstructive jaundice, body composition and preoperative systemic
inflammation and post-operative complications and the post-surgical systemic
inflammatory response in patients undergoing pancreaticoduodenectomy.
More specifically the aims of the thesis were:
To evaluate the clinical utility of preoperative cardiopulmonary exercise testing in
predicting postoperative adverse events after pancreaticoduodenectomy.
To examine the patient factors that are related to cardiopulmonary exercise
physiology with particular attention to the effect of obstructive jaundice and body
composition on aerobic capacity in patients undergoing pancreaticoduodenectomy.
To examine the value of serial daily postoperative markers of systemic
inflammatory response like white cell count, albumin and C-reactive protein
concentrations in the prediction of post-operative complications after
pancreaticoduodenectomy.
To examine the effect of preoperative systemic inflammation and poor aerobic
capacity on the magnitude of the post-operative systemic inflammatory response
after pancreaticoduodenectomy.
Chapter 2
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2.1 Introduction
Pancreatic cancer is the tenth most common cancer in the UK but the fifth most
common cause of cancer death with only 21% surviving beyond the first year and
3% surviving beyond 5 years [CancerResearchUK 2011]. The majority of patients
(80-85%) with pancreatic cancer present with inoperable disease
[CancerResearchUK 2011; Sener et al. 1999]. In patients with resectable disease,
surgery [Sener et al. 1999; Sohn et al. 2000; Geer et al. 1993] followed by adjuvant
chemotherapy in selected patients [Neoptolemos et al. 2004; Neoptolemos et al.
2009] remains the primary modality of cure.
The decision to operate on these patients depends not only on preoperative tumour
stage but also on patient factors [Bilimoria et al. 2007; Sandroussi et al. 2010].
Patient factors, in particular those that affect fitness, are also important in
determining short term outcome in those that do undergo potentially curative
surgery [Mann et al. 2010; Mayo et al. 2012]. However, major pancreatic surgery is
associated with significant morbidity and mortality and patients who have
postoperative complications are less likely to get adjuvant therapy [Teh et al. 2009].
There have been a number of attempts to objectively define patient fitness and its
relationship with postoperative outcome. Copeland and co-workers (1991) reported
that the Physiological and Operative Severity Score for the enumeration of
Mortality and Morbidity (POSSUM) criteria, in particular the POSSUM
physiology score (PPS) could be used to quantify the risk of postoperative
morbidity and mortality [Copeland et al. 1991]. However, the role of POSSUM in
predicting postoperative outcome after surgery for pancreatic cancer is not entirely
clear [Castro et al. 2009; Khan et al. 2003; Kocher et al. 2005; Pratt et al. 2008b;
Tamijmarane et al. 2008]. The physiological component of POSSUM as well as
other similar risk scoring systems such as E-PASS (Estimation of Physiologic
Ability and Surgical Stress)[Haga et al. 1999] are calculated based on known
comorbidities, clinically evident abnormalities in patient physiology or blood tests.
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More recently, there has been some evidence that the presence of an ongoing
systemic inflammatory response before surgery is associated with the development
of postoperative complications in patients undergoing surgery for colorectal cancer
[Moyes et al. 2009], oesophageal cancer [Vashist et al. 2010] as well as pancreatic
cancer [Knight et al. 2010].
Older and co-workers (1993) reported that cardiopulmonary exercise testing
(CPET) was an objective evaluation of the response of the cardiovascular and
respiratory systems to an increase in oxygen demand during exercise and was
useful in predicting perioperative morbidity and mortality in patients undergoing
major abdominal surgery [Older et al. 1993].
2.1.1 Aim
The aim of the present study was to evaluate the role of various measures of
patient physiological fitness including cardiopulmonary exercise testing in
predicting postoperative length of stay, major postoperative adverse events
including operative mortality and fitness to undergo adjuvant therapy when
indicated after pancreaticoduodenectomy.
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2.2 Patients and Methods
2.2.1 Patients
Patients who underwent pancreaticoduodenectomy or total pancreatectomy for
pancreatic head lesions between August 2008, when cardiopulmonary exercise
testing was first used for fitness assessment at our hospital, and January 2012 were
considered for this retrospective study. Patients who had not undergone
cardiopulmonary exercise testing as part of their preoperative assessment and
patients who underwent cardiopulmonary exercise testing but did not undergo
surgery were excluded.
2.2.2 Preoperative data
Data on patient demographics, comorbidity including cardiovascular and
respiratory disease, preoperative blood tests, chest x-ray and cardiopulmonary
exercise tests were collected from prospectively maintained databases (march 2009
- January 2012) and case note review (August 2008 - March 2009). Data was also
collected for patients who did not undergo cardiopulmonary exercise testing to
allow comparison with the study group. The POSSUM Physiology Score was
calculated based on 11 physiological parameters (cardiac disease including
hypertension, ischaemic heart disease and heart failure, respiratory disease causing
breathlessness on exertion and COPD, ECG changes, pulse rate, blood pressure,
haemoglobin, white cell count, serum sodium, serum potassium, serum urea and
Glasgow Coma Scale) as described previously.
2.2.3 Cardiopulmonary exercise test
Cardiopulmonary exercise tests were performed in the Department of Respiratory
Medicine at the Glasgow Royal Infirmary using the ZAN-600 CPET suite (nSpire
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Health, Longmont, CO 80501, USA). An electrically-braked cycle ergometer was
used to perform a symptom-limited, incremental work-load test preceded by a
3-minute rest period. The test was stopped at maximum exercise tolerance,
significant ischaemic changes on ECG or for other safety reasons. The V˙O2AT was
calculated using the V-slope [Beaver et al. 1986; Sue et al. 1988] and ventilatory
equivalents [Sue et al. 1988] methods. Low V˙O2AT was defined as oxygen
consumption less than 10 ml/kg/min based on work by Snowden and co-workers
[Snowden et al. 2010] who reported that V˙O2AT less than 10.1 ml/kg/min was
associated with an increase in postoperative complications after major abdominal
surgery. A detailed description of the cardiopulmonary exercise testing
methodology and calculation of V˙O2AT is in Sections 1.5.2 and 1.5.3.
2.2.4 Perioperative care
The decision to operate was based on overall preoperative evaluation of the
patient’s comorbid conditions and performance status and not exclusively on the
result of cardiopulmonary exercise testing. Whilst the results of cardiopulmonary
exercise tests were available to the clinicians before surgery, no specific changes
were made to perioperative management based exclusively on these results. These
results were used in conjunction with other established forms of preoperative
evaluation for risk assessment and perioperative care. All patients were routinely
admitted to the surgical high dependency unit unless intra-operative events or
postoperative complications required admission to the intensive care unit. Patients
were discharged after resolution of organ dysfunction and/or sepsis and when
nutrition, analgesia and mobilisation were adequately established to the clinician’s
and patient’s satisfaction.
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2.2.5 Outcome measures
Postoperative adverse events were recorded using internationally recognised
definitions. The International Study Group for Pancreatic Surgery (ISGPS)
definitions were used to classify pancreatic fistulae [Bassi et al. 2005a] and
post-operative haemorrhage [Wente et al. 2007]. The Clavien-Dindo (CD)
classification [Clavien et al. 2009; Dindo et al. 2004] was used to grade other
complications and CD grades III-V were considered major. Multiple admissions to
critical care as well as re-operations were recorded. Operative mortality was
defined as postoperative death in-hospital regardless of duration of stay or
occurring within 30 days of the surgery. All complications were discussed at a
weekly multidisciplinary meeting attended by three pancreatic surgeons and a
radiologist with a specialist interest in pancreatic diseases and recorded in a
prospective database.
Primary outcome measures were length of stay in hospital, major postoperative
adverse events including operative mortality and fitness to undergo adjuvant
therapy when indicated. Secondary outcome measures included cumulative length
of stay in critical care and number of critical care admissions.
2.2.6 Statistics
Grouping of the variables was carried out using standard or previously published
thresholds. In the absence of such thresholds, the variables were treated as
continuous variables and analysed using non-parametric statistical methods. Cox
proportional hazards regression analysis was used to study the relationship
between preoperative risk factors and length of hospital stay. Chi-square test was
used to examine the relationship between complications and V˙O2AT as a
categorical variable. Univariate binary logistic regression analysis with calculation
of hazard ratios (HR) and 95% confidence intervals was used to explore the
association between perioperative clinico-pathological factors and receipt of
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adjuvant therapy. Multivariate binary logistic regression analysis was performed on
all variables showing a significant association on univariate analysis. Backward
stepwise regression was used starting with a saturated model and variables with
P-value> 0.1 were excluded at each step until no more variables could be excluded.
SPSS software (Version 17.0; SPSS Inc., Chicago, IL, USA) was used to perform
statistical analysis.
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2.3 Results
2.3.1 Clinico-pathological characteristics
One hundred and twenty-nine patients had undergone pancreaticoduodenectomy
(n=127), sub-total pancreatectomy (n=1) or total pancreatectomy (n=1) during
the study period. Sub-total and total pancreatectomy were performed in patients
scheduled for a pancreaticoduodenectomy but were found to have pancreatic
remnants either too friable or too atrophic during the operation to perform an
anastomosis. Of these, 100 patients (pancreaticoduodenectomy - 98,
sub-total/total pancreatectomy - 2) had undergone cardiopulmonary exercise
testing as part of their preoperative assessment and were included in the study.
Pathological examination of the resected specimen showed pancreatic ductal
adenocarcinoma (n=37), ampullary adenocarcinoma (n=18), cholangiocarcinoma
(n=17), duodenal adenocarcinoma (n=6), intra-ductal papillary mucinous
neoplasia (n=4), neuroendocrine tumours (n=7), other neoplasia (n=6) or chronic
pancreatitis (n=5).
Twenty-nine patients did not undergo cardiopulmonary exercise testing due to
reasons including subjective assessment of fitness, resource constraints and
logistics. Table 2.1 shows the clinico-pathological characteristics of patients
included in the study compared to the excluded patients. The median age in the
study cohort was higher than in the excluded cohort (66 vs. 54 years, p=0.001).
However, there was no difference in gender, body mass index, preoperative biliary
drainage, jaundice at the time of surgery, modified Glasgow Prognostic Score,
POSSUM physiology score, preoperative blood tests including haemoglobin and
liver function tests and length of critical care/hospital stay. The overall
postoperative mortality during the study period was 5.4% (7/129) with all deaths
occurring in the study cohort (p=0.144).
The median V˙O2AT was 10.3 ml/kg/min (inter-quartile range, IQR 8.8 - 11.6). The
V˙O2AT was less than 10 ml/kg/min in 49 patients. The distribution of V˙O2AT
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Table 2.1: Clinico-pathological characteristics of patients undergoing pancreatic
resections during the study period.
All Patients Excluded Included p
n = 129 n = 29 n = 100
Age (years)
≤ 65 71 (55%) 24 47 0.001
> 65 58 (45%) 5 53
Sex
Male 77 (60%) 17 60 0.894
Female 52 (40%) 12 40
Body mass index (kg/m2)
≤ 25 53 (44%) 8 45 0.817
> 25 66 (56%) 11 55
Preoperative Biliary Drainage
No 68 (59%) 12 56 0.154
Yes 48 (41%) 4 44
modified Glasgow Prognostic Score (mGPS)
0 76 (59%) 13 63 0.279
1 11 (9%) 5 6
2 41 (32.0%) 10 31
Haemoglobin (g/dl)
≥ 12 80 (64%) 18 62 0.353
< 12 45 (36%) 7 38
POSSUM Physiology Score
11-14 61 (51%) 12 50 0.701
> 14 59 (49%) 10 50
Serum Bilirubin (µmol/L)
≤ 35 70 (55%) 12 58 0.156
> 35 58 (45%) 16 42
Operation Type
Pancreatico-duodenectomy 127 (98%) 29 98 0.045
(Sub-)Total Pancreatectomy 2 (2%) 0 2
Operative mortality 7 (5%) 0 7 0.144
Postoperative stay (days) 17 (13-27) 20 (13-30) 17 (13-26) 0.518
Critical care stay (days) 7 (6-12) 7 (6-14) 7 (6-12) 0.448
Values are median (inter-quartile range), p using Mann-Whitney U test or
number of patients (percentage), p using Chi-square test.
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across the study cohort is shown in Figure 2.1.
2.3.2 Anaerobic threshold vs. complications
The relationship between V˙O2AT and major postoperative adverse events including
mortality is shown in Table 2.2. Patients with V˙O2AT less than 10 ml/kg/min had
significantly greater incidence of postoperative pancreatic fistula (35.4% vs.16%,
p=0.028) as well as major intra-abdominal abscesses (Clavien-Dindo Grade III - V,
22.4% vs.7.8%, p=0.042). While there was an association between low V˙O2AT and
grade of pancreatic fistula, this was not statistically significant (p=0.091). There
was no association between low V˙O2AT and cardiopulmonary complications or
postoperative mortality. Major cardiopulmonary complications occurred more
often in patients with major intra-abdominal adverse events including major
intra-abdominal abscesses or Grade B and C pancreatic fistulae or haemorrhage
than in patients who did not have these complications (5/31,16.1% vs. 2/69,2.9%,
p=0.017). Postoperative mortality was not associated with V˙O2AT (HR 0.77, 95%
CI 0.16-3.61, p 0.737) or the POSSUM Physiology Score (HR 0.39, 95% CI
0.07-2.12, p 0.277). Postoperative mortality was associated with postoperative
pancreatic fistula (n=5), post-pancreatectomy haemorrhage (n=3), major
intra-abdominal sepsis (n=6) and major cardiorespiratory complications (n=4)
with 6 patients requiring radiological or operative intervention.
2.3.3 Anaerobic threshold vs. length of stay
The median length of postoperative stay was 17 days (IQR 13 - 26). The median
cumulative length of stay in critical care was 7 days (IQR 6 - 12). Twenty-six
patients were admitted to critical care more than once. The relationship between
preoperative clinico-pathological characteristics and length of postoperative stay in
patients who were discharged from hospital (n=93) is shown in Table 2.3. On
univariate analysis, age over 65 years (p=0.072) and low V˙O2AT (p=0.010) were
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Table 2.2: The relationship between anaerobic threshold and complications in
patients undergoing major pancreatic surgery.
Complications V˙O2AT ≥10 V˙O2AT < 10
n n n p
Cardiac complications
Grade 0 - II 99 51 48 0.308
Grade III - V 1 0 1
Respiratory complications
Grade 0 - II 93 48 45 0.657
Grade III - V 7 3 4
Intra-abdominal abscess
Grade 0 - II 85 47 38 0.042
Grade III - V 15 4 11
Pancreatic Fistula (Total/Sub-total pancreatectomies excluded)
No 73 42 31 0.028
Yes 25 8 17
Pancreatic Fistula (ISGPS Classification)
No 73 42 31 0.091
Grade A 9 3 6
Grade B 8 1 7
Grade C 8 4 4
Post-Pancreatectomy Haemorrhage (ISGPS Classification)
No 84 41 43 0.207
Grade A 4 2 2
Grade B 4 2 2
Grade C 8 6 2
Admissions to critical care
1 74 38 36 0.906
>1 26 13 13
Reoperation
No 89 47 42 0.306
Yes 11 4 7
Operative mortality
No 93 47 46 0.737
Yes 7 4 3
p - Chi-square test
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associated with prolonged postoperative stay. On multivariate Cox proportional
hazards regression analysis, V˙O2AT less than 10 ml/kg/min (hazard ratio 1.74, 95%
confidence intervals 1.14-2.65, p=0.010) was the only significant factor associated
with prolonged postoperative stay. A Kaplan-Meier plot for the probability of
remaining in hospital over time for patients with low or normal V˙O2AT is shown in
Figure 2.2. Patients with a low V˙O2AT stayed a median 6 days longer in hospital
(14 versus 20 days, Mann-Whitney Test p=0.001). There was no significant
association between any of the preoperative factors including V˙O2AT and length of
critical care stay or number of critical care admissions.
2.3.4 Anaerobic threshold vs. receipt of adjuvant therapy
The relationship between clinico-pathological patient factors and receipt of
adjuvant therapy is shown in Table 2.4. Fifty-five patients were included in the
analysis. Patients were excluded if chemotherapy was not indicated (n=28,
ampullary carcinoma=8, neuroendocrine tumours=7, IPMN=4, other neoplasia=5,
chronic pancreatitis=4), in the event of operative mortality (n=7), if chemotherapy
was offered but declined by the patient (n=4), or where they had not been seen by
an oncologist yet (n=6). On binary logistic regression analysis, V˙O2AT less than 10
ml/kg/min was the only preoperative factor that was associated with with
non-receipt of adjuvant therapy (HR 6.30, 95% CI 1.25-31.75, p=0.026).
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Table 2.3: The relationship between clinico-pathological factors and postopera-
tive stay in patients (excluding operative mortality) undergoing major pancreatic
surgery (n=93): Cox regression analysis
Variable n HR 95% CI p HR 95% CI p
Age (years)
≤ 65 44
> 65 49 1.47 0.97-2.24 0.072 1.48 0.97-2.25 0.068
Sex
Male 56
Female 37 1.32 0.86-2.03 0.199
Body mass index (kg/m2)
≤ 25 42
> 25 51 0.87 0.58-1.32 0.512
Smoking
No 56
Yes 37 1.26 0.82-1.94 0.294
POSSUM Physiology Score
≤ 14 45
> 14 48 1.28 0.85-1.95 0.24
Preoperative Biliary Drainage
No 53
Yes 40 1.08 0.71-1.65 0.724
Serum Bilirubin (µmol/L)
≤ 35 54
> 35 39 1.26 0.83-1.92 0.277
modified Glasgow Prognostic Score (mGPS)
0 59
1 5 1.22 0.78-1.92 0.387
2 29 1.87 0.71-4.88 0.204
Haemoglobin (g/dl)
≥ 12 57
< 12 36 1.19 0.78-1.81 0.422
V˙O2AT (ml/kg/min)
≥ 10 47
< 10 46 1.74 1.14-2.64 0.01 1.74 1.14-2.65 0.01
V˙O2AT (ml/kg/min)
≥ 11 33
< 11 60 1.44 0.94-2.22 0.097 0.395
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Table 2.4: The relationship between clinico-pathological characteristics and re-
ceipt of adjuvant therapy in patients undergoing major pancreatic surgery (n =
55) - Binary logistic regression
Variable n = 55 HR 95% CI p
Age (years)
≤ 65 25
> 65 30 2.63 0.71-9.74 0.149
Sex
Male 31
Female 24 2.08 0.61-7.13 0.242
BMI (kg/m2)
≤ 25 25
> 25 30 0.78 0.23-2.64 0.693
Smoking
No 35
Yes 20 0.96 0.27-3.41 0.953
POSSUM Physiology Score
≤ 14 25
> 14 30 1.63 0.46-5.73 0.447
Preoperative Biliary Drainage
No 27
Yes 28 0.95 0.28-3.21 0.937
Serum Bilirubin (µmol/L)
≤ 35 27
> 35 28 2.08 0.60-7.30 0.251
modified Glasgow Prognostic Score (mGPS)
0 32
1 2 0 0
2 21 1.2 0.35-4.15 0.773
Haemoglobin (g/dl)
≥ 12 31
< 12 24 0.96 0.28-3.26 0.946
Anaerobic Threshold (ml/kg/min)
≥ 10 23
< 10 32 6.3 1.25-31.75 0.026
Anaerobic Threshold (ml/kg/min)
≥ 11 16
< 11 39 3.11 0.61-15.88 0.172
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Figure 2.1: Distribution of V˙O2AT across the study population.
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Figure 2.2: Kaplan-Meier Plot of postoperative length of stay in patients with
V˙O2AT >= 10 ml/kg/min versus < 10 ml/kg/min.
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2.4 Discussion
The results of the present study show that a low V˙O2AT is associated with
prolonged postoperative stay in hospital, postoperative pancreatic fistula and
intra-abdominal abscesses in patients undergoing major resections for pancreatic
head lesions. The results of this study also show that patients with low V˙O2AT are
less likely to receive adjuvant therapy.
Patients with a low V˙O2AT stayed longer in hospital after their operation. While
length of stay in hospital is influenced by multiple factors including postoperative
complications, it would appear that patients with a low V˙O2AT take longer to
recover from the physiological stress placed by major pancreatic surgery and its
sequelae.
The incidence of pancreatic fistula was greater in patients with a low V˙O2AT. This
association needs further evaluation taking into consideration other well-recognised
risk factors for pancreatic fistula such as pancreatic texture, pancreatic duct size
and intra-operative blood loss [Braga et al. 2011; Pratt et al. 2008b; Winter et al.
2006]. It is possible that local or operative factors may be compounded by poor
oxygen delivery and organ perfusion as measured by cardiopulmonary exercise
testing. There was a non-significant trend towards clinically relevant pancreatic
fistulae (ISGPS Grades B and C) as well as a significant association with major
intra-abdominal abscesses (Clavien-Dindo Grades 3-5 i.e., requiring intervention,
associated with organ dysfunction requiring intensive care or resulting in
mortality). This would suggest that complications in patients with low V˙O2AT are
more likely to be severe than in patients with normal V˙O2AT. However, there was
no difference in mortality between patients with normal or low V˙O2AT, indicating
that multiple factors including preoperative patient fitness, local and operative
factors, systemic inflammatory response, number of complications as well as
perioperative critical care all play a role.
The results of this study also show that patients with a low V˙O2AT were less likely
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to receive adjuvant therapy. Adjuvant therapy in patients undergoing pancreatic
resections for cancer has been shown in multiple randomised trials to improve
survival significantly [Neoptolemos et al. 2004; Neoptolemos et al. 2009] While
postoperative mortality after pancreatic surgery has steadily improved over the
years with major improvements in the quality of surgical and critical care over the
past decade [Winter et al. 2006] even in elderly patients [Makary et al. 2006],
postoperative morbidity remains high [Mann et al. 2010]. The results of this study
show that poor preoperative fitness is not only associated with a protracted
protracted postoperative course with complications but also with non-receipt of
adjuvant therapy.
In the present study, V˙O2AT was less than 10 ml/kg/min in 49% of patients and
less than 11 ml/kg/min in 64% of patients. The proportion of patients with V˙O2AT
less than 11 ml/kg/min in this study was much greater than reported in studies
involving patients undergoing oesophageal surgery (16%),[Forshaw et al. 2008] liver
transplantation (39%)[Epstein et al. 2004] or other major abdominal surgery
(29%)[Older et al. 1993] and may indicate the poor preoperative fitness levels of
patients undergoing major pancreatic surgery at our unit.
While several studies have shown that low V˙O2AT and/or low V˙O2peak are
associated with postoperative complications or prolonged hospital stay following
major abdominal surgery as well as non-abdominal surgery,[Older et al. 1993;
Epstein et al. 2004; McCullough 2006; Nagamatsu et al. 2001; Older et al. 1999;
Older et al. 2004] others have disputed this [Forshaw et al. 2008; Clayton et al.
2011; Hightower et al. 2010].
Older and co-workers reported in 1993 that low V˙O2AT less than 11 ml/kg/min
was associated with a significantly higher risk of postoperative mortality from
cardiovascular causes in a series of 187 elderly patients undergoing major
abdominal surgery [Older et al. 1993]. However, Snowden and co-workers
[Snowden et al. 2010] reported that patients with an V˙O2AT less than 10.1
ml/kg/min had significantly greater cardiopulmonary complications as well as
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non-cardiopulmonary and infectious complications while Forshaw and co-workers
[Forshaw et al. 2008] reported that using a cut-off of 11 ml/kg/min for the V˙O2AT
did not predict postoperative adverse events less after oesophagectomy.
The lack of association between low V˙O2AT and cardiopulmonary complications in
this study may have been due to two reasons. Major cardiopulmonary
complications occurred more often in association with major intra-abdominal
adverse events which are determined largely by pancreatic morphology and local
anatomy [Braga et al. 2011]. Moreover, the stringent fitness criteria for undergoing
pancreaticoduodenectomy may have excluded patients with known co-morbid
cardiorespiratory diseases such as severe chronic obstructive pulmonary disease or
cardiac failure.
The results of this study are consistent with the findings by Ausania and
co-workers [Ausania et al. 2012b] who reported increased incidence of pancreatic
fistula and prolonged postoperative stay in patients with V˙O2AT less than 10.1
ml/kg/min. However, this study did not report the association between V˙O2AT
and receipt of adjuvant therapy.
The physiological demands placed on a patient undergoing major pancreatic
surgery are significant, both during and after the operation. It is not entirely
surprising therefore, that conventional parameters of patient fitness like the
POSSUM Physiology Score or the modified Glasgow Prognostic Score are limited
in their ability to distinguish patients based on their performance under
physiological stress. Cardiopulmonary exercise testing overcomes this disadvantage
by replicating some of the physiological burden major pancreatic surgery places on
the functional capacity of the patient’s cardiovascular and respiratory systems.
This functional capacity of patients to withstand the physiological burden of major
surgery can be improved by the process of ‘prehabilitation’ [Topp et al. 2002]. It
has been suggested that prehabilitation not only improves aerobic capacity [Jones
et al. 2007] but may also improve postoperative recovery [Mayo et al. 2011;
Pehlivan et al. 2011]. The results of this study show that impaired aerobic capacity
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is associated with postoperative adverse events. Therefore, it would appear that
prehabilitation using interventions such as exercise and nutrition, by improving
physiological fitness, may have a role in improving postoperative outcomes after
major pancreatic surgery and may improve the proportion of patients receiving
adjuvant therapy.
Further work needs to be carried out to study the value of cardiopulmonary
exercise testing in predicting postoperative complications in conjunction with
previously established factors such as pancreatic morphology and operative factors
before it can be used on its own to select or exclude patients for
pancreaticoduodenectomy. Cardiopulmonary exercise testing would play an
important role not only in identifying patients who will benefit from
prehabilitation, but also in the objective measurement of the effects of such
interventions on aerobic capacity as well as in identifying high risk patients who
may not be able to complete oncological treatment. Prehabilitation and optimised
perioperative care may allow a greater proportion of high risk patients to progress
to oncological treatment after surgery.
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3.1 Introduction
Patients with tumours involving the pancreatic head or the periampullary region
often present with inoperable disease. In the minority of patients with operable
disease, resectional surgery in the form of a pancreaticoduodenectomy remains the
main modality of treatment and only chance of a potential cure. However, major
pancreatic surgery is associated with significant morbidity and mortality and is
only undertaken in specialist centres. Patient selection, preoperative optimisation,
good surgical technique and improvements in postoperative care have all
contributed to a reduction in mortality [Winter et al. 2006] but morbidity remains
high [Mann et al. 2010]. While several technical strategies have been described in
recent years to minimise morbidity, these strategies are not necessarily based on a
better understanding of the physiological basis of postoperative complications in
these patients.
The close anatomical relationship between the distal bile duct, distal pancreatic
duct, head of the pancreas and the duodenum is responsible for obstructive
jaundice being the most common presenting symptom in patients with tumours
affecting this region. Distal bile duct strictures also occur in a proportion of
patients with severe chronic pancreatitis involving the pancreatic head. In such
patients, it may be impossible to distinguish inflammation from malignant disease
on preoperative imaging and a proportion of these patients will require a
pancreaticoduodenectomy [Abraham et al. 2003]. The perioperative management
of the patient with obstructive jaundice is complex and management algorithms
are still evolving [Wang et al. 2008].
Obstructive jaundice has been shown to be associated with abnormal
cardiovascular physiology in several animal and human studies. Surgery in the
jaundiced patient has been reported to be associated with adverse postoperative
haemodynamic events and renal dysfunction [Pain et al. 1985; Green et al. 1995].
The association between jaundice and cardiovascular physiology was reported over
a hundred years ago by King and co-workers who found that injection of porcine
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bile pigment into dogs resulted in bradycardia, hypotension and eventually death
[King et al. 1909]. Green and co-workers (1986) described the effects of ‘cholemia’
in dogs that were subjected to choledochocaval anastomosis. The resultant
myocardial depression was described by them as the ‘jaundiced heart’ [Green et al.
1986] and was associated with poor myocardial response to inotropic stimulation in
dogs [Binah et al. 1985; Bomzon et al. 1986] as well as humans [Lumlertgul et al.
1991].
As a result, preoperative biliary drainage (PBD) used to be advocated routinely
before subjecting a patient to pancreaticoduodenectomy with the intention of
reducing postoperative morbidity. A recent multi-center, randomised trial found
that PBD was associated with increased incidence of complications after
pancreaticoduodenectomy [Gaag et al. 2010]. However, this trial excluded patients
with a bilirubin levels greater than 250 µmol/l from the study. A Cochrane
meta-analysis of 6 studies including 520 patients also concluded that pre-operative
biliary drainage was associated with increased incidence of complications and
should not be used routinely in patients scheduled to undergo
pancreaticoduodenectomy [Fang et al. 2012].
3.1.1 Aim
The results presented in Chapter 2 demonstrated that poor performance at
cardiopulmonary exercise testing (CPET) was associated with adverse outcomes
after pancreaticoduodenectomy with an increased incidence of POPF and
prolonged hospital stay. Obstructive jaundice was present in a large proportion of
these patients but not associated with prolonged hospitalisation (Table 2.3). The
aim of the present study was to evaluate the relationship between cardiopulmonary
exercise testing, obstructive jaundice (especially severe obstructive jaundice with
serum bilirubin > 250 µmol/l) and preoperative pathophysiology in patients
undergoing pancreaticoduodenectomy.
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3.2 Patients and methods
3.2.1 Patients
Patients who underwent classical or pylorus-preserving pancreaticoduodenectomy
for periampullary lesions (both benign and malignant) between August 2008 and
December 2012 and had undergone cardiopulmonary exercise testing as part of
their preoperative assessment at the West of Scotland Pancreatic Unit, Glasgow
Royal Infirmary, Glasgow were included in the study. Established criteria for
resectability in patients with malignant disease were used as outlined in Section
1.2.1. Segmental or wedge resection of the portal vein or superior mesenteric vein
was carried out if the lesion was otherwise resectable.
3.2.2 Preoperative data
Patient demographics, preoperative clinico-pathological characteristics including
cardiorespiratory comorbidity, results of preoperative blood tests, chest x-ray, ECG
and cardiopulmonary exercise tests were collected from prospectively held
databases. The POSSUM Physiology Score was calculated based on 11
physiological parameters (cardiac disease, respiratory disease, ECG changes, pulse
rate, blood pressure, haemoglobin, white cell count, serum sodium, serum
potassium, serum urea and Glasgow Coma Scale) and was used as an objective
score of comorbidity (Table 1.4 on p18). Cardiovascular comorbidity was defined
as a score of 2 or more for either the cardiac disease or ECG component of the
POSSUM score. Respiratory comorbidity was defined as a score or 2 or more for
the respiratory disease component of the POSSUM score.
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3.2.3 Obstructive jaundice
Serum bilirubin levels and liver function tests were measured in all patients on the
day before surgery. Obstructive jaundice was defined as serum bilirubin > 35
µmol/litre and severe obstructive jaundice was defined as serum bilirubin > 250
µmol/litre. These thresholds were chosen as a recent randomised controlled trial
that demonstrated increased complications in patients who underwent PBD
excluded patients with serum bilirubin > 250 µmol/litre from the study [Gaag
et al. 2010]. The present study aimed to evaluate preoperative pathophysiology in
this particular group of patients with ‘severe obstructive jaundice’. Due to referral
practices at the time of this study, a proportion of patients underwent preoperative
biliary interventions and drainage before referral to the West of Scotland
Pancreatic Unit. Data regarding biliary intervention and stenting was collected
where feasible.
3.2.4 Cardiopulmonary exercise test
Cardiopulmonary exercise tests were performed in the Department of Respiratory
Medicine at the Glasgow Royal Infirmary using the ZAN-600 CPET suite (nSpire
Health, Longmont, CO 80501, USA). All patients underwent standard pulmonary
function tests and spirometry prior to cardiopulmonary exercise testing. A cycle
ergometer was used to perform a symptom-limited, incremental work-load test
preceded by a 3-minute rest period. The test was stopped when patients achieved
their maximum exercise tolerance, when significant ischaemic changes occurred on
ECG or for other safety reasons. Peak oxygen consumption achieved at this stage
was defined as V˙O2Peak. The V˙O2AT was calculated using the V-slope [Beaver
et al. 1986; Sue et al. 1988] and ventilatory equivalents [“ATS/ACCP Statement
on Cardiopulmonary Exercise Testing” 2003] methods. V˙O2AT less than 10
ml/kg/min was considered to be low based on previous work by us (Chapter 2) as
well as Ausania and co-workers [Ausania et al. 2012b] which has shown increased
incidence of complications in patients with V˙O2AT below this threshold. Oxygen
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consumption at peak exercise (V˙O2Peak) was dichotomised using a cut-off of 16
ml/kg/min. Cardiopulmonary exercise testing methodology and calculation of
V˙O2AT is described in detail in Sections 1.5.2 and 1.5.3. The cardiopulmonary
exercise testing parameters described in this study are explained in detail in
Section 1.6 on p28 and in published literature [Balady et al. 2010].
3.2.5 Statistics
Grouping of the variables was carried out using standard or previously published
thresholds. In the absence of such thresholds, the variables were treated as
continuous variables. Non-parametric tests were used to analyse the association
between categorical and continuous variables while Chi-square tests were used to
analyse the association between categorical variables. Univariate and multivariate
binary logistic regression analysis was used to study the relationship between
preoperative patient characteristics and V˙O2AT / V˙O2Peak. Scatter-plots were used
for visual representation of the relationship between serum bilirubin and V˙O2 .
The level of significance was set at p < 0.05. SPSS software (Version 17.0; SPSS
Inc., Chicago, IL, USA) was used to perform statistical analysis.
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3.3 Results
3.3.1 Clinico-pathological characteristics
One-hundred and thirty eight patients underwent pancreaticoduodenectomy with
preoperative cardiopulmonary exercise testing during the study period. Over half
of the patients were male (n=93, 67%). Approximately half the number of patients
were over the age of 65 (n=68, 49%) and overweight or obese (n=69, 50%).
Cardiovascular comorbidity was present in 58 patients (42%) and respiratory
comorbidity was present in 12 patients (9%). Fifty patients (36%) had a history of
cigarette smoking. The POSSUM Physiology Score was greater than 14 in 61
patients (44%). Obstructive jaundice (serum bilirubin 35-250 µmol/l) was present
in 32 (23%) patients while severe obstructive jaundice (serum bilirubin > 250
µmol/l) was present in 19 (14%) patients.
The baseline demographic and clinical characteristics of non-jaundiced and
jaundiced patients are shown in Table 3.1. A greater proportion of jaundiced
patients were females (p=0.028) and smokers (p=0.038) compared to the
non-jaundiced cohort. Elevated POSSUM Physiology Score (p=0.004) and
malignancy (p<0.001) were significantly associated with the presence of jaundice.
However, there was no statistically significant difference in age, body mass index,
cardiovascular comorbidity, respiratory comorbidity or PBD between the
non-jaundiced and jaundiced patients.
3.3.2 Obstructive jaundice vs. preoperative blood tests
The relationship between obstructive jaundice and preoperative blood tests is
shown in Table 3.2. Obstructive jaundice was associated with the presence of a
systemic inflammatory response as characterised by raised serum C-reactive protein
levels and decrease in serum albumin levels (p<0.001). The degree of systemic
inflammation was proportionate to the severity of jaundice. Non-jaundiced
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patients had a median CRP of 3.6 mg/l (inter-quartile range 0.3 - 89) and serum
albumin of 37 g/l (IQR 18 - 46) while patients with severe obstructive jaundice
had a median CRP of 13 (IQR 1.7 - 51) and a median serum albumin of 25 g/l
(IQR 18 - 33). Obstructive jaundice was also associated with electrolyte
abnormalities including serum sodium, serum potassium and serum chloride levels.
Jaundiced patients were more likely to be anaemic (p<0.001) with lower
haematocrit (p<0.001) and lower mean corpuscular volume (p=0.001). However,
there was no significant difference in the preoperative renal function, prothrombin
time and white cell count between jaundiced and non-jaundiced patients.
3.3.3 Obstructive jaundice vs. pulmonary function tests
Pulmonary function tests including forced vital capacity (FVC), forced expiratory
volume in one second (FEV1) and their derived parameters (predicted FEV1,
FEV1/FVC, predicted FEV1/FVC) were compared between jaundiced and
non-jaundiced patients. There was a trend towards lower forced vital capacity with
increasing severity of jaundice but this did not reach statistical significance
(p=0.092). There was no association between the other pulmonary function tests
and jaundice (Table 3.3).
3.3.4 Obstructive jaundice vs. CPET
Cardiopulmonary exercise test parameters measured at the anaerobic threshold
and at peak exercise were compared between jaundiced and non-jaundiced patients
using the Kruskal-Wallis test. Obstructive jaundice was associated with lower tidal
volume (p=0.017), lower absolute V˙O2 (p=0.003), lower corrected V˙O2 (p=0.029),
lower oxygen pulse (p=0.037) and lower respiratory rate (p=0.022) at the
anaerobic threshold. At peak exercise, jaundice was associated with lower tidal
volume (p=0.028), lower absolute V˙O2Peak (p=0.007), lower absolute V˙CO2
(p=0.016) and lower end-tidal O2 or PETO2 (p=0.026). However, as shown in
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Tables 3.4 and 3.5, several of these associations were not linear with a trend
towards poorer results between non-jaundiced and mildly jaundiced patients and
better values in the severely jaundiced cohort.
Scatter-plot analysis comparing serum bilirubin versus V˙O2AT and V˙O2Peak as
continuous variables is depicted in Figure 3.1. This shows that the relationship
between serum bilirubin and V˙O2AT is weak with a ρ
2 value of 0.035 Pearson’s ρ =
- 0.187, p = 0.028. There was no correlation between serum bilirubin and V˙O2Peak
(Pearson’s ρ = - 0.132, ρ2 = 0.017, p = 0.123)
(a) V˙O2AT versus serum bilirubin (b) V˙O2Peak versus serum bilirubin
Figure 3.1: Scatter-plot analysis comparing serum bilirubin versus V˙O2AT and
V˙O2Peak.
The relationship between serum bilirubin and V˙O2AT was weak (Pearson’s ρ = -
0.187, ρ2 = 0.035, p = 0.028). There was no correlation between serum bilirubin
and V˙O2Peak (Pearson’s ρ = - 0.132, ρ
2 = 0.017, p = 0.123)
3.3.5 Preoperative factors related to CPET
Binary logistic regression analysis was undertaken to assess preoperative
clinico-pathological patient factors associated with a low V˙O2AT and low V˙O2Peak.
On univariate analysis, female sex (HR 2.74, 95% CI 1.30-5.74, p=0.008), body
mass index > 25 (HR 3.09, 95% CI 1.51-6.32, p=0.002), presence of malignancy
(HR 3.59, 95% CI 1.36-9.43, p=0.010), POSSUM Physiology Score > 14 (HR 2.06,
Chapter 3. CPET, Jaundice and Preoperative Pathophysiology 88
95% CI 1.02-4.17, p= 0.044), serum bilirubin > 250 µmol/l (HR 5.66, 95% CI
1.87-17.16, p=0.002), haemoglobin < 12 g/dl (HR 2.74, 95% CI 1.30-5.74,
p=0.008) and serum C-reactive protein > 10 mg/l (HR 2.18, 95% CI 1.06-4.51,
p=0.035) were associated with V˙O2AT < 10 ml/kg/min. Age, cardiovascular and
respiratory comorbidity, PBD, mild jaundice and serum albumin were not
significantly related to a low V˙O2AT.
The statistically significant independent variables with p<0.05 were entered into a
backward step-wise regression model with V˙O2AT < 10 ml/kg/min as a categorical,
binomial, dependent variable. Female sex (HR 3.75, 95% CI 1.57-8.95 p<0.005),
body mass index > 25 (HR 3.65, 95% CI 1.61-8.26, p<0.005), malignancy (HR
4.02, 95% CI 1.33-12.16, p<0.05) and C-reactive protein > 10 mg/l (HR 2.98, 95%
CI 1.29-6.86, p<0.05) were independently related to low V˙O2AT. Obstructive
jaundice was not related to low V˙O2AT on multivariate analysis. (Table 3.6)
Binary logistic regression analysis of the relationship between patient factors and
low V˙O2Peak (< 16 ml/kg/min) is shown in Table 3.7. On both univariate and
multivariate analysis, female sex, body mass index > 25 and haemoglobin < 12
g/dl were significantly associated with a low V˙O2Peak.
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Table 3.1: The relationship between obstructive jaundice and preoperative pa-
tient characteristics in patients undergoing pancreaticoduodenectomy.
Preoperative Serum Bilirubin (µmol/L)
n = 138 ≤ 17 18-35 35-250 > 250 p
Age (≤65/>65 years) 32/33 13/9 16/16 9/10 0.935
Sex (Male/Female) 48/17 14/8 22/10 9/10 0.028
BMI (Normal/Overweight) 30/35 12/10 20/12 7/12 0.82
Smoking (No / Yes) 48/17 12/10 18/14 10/9 0.038
PPS (≤14/>14) 39/22 16/5 9/23 8/11 0.004
Cardiac disease (No/Yes) 35/28 13/9 17/15 13/6 0.539
Respiratory disease (No/Yes) 57/6 20/2 29/3 18/1 0.664
Biliary Stent (No/Yes) 29/20 3/12 6/17 18/0 0.201
Cancer (No/Yes) 26/39 3/19 3/29 0/19 <0.001
p - Chi-square test
Obstructive jaundice was more common in females, smokers, patients with el-
evated POSSUM Physiology Score (PPS) and in patients with cancer. BMI -
Body Mass Index, PPS - POSSUM Physiology Score
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3.4 Discussion
The results of the present study demonstrate that obstructive jaundice, even when
severe, is not an independent risk factor for poor preoperative cardiopulmonary
exercise physiology in patients undergoing pancreaticoduodenectomy. The results
also demonstrate that obstructive jaundice is associated with elevated preoperative
systemic inflammation with the severity of systemic inflammation related to the
severity of the jaundice. The results also appear to suggest that there may be
multiple other determinants of aerobic capacity including female sex, body mass
index, haemoglobin, presence of cancer and systemic inflammation.
The use of CPET in preoperative risk prediction was first made popular over two
decades ago by Older and co-workers [Older et al. 1993]. Since then
cardiopulmonary exercise testing has been reported to be useful in identifying high
risk patients prior to major general [Snowden et al. 2010], pancreatic [Ausania
et al. 2012b][Chapter 2 of this thesis], oesophagogastric [Nagamatsu et al. 2001] as
well as vascular [Carlisle et al. 2007] surgery. Cardiopulmonary exercise testing is
superior to conventional measures of fitness due to the dynamic nature of the test
that evaluates the adequacy of oxygen delivery to tissues under physiological
stress. However, the factors responsible for poor aerobic capacity in surgical
patients have not been adequately studied. The present study aimed to address
this in patients undergoing major pancreatic surgery.
Experimental and animal studies have shown that obstructive jaundice was
associated with myocardial depression [Green et al. 1986], poor myocardial
response to inotropic stimulation [Lumlertgul et al. 1991], impaired sympathetic
baroreflex sensitivity [Song et al. 2009] and deranged atrial natriuretic peptide
levels [Pereira et al. 1994; Gallardo et al. 1998].
Historically, obstructive jaundice has also been reported to be associated with
adverse haemodynamic events in patients undergoing major surgery.
Intra-operative blood loss, postoperative hypotension, increased susceptibility to
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shock and renal dysfunction were more common in patients with obstructive
jaundice [Dixon et al. 1983; Pain et al. 1985; Green et al. 1995]. A recent review
noted that bile acids had a complex range of receptor mediated effects on the
cardiovascular system [Khurana et al. 2011]. Moreover, some of these effects
appear to be partly reversible by biliary drainage as demonstrated by Padillo and
co-workers [Padillo et al. 2001b].
These observations led to routine pre-operative biliary drainage being
recommended in all jaundiced patients before undertaking major surgery.
Pancreaticoduodenectomy was described by Whipple initially as a two-stage
operation, with the first stage involving a cholecysto-gastrostomy aimed at
relieving biliary obstruction before undertaking the resection at a later second
operation [Whipple et al. 1935].
However, several recent studies have reported that PBD is associated with
increased incidence of complications and that surgery in the jaundiced patients is
safe. Pitt and co-workers in a prospective randomised trial compared outcomes in
jaundiced patients undergoing surgery with or without PBD. They reported that
PBD was associated with increased cost without any decrease in postoperative
complications [Pitt et al. 1985]. A recent meta-analysis [Sewnath et al. 2002]
pooled data from 5 randomised controlled trials comparing surgery with PBD
versus surgery without drainage. The authors concluded that PBD not only did
not improve postoperative complication rates or mortality but resulted in a higher
overall complication rate due to the morbidity associated with the procedure itself.
These findings have been reproduced in a more recent multicenter, randomised trial
[Gaag et al. 2010]. A recent Cochrane Collaboration review of six trials including
520 patients concluded that PBD may be associated with serious adverse events
and must not be performed routinely outside trial settings [Wang et al. 2008].
In the present study, obstructive jaundice was not independently related to V˙O2AT
or V˙O2Peak. There was only a weak negative correlation between serum bilirubin
and V˙O2AT in our cohort. These findings are similar to those of Parker and
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co-workers who reported that there was only a weak negative correlation between
serum bilirubin and V˙O2Peak (Pearson’s ρ -0.21, p=0.02) and no correlation with
V˙O2AT (ρ = -0.15, p=NS) in patients undergoing pancreaticoduodenectomy
[Parker et al. 2014]. Junejo and co-workers studied oxygen extraction in 9
jaundiced patients during cardiopulmonary exercise test by placing catheters
within the femoral vein and reported that oxygen extraction was normal during
cardiopulmonary exercise even in the presence of jaundice [Junejo et al. 2014a]
However, jaundice was associated with elevated preoperative systemic
inflammation as measured by C-reactive protein levels and serum albumin.
Obstructive jaundice is known to be associated with wide ranging abnormalities of
both humoral and innate immune systems [Nehe´z et al. 2002; Padillo et al. 2001a;
Scott-Conner et al. 1994]. It is unclear if this preoperative immune dysfunction
continues after surgery as an abnormal postoperative systemic inflammatory
response and this is explored further in Chapter 5. However, studies suggest that
the immunological abnormalities associated with obstructive jaundice did not
improve after biliary drainage [Kimmings et al. 2000].
Elevated preoperative CRP was also independently associated with a low V˙O2AT
suggesting that impaired aerobic capacity may be associated with a systemic
inflammatory response. This finding is similar to that reported by Sultan and
co-workers who found that low V˙O2AT was independently associated with an
elevated preoperative neutrophil-lymphocyte ratio in patients undergoing
colorectal surgery [Sultan et al. 2014].
The association between low haemoglobin and low V˙O2Peak would appear to be
more easily explained since the oxygen carrying capacity of blood depends on
haemoglobin concentration. Indeed, the linear relationship between oxygen
consumption during exercise and haemoglobin concentration has been shown both
in disease states [Agostoni et al. 2010] as well as in healthy volunteers [Dellweg
et al. 2008]. This would suggest that maintaining optimal haemoglobin levels in
the perioperative period will improve oxygen delivery and perhaps outcome as
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well. Excessive intra-operative blood loss has been reported to be associated with
postoperative complications [Pratt et al. 2008a] and this may in part be due
impaired oxygen delivery at a time of maximal physiological burden.
In the present study, it was of interest that V˙O2 , both at anaerobic threshold and
at peak exercise, was significantly lower in females as well as in patients with a
high body mass index. The basis of this relationship is not clear and may be
related to body composition differences between these groups. However, such an
association has been previously reported [Horwich et al. 2009]. This may reflect
the difficulty in obtaining accurate V˙O2 values in obese patients as a result of the
calculations involved rather than due to true cardiopulmonary dysfunction. Other
authors have suggested that different thresholds for CPET parameters may have to
be considered in obese patients to improve risk-prediction [Donnelly et al. 1990;
Hulens et al. 2001]. Presence of cancer was also an independent predictor of low
V˙O2AT. Sarcopenia is associated with reduced aerobic capacity [Evans et al. 1993]
and is common in pancreatic cancer [Joglekar et al. 2015]. V˙O2AT and V˙O2Peak
must be interpreted with caution in these patient groups. This is the subject of
further study in Chapter 4.
In conclusion, obstructive jaundice, including severe obstructive jaundice did not
affect preoperative cardiopulmonary exercise physiology. Therefore, preoperative
biliary drainage cannot be expected to improve aerobic capacity in patients
undergoing pancreaticoduodenectomy. Both obstructive jaundice and low V˙O2AT
were associated with elevated preoperative systemic inflammation and provide
further evidence of the role of jaundice and impaired aerobic capacity in immune
dysregulation in these patients.
Chapter 4
An investigation into the
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cardiopulmonary exercise testing
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4.1 Introduction
Major abdominal surgery especially for pancreatic disease is associated with
significant morbidity and mortality. Patient selection is as important as identifying
surgically treatable pathology in ensuring optimal outcomes [Bilimoria et al. 2007;
Sandroussi et al. 2010].
4.1.1 Role of preoperative CPET
Cardiopulmonary exercise testing has become a useful tool in the preoperative
evaluation and risk assessment/stratification of patients undergoing major thoracic
and abdominal surgery. A number of studies have shown that poor aerobic fitness
demonstrated by a low V˙O2AT or low V˙O2Peak or both was associated with
increased morbidity and mortality after major surgery including bariatric
[McCullough 2006], pancreatic [Ausania et al. 2012b][Chapter 2], liver [Epstein
et al. 2004], cardiothoracic [Brunelli 2010; Campione et al. 2010; Torchio et al.
2010] and abdominal aortic aneurysm surgery [Carlisle et al. 2007; Thompson et al.
2011]. It is now routinely used in preoperative assessment to aid in risk assessment
and patient selection. Cardiopulmonary exercise tests also help in identifying
patients who may benefit from perioperative optimisation and more focussed care
before, during and after major pancreatic surgery. Occasionally, patients may be
denied surgery if their aerobic fitness as determined by cardiopulmonary exercise
testing is felt to be too poor based on currently available evidence.
4.1.2 Factors affecting aerobic fitness
Aerobic fitness, as defined by the ability to perform physical exercise, is dependant
on and often limited by the ability of the cardiorespiratory and circulatory systems
to supply oxygen to skeletal muscles at times of increased demand as well as
remove the main end product of aerobic metabolism, CO2.
Chapter 4. CPET and Body Composition 102
Several factors play an important role in meeting this increased metabolic demand.
These include a normal cardiac and respiratory response to exercise and the
oxygen carrying capacity of blood primarily determined by haemoglobin levels.
Peripherally, an adequate circulatory response to local humoral factors and central
autonomic control, capillary density within the skeletal muscle and the ability of
skeletal muscle to utilise oxygen, which is in turn determined by mitochondrial
mass and function are important factors.
Inadequate or inappropriate response of any of the above mentioned factors will
result in overall limitation of oxygen delivery or utilisation and aerobic fitness.
Cardiopulmonary exercise testing allows the accurate measurement of most of
these factors either directly or indirectly during dynamic exercise. This allows
identifying not only limitations in aerobic fitness but also the possible causes for
such limitation.
A low V˙O2 has universally been attributed to low aerobic fitness due to an
inadequate response of the cardiovascular and respiratory systems. This is often
thought to be due to cardiorespiratory disease, overt or sub-clinical. Occasionally,
other factors such as anaemia [Agostoni et al. 2010], peripheral vascular disease
and rarely, mitochondrial diseases [Ferna´ndez et al. 2000] have been identified as
contributing to low aerobic capacity.
The most common parameters used to quantify perioperative risk in surgical
patients are oxygen consumption at the anaerobic threshold (V˙O2AT) and at peak
exercise capacity (V˙O2Peak). Conventionally these have been reported as per
weight ratios (ml/kg/min) to allow comparison between patients. However,
numerous studies on cardiorespiratory exercise physiology have reported that
normalising V˙O2 using total body weight leads to spurious correlation errors
unfairly penalising obese subjects [Seltzer 1940; Tanner 1949; Toth et al. 1993;
Batterham et al. 1999; Goran et al. 2000; Krachler et al. 2014]
Chapter 4. CPET and Body Composition 103
4.1.3 Aims
In chapter 2, we reported that low V˙O2AT in patients undergoing
pancreaticoduodenectomy was associated with increased incidence of postoperative
pancreatic fistula and prolonged hospital stay. We also reported that patients with
a V˙O2AT less than 10 ml/kg/min were less likely to receive postoperative adjuvant
chemotherapy. In chapter 3, while examining the relationship between preoperative
clinico-pathological characteristics and cardiopulmonary exercise physiology, we
observed that a high body mass index was associated with a low V˙O2AT and
V˙O2Peak independent of all other factors. Moreover, most of our patients did not
have overt cardiac or respiratory comorbidity to explain these findings.
We hypothesised at the end of chapter 3 that low V˙O2 values in obese patients may
be a result of the calculations involved rather than due to true cardiopulmonary
dysfunction. The aim of the present study was to examine the relationship
between cardiopulmonary exercise testing and body composition in patients
undergoing pancreaticoduodenectomy in an attempt to explain the strong negative
correlation between low V˙O2 and body mass index.
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4.2 Patients and methods
4.2.1 Patients
Patients scheduled to undergo pancreaticoduodenectomy for malignant or benign
disease involving the head of the pancreas and periampullary region between
August 2008 and October 2010 were included in this study. All data were recorded
in a prospectively maintained database. Data was collected on demographics,
preoperative clinico-pathological characteristics including blood tests, body mass
index, weight, height and the underlying surgical pathology. Detailed
breath-by-breath data on a variety of physiological and gas-exchange parameters
measured at cardiopulmonary exercise testing were also collected from a
prospectively maintained database. Cardiopulmonary exercise testing methodology
is discussed in Section 1.5.2 (page 28)and a description of the parameters measured
at cardiopulmonary exercise testing is provided in Section 1.6 (page 28). A
complete dataset for one sample patient is shown in Appendix C on page 198.
4.2.2 Calculation of body composition
Computed tomography of the abdomen, performed as part of the routine
preoperative staging, was used to calculate body composition based on previously
published methods [Bredella et al. 2010; Shen et al. 2004].
The coronal and sagittal reconstructions were used to accurately identify the L3
and L4 vertebrae. The CT window width (W) was set at 400 and the level/centre
(C) was set at 40. This allowed tissue between -160 Hounsfield units and +240
Hounsfield units to be represented in grayscale with adequate contrast between
tissues of interest. The cross-sectional images at these levels where then exported
as grayscale bitmap images. The scale in millimetres was included with every
image. A representative image is shown in Fig. 4.1a. The GNU Image
Manipulation Program (GIMP), an advanced, free, open-source, raster graphics
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editor was used for analysis of all images (www.gimp.org). The use of GIMP to
analyse cross-sectional imaging for body composition has been described previously
although by using a different technique to what has been employed by us
[Anblagan et al. 2013].
The first step involved converting the bitmap images into JPEG images using lossy
compression set at 85% to minimise sharp transitions between grey areas of very
similar colour values. This allowed more consistent selection of contiguous areas of
similar grey shades.
The next step involved standardising the scale of all images by dividing the length
of the scale on every image by the number of pixels along the scale. This resulted
in a length in millimetres for each pixel in each image. As pixels on a CT image
are square, the area of each pixel was calculated as the square of its length.
The Fuzzy Select (Magic Wand) tool was used to select contiguous areas of similar
colour while simultaneously confirming visually that the correct anatomical
structures had been selected without overspill into adjoining unwanted tissue areas.
The number of pixels within the selection was obtained using the ’Histogram’
dialog window and entered into a Microsoft Excel spreadsheet. The area was
calculated by multiplying the number of pixels by the area of each pixel.
Selecting tissue compartments:
The sequence of steps followed to calculate the area of each tissue compartment is
depicted in Fig. 4.1 on page 106. The total cross-sectional area of the abdomen at
the level of L3/L4 was calculated by first selecting all the empty space outside the
image followed by inverting this selection. This is depicted in Fig. 4.1a.
Subcutaneous fat in the image was selected using the Fuzzy Select tool (if necessary
by choosing multiple times and removing any unnecessary areas) as depicted in
Fig. 4.1b. The same process was repeated for visceral adipose tissue and skeletal
muscle as depicted in Fig. 4.1c and Fig. 4.1d respectively. Every selection was
visually confirmed for anatomical accuracy by using the layer selection tool to
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inspect the selected area as shown in the insets in each of the images.
(a) Total Cross-sectional Area (b) Subcutaneous Adipose Tissue
(c) Visceral Adipose Tissue (d) Skeletal Muscle
Figure 4.1: Selection of components of body composition from CT images using
GIMP.
The total cross-sectional area was selected by first selecting the empty space out-
side the image followed by inverting this selection as depicted in (A). The ’Fuzzy
Select’ tool was then used to select individual body composition components with
visual confirmation using the ’layer selection’ tool. This is shown in B, C and D.
The selected area has been removed for representation purposes. The insets in
each image confirm the area selected.
4.2.3 Cardiopulmonary exercise testing
All patients performed cardiopulmonary exercise testing on a cycle ergometer as
described in Section 1.5.2. Raw data of all breath-by-breath parameters averaged
every 10 seconds was collected for analysis. The first three minutes of the recorded
data were during the rest period when the patients were on the exercise bike but
did not exercise. The average of each parameter measured between the first and
second minute (6 readings) was treated as the rest value. Anaerobic threshold was
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identified using previously established methods [Beaver et al. 1986; Sue et al. 1988]
and all corresponding parameters at this point were recorded. Peak exercise was
identified by the maximum oxygen consumption recorded towards the end of the
exercise period and all other parameters recorded at this point were considered as
peak exercise values.
In order to distinguish between absolute values and values scaled to total body
weight, the terms ‘absolute V˙O2 ’ and ‘corrected V˙O2 ’ are used throughout this
chapter. When V˙O2 has been scaled to an alternate factor, this is stated clearly.
4.2.4 Estimation of lean body mass
Estimated lean body mass (eLBM) was calculated using the Boer formula [Boer
1984] as shown below.
Men : eLBM = 0.407× weight(kg) + 0.267× height(cm)− 19.2 (4.1)
Women : eLBM = 0.252× weight(kg) + 0.473× height(cm)− 48.3 (4.2)
4.2.5 Statistics
Comparison between body composition and cardiopulmonary exercise testing
parameters was done using Partial correlations controlling for the effect of sex
(and/or age). The relationship between body composition and preoperative
clinico-pathological characteristics (as categorical variables) was analysed using
non-parametric tests. The Mann-Whitney U test was used for variables with two
categories while the Kruskal-Wallis test was used for variables with more than two
categories. Previously established thresholds were used for categorising continuous
variables where applicable. All reported p-values are two-sided. The level of
significance was set at p < 0.05. SPSS software (Version 22.0; SPSS Inc., Chicago,
IL, USA) was used to perform statistical analysis.
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4.3 Results
4.3.1 Body composition and clinico-pathological
characteristics
Eighty-two patients (52 male) were included in the study. The clinico-pathological
characteristics of the study patients and their relationship to body composition is
shown in Table 4.1 on page 109. There were several significant associations
between clinico-pathological variables and body composition as shown in this
table. Females had a greater area of subcutaneous adipose tissue (223.9 versus
141.6 cm2, p<0.001) but less visceral adipose tissue (79.1 versus 174.9 cm2,
p<0.001). However, there was no difference in the total adipose tissue area
between men and women (316.6 versus 303.0 cm2, p=0.665). Skeletal muscle area
was greater in males than in females (141.3 versus 99.7 cm2).
There was no association between deprivation as defined by the Scottish Index of
Multiple Deprivation (SIMD) and body composition. Hypoalbuminemia was
associated with less visceral adipose tissue (p=0.013) and less skeletal muscle area
that did not reach statistical significance (p=0.054). Anaemia (haemoglobin < 12
g/dl) was associated with increased adiposity in the subcutaneous plane and
reduced skeletal muscle area.
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4.3.2 Body composition vs. BMI/sex
Figure 4.2: Differences in body composition according to sex and BMI.
Body composition differed significantly between men and women and with increas-
ing body mass index (BMI). The proportion of skeletal muscle area decreased with
increasing BMI in both sexes but there was a larger decrease in women than men.
Visceral adipose tissue contributed more to weight in obese men than subcuta-
neous adipose tissue while the opposite was true in women.
The body composition differences between male and female patients with
increasing body mass index is shown in Figure 4.2 on page 110. There were
significant differences in the proportion of subcutaneous adipose tissue versus
visceral adipose tissue between males and females. Men generally had less
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subcutaneous fat but more visceral fat and skeletal muscle areas. However, the
proportion of skeletal muscle in both males and females decreased significantly
with increasing body mass index.
The proportion of skeletal muscle area decreased from 38% in male patients with
normal BMI to 22% in obese males. There was a greater decrease in the
proportion of skeletal muscle in females with increasing BMI, with skeletal muscle
area decreasing from 32% in females with normal BMI to 14% in obese females.
The higher weight in the overweight/obese patients was due to a disproportionate
increase in adipose tissue rather than skeletal muscle. Moreover, the distribution of
the adipose tissue differed between males and females. Visceral adipose tissue
contributed more to weight in obese males (43% VAT vs. 35% SAT) while obese
females had a greater proportion of subcutaneous adipose tissue than visceral
adipose tissue (18% VAT vs. 68% SAT).
4.3.3 Body composition vs. pulmonary function tests
Partial correlation analysis was performed to study the relationship between
pulmonary function tests and body composition. It has been well-established in
previous studies that pulmonary function tests are correlated with age and sex and
the analysis was therefore adjusted for these two variables. Forced Vital Capacity
(FVC, litres), Forced Expiratory Volume in 1 second (FEV1, litres) and the ratio
FEV1/FVC (Tiffeneau-Pinelli index,%) were compared against the various
components of body composition. Both FVC and FEV1 were positively correlated
with skeletal muscle but not with adipose tissue area. FEV1/FVC was not
associated with any of the body composition components.
This would indicate that pulmonary function was dependent on skeletal muscle
area while FEV1/FVC, a calculated index to quantify restrictive or obstructive
lung disease, was not associated with skeletal muscle area. These results are shown
in Table 4.2 on page 115.
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4.3.4 Body composition vs. exercise load
Exercise loads achieved at anaerobic threshold and at peak exercise capacity were
plotted against skeletal muscle area to create scatter-plots(Fig. 4.3 on page 112).
Exercise load correlated positively with skeletal muscle area both at anaerobic
threshold (ρ2 = 0.284, p < 0.001, Fig. 4.3a) and at peak exercise
(ρ2 = 0.350, p < 0.001, Fig. 4.3b). However, no correlation was identified between
exercise loads achieved and adipose tissue area either at anaerobic threshold
(ρ2 = 0.004, p = 0.587) or peak exercise (ρ2 = 0.020, p = 0.206) as shown in Table
4.2 on page 115.
(a) Anaerobic Threshold (b) Peak Exercise
Figure 4.3: Correlation between exercise load and skeletal muscle area.
Scatter plots A and B show a positive correlation between exercise load achieved
and skeletal muscle area both at anaerobic threshold (p < 0.001) and peak exercise
(p < 0.001) respectively.
4.3.5 Body composition vs. oxygen consumption
Partial correlations between cardiopulmonary exercise parameters at rest,
anaerobic threshold and peak exercise versus body composition were adjusted for
sex. Our own findings (Tables 3.6 and 3.7 on pages 94, 95) and the findings of
other authors suggest that age is not related to V˙O2AT or V˙O2Peak and therefore
no adjustments were made for age. The results of this analysis are shown in Table
4.2 (page 115).
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Tidal volume (V˙T , litres) was significantly correlated with skeletal muscle area at
all phases of exercise including at rest, anaerobic threshold and peak exercise.
There was a statistically significant but weak positive correlation between minute
ventilation (V˙E, litres) and skeletal muscle at anaerobic threshold and peak
exercise but not at rest. There was no correlation between either of these measures
of pulmonary function and adipose tissue area at any phase of exercise.
(a) V˙O2AT vs. Skeletal Muscle (b) V˙O2AT vs. Total Adipose Tissue
Figure 4.4: Correlation between body composition and V˙O2AT before and after
correction for total body weight.
The solid line in A shows a positive correlation between absolute V˙O2 and skeletal
muscle area (p < 0.001) while in B it shows no correlation with total adipose tissue
as expected of exercise physiology. However, normalisation of V˙O2 using total body
weight results in a ’spurious’ negative correlation with total adipose tisue area as
depicted by the dotted line in B (p < 0.001). This indicates that patients with
high body mass index and excess adipose tissue will have low corrected V˙O2 , the
value that is commonly used in clinical practice.
Absolute V˙O2 (litres/min) had a strong positive correlation with skeletal muscle
area at rest (ρ = 0.353, p = 0.001), at anaerobic threshold (ρ = 0.463, p < 0.001)
and at peak exercise (ρ = 0.375, p = 0.001). However, this correlation was lost
after correction of V˙O2 for total body weight and there was a non-significant change
in the direction of correlation to the negative.
Absolute V˙O2 (litres/min) had no correlation with total adipose tissue at rest or at
peak exercise and only a weak correlation at anaerobic threshold. However, when
corrected for total body weight, there was a strong negative correlation between
corrected V˙O2 (ml/kg/min)and total adipose tissue at rest (ρ = −0.482, p < 0.001),
Chapter 4. CPET and Body Composition 114
anaerobic threshold (ρ = −0.400, p < 0.001) and peak exercise
(ρ = −0.374, p = 0.001).
The loss of physiological relationship between V˙O2 and skeletal muscle after
correcting for total body weight is shown in Fig.4.4a and the creation of a spurious
relationship with total adipose tissue after correction for total body weight is
shown in Fig. 4.4b.
O2Pulse at the anaerobic threshold and peak exercise was strongly associated with
skeletal muscle area with weaker positive correlations with visceral fat and total fat
content. There was no correlation between O2Pulse and subcutaneous adipose
tissue at any phase of exercise.
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Table 4.2: The relationship between body composition and cardiopulmonary
exercise testing controlled for sex in patients undergoing major pancreatic surgery.
Subcut Fat Visceral Fat Total Fat Skeletal
area (cm2) area (cm2) area (cm2) muscle (cm2)
Variable ρ p ρ p ρ p ρ p
Pulmonary Function Testsa
FVC -0.084 0.461 -0.111 0.332 -0.112 0.325 0.303 0.007
FEV1 -0.050 0.659 0.043 0.704 -0.012 0.919 0.350 0.002
FEV1/FVC 0.0 1.0 0.200 0.077 0.101 0.374 0.003 978
At Restb
Minute Ventilation 0.117 0.303 0.076 0.504 0.116 0.307 0.136 0.230
Tidal Volume 0.076 0.505 0.130 0.252 0.116 0.305 0.301 0.007
Absolute V˙O2 0.123 0.277 0.163 0.148 0.164 0.145 0.353 0.001
Corrected V˙O2 -0.424 <0.001 -0.396 <0.001 -0.482 <0.001 -0.194 0.085
O2 Pulse 0.110 0.330 0.134 0.238 0.141 0.212 0.192 0.087
At Anaerobic Thresholdb
Exercise Load 0.085 0.454 0.085 0.454 0.105 0.349 0.377 0.001
Minute Ventilation 0.194 0.085 0.127 0.261 0.198 0.076 0.263 0.018
Tidal Volume 0.124 0.274 0.154 0.172 0.170 0.128 0.436 <0.001
Absolute V˙O2 0.191 0.089 0.184 0.103 0.231 0.038 0.463 <0.001
Corrected V˙O2 -0.326 0.003 -0.365 0.001 -0.400 <0.001 -0.078 0.487
O2 Pulse 0.181 0.108 0.227 0.043 0.242 0.029 0.338 0.002
At Peak Exerciseb
Exercise Load 0.029 0.799 -0.025 0.824 0.020 0.859 0.373 0.001
Minute Ventilation 0.080 0.483 0.080 0.483 0.112 0.321 0.242 0.029
Tidal Volume 0.061 0.593 0.153 0.174 0.138 0.219 0.409 <0.001
Absolute V˙O2 0.087 0.444 0.041 0.716 0.093 0.407 0.375 0.001
Corrected V˙O2 -0.295 0.008 -0.365 0.001 -0.374 0.001 -0.027 0.813
O2 Pulse 0.200 0.075 0.240 0.032 0.261 0.019 0.363 0.001
ρ - Pearson’s r adjusted for a - age and sex and b - sex.
Skeletal muscle area (but not adipose tissue) was positively correlated with FVC
and FEV1. Skeletal muscle area also showed positive correlations with CPET
parameters that had not been corrected for total body weight as expected during
exercise. Exercise load, minute ventilation, tidal volume and O2Pulse were all
positively correlated with skeletal muscle area. However, V˙O2 corrected for total
body weight was negatively correlated with adipose tissue area at all phases of
exercise suggesting a non-physiological ’spurious’ correlation. FVC - Forced Vital
Capacity, FEV1 - Forced Expired Volume in 1 second.
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4.3.6 Scaling oxygen consumption to body composition
and other factors
Absolute V˙O2 at the anaerobic threshold was corrected for weight, the square of
height, body mass index, skeletal muscle area and estimated lean body mass.
Calculation of estimated lean body mass is shown in Section 4.2.4. The resulting
values were compared to body composition, height, weight and body mass index
using partial correlations controlling for sex (Table 4.3 on page 117). The results
from Table 4.2 comparing absolute V˙O2 and corrected V˙O2 at the anaerobic
threshold with body composition are reproduced in the first two columns of this
table to allow comparison with the new indices.
V˙O2 scaled for skeletal muscle area had no significant correlation with adipose
tissue, height, weight or BMI but had a negative correlation with skeletal muscle
area. V˙O2 corrected for the square of patient’s height had no correlation with
adipose tissue but retained a positive correlation with skeletal muscle area as well
as a positive correlation with total body weight and BMI.
However, when absolute V˙O2 was corrected for lean body mass, there was no
correlation with any of the body composition indices or with height, weight or
body mass index. The negative correlation between adipose tissue and V˙O2
corrected for total body weight did not occur when V˙O2 was corrected for lean
body mass (Fig. 4.5b). Moreover, the correlation with skeletal muscle area
remained unchanged regardless of whether V˙O2 was corrected for total body weight
or lean body mass (Fig. 4.5a).
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(a) V˙O2AT vs. Skeletal Muscle (b) V˙O2AT vs. Total Adipose Tissue
Figure 4.5: Correlation between body composition and V˙O2AT corrected for
total body weight and estimated lean body mass.
Fig. A shows that there is little difference in the relationship between skeletal
muscle area and V˙O2 corrected using either total body weight or estimated lean
body mass. However, while V˙O2 corrected for total body weight had a ’spurious’
negative correlation with total adipose tissue area (solid line in B), this ’spurious’
relationship was no longer present when V˙O2 was normalised using estimated lean
body mass (dotted line in B).
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4.4 Discussion
The results of this study demonstrate that the most important cardiopulmonary
exercise test parameters used for preoperative risk evaluation in surgery are
influenced significantly by the patient’s body composition. Both V˙O2AT and
V˙O2Peak were significantly affected by patient’s body habitus when scaled using
total body weight. Furthermore, the results suggest that there may be alternate
methods of scaling of V˙O2 that removes the effect of body composition on these
parameters. The results also demonstrate the disproportionate decrease in skeletal
muscle area with associated increase in adipose tissue with increasing body mass
index.
Taken together, these results would suggest that caution should be exercised in
interpreting V˙O2 (corrected for total body weight, ml/kg/min) in patients with a
raised BMI. Abnormally low values in these patients may not necessarily be due to
poor aerobic fitness or lack of cardiopulmonary reserve and may simply be due to
current convention used for scaling/representing V˙O2 .
4.4.1 Oxygen consumption and body composition
Increased physical activity such as during cardiopulmonary exercise testing or
during and after surgery results in greater oxygen consumption (V˙O2). The
increased demand for oxygen is primarily due to increased metabolic activity
within the exercising skeletal muscle. Therefore, the positive correlation between
absolute V˙O2 and skeletal muscle area as has been found here is easily explained by
the physiology of aerobic exercise.
However, current convention is to report V˙O2 measured at cardiopulmonary
exercise testing according to the following formula:
Corrected V˙O2(ml.kg
−1.min−1) =
Absolute V˙O2 (litres.min
−1) ∗ 1000
Total body weight (kg)
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In chapter 3, we reported that there was a significant negative correlation between
corrected V˙O2 (ml/kg/min) and the patient’s body mass index in spite of no
observable cardiopulmonary comorbid disease (Tables 3.6 and 3.7). This negative
correlation existed both at anaerobic threshold and peak exercise. The results of
the present study demonstrate that this negative correlation is consequent to the
scaling convention used rather than due to any pathophysiological effect of obesity.
The loss of the strong positive correlation between absolute V O2 (litres/min) and
skeletal muscle area after correcting for total body weight further supports the
argument that the corrected value for V˙O2 under-reports aerobic capacity in obese
patients. There was no correlation between pulmonary function tests, tidal volume
and minute ventilation and adipose tissue area. However, a statistically significant,
positive correlation was present between adipose tissue and O2Pulse at anaerobic
threshold as well as peak exercise but not at rest. These findings suggest that
adiposity did not contribute to poor cardiopulmonary exercise performance in this
cohort of patients.
4.4.2 Comparison with previous studies
Our findings are similar to those reported by several authors previously. The
relationship between body size, body composition and aerobic capacity both at
rest and during exercise has been studied extensively for over a hundred years.
Seltzer reported in his 1940 study of 34 subjects that individuals who were more
‘lateral’ than ‘linear’ had lower oxygen intakes per kilo body weight [Seltzer 1940].
Tanner in his article titled ‘Fallacy of per-weight and per-surface area standards,
and their relation to spurious correlation’ in the Journal of Applied Physiology in
1947 recognised the dangers of expressing physiological variables as a function of
total body mass [Tanner 1949]. In a detailed analysis comparing V˙O2 and body
build, he concluded that ’as the index wt./stature increases, O2/wt. must be
expected to decrease purely as a result of the method used for representing the data.’
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Batterham and co-workers studied 1314 apparently healthy men employed at the
National Aeronautics and Space Administration Johnson Space Center in Houston,
Texas [Batterham et al. 1999]. The authors reported that as body mass increased,
the proportion composed of fat-free mass decreased. They also found that fat-free
mass had a linear relationship with oxygen consumption while total body mass did
not. They suggest that ideally estimates of fat-free mass should be used in the
representation of oxygen consumption to allow more reliable comparison between
subjects. These findings are similar to our results where the proportion of skeletal
muscle area decreased significantly as body mass index increased with a greater
decrease in females than males. Moreover, the linear relationship between skeletal
muscle area and absolute V˙O2 has also been clearly demonstrated in our findings.
We used the Boer formula [Boer 1984] to estimate lean body mass and used this to
normalise V˙O2 . The resulting value for V˙O2 showed no ‘spurious’ correlations with
body composition, height, total body weight or body mass index. These findings
are similar to the recommendations made by Janz and co-workers who studied
oxygen consumption and aerobic capacity in adolescents over several years as part
of the Muscatine study and reported their findings in 1997 [Janz et al. 1997] and
1998 [Janz et al. 1998]. Aerobic capacity in the form of V˙O2Peak was evaluated
annually in 126 children (mean age 10.3 years) for five years. Body composition
changes were also tracked over this period. They reported on the changes in body
composition that occur over time and the differences in these changes between
circum-pubertal boys and girls. They demonstrate significant difficulties in
normalising V˙O2 using total body mass and suggested that fat-free mass was the
most appropriate variable for normalising V˙O2 . They found that V˙O2 normalised
using total body mass underestimated aerobic fitness levels of heavier boys and
girls. However, this underestimation was greater in girls than in boys.
In a study aimed at determining the optimal method of expressing V˙O2Max,
Maciejczyk and co-workers analysed the differing influence of body fat and lean
body mass on aerobic performance in two groups of physically fit men categorised
based on their body fat percentage [Maciejczyk et al. 2014]. High body mass
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regardless of composition was correlated negatively with V˙O2 (ml/kg/min) when it
was corrected for total body weight. This penalised otherwise fit men purely based
on the proportion of body weight that was contributed by body fat. However,
when V˙O2 was corrected for lean body mass, they found that the results were
similar between the low body fat and high fat body groups. They, similar to Goran
and co-workers [Goran et al. 2000], recommend that V˙O2 be normalised to lean
body mass rather than total body weight.
Our results demonstrate that there is no correlation between absolute oxygen
consumption at rest or during exercise and the amount of adipose tissue. This
further emphasises the fact that adipose tissue is metabolically inactive during
exercise although it contributes to increased work load. Therefore, dividing
absolute V˙O2 (l/min) by total body weight in overweight/obese subjects whose
extra weight is largely due to adipose tissue would result in lower corrected V˙O2
(ml/kg/min) as we have demonstrated here.
Goran and co-workers reported that total body fat did not affect maximal aerobic
capacity [Goran et al. 2000]. They reported on V˙O2Max in obese women before and
after weight loss. V˙O2Max corrected for total body weight was significantly lower in
obese subjects while V˙O2Max corrected for fat-free mass did not change
significantly after weight loss. They also reported that the limiting factor in obese
patients was not the cardio-respiratory system but the fact that it was more
difficult for obese individuals to do the same amount of work as a normal weight
person in weight-bearing activities. This is likely due to the extra fat mass in these
individuals that did not contribute to aerobic capacity but instead may have
increased the exercise load in addition to that set by the investigator during the
exercise.
These findings have been replicated by several other authors in different subject
groups [Loftin et al. 2001; Lemaitre et al. 2006; Savonen et al. 2012; Krachler et al.
2014]. Several of the above studies also recommended using allometric scaling to
avoid the confounding effects of total body weight. However, this has not gained
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widespread clinical use.
The conclusion from the above studies would be that oxygen consumption
normalised for total body weight unfairly penalises obese patients in the absence of
true impairment of cardio-respiratory function. This has significant clinical
implications as outlined below.
4.4.3 Clinical implications of spurious correlation
The term ‘spurious correlation’ was first introduced by English mathematician and
biometrician, Karl Pearson, in 1896. He used the term to describe correlations that
occurred as a result of using ratios instead of absolute values rather than because
of any actual correlations between the variables being studied [Pearson 1896].
Older and co-workers in their pioneering study in 1993 reported that V˙O2AT < 11
ml/kg/min was associated with increased mortality in elderly patients undergoing
major abdominal surgery [Older et al. 1993]. While they did not provide any data
on other preoperative or intra-operative factors, they concluded that
cardiopulmonary exercise testing was useful in predicting postoperative outcome
and that a low V˙O2AT represented cardiac failure. This assertion is repeated in
their later work on 548 patients which also showed a clear association between low
V˙O2AT (ml/kg/min) and mortality due to cardiovascular causes [Older et al. 1999].
The concepts of ’surgical anaerobic threshold’ and ’postoperative cardiac failure’
were introduced later and were described as the ’inability of the heart to meet the
demand of postoperative stress.’ [“ATS/ACCP Statement on Cardiopulmonary
Exercise Testing” 2003].
Swart and Carlisle also reported that V˙O2AT < 11 ml/kg/min in patients
undergoing open colorectal surgery was associated with adverse outcomes [Swart
et al. 2012]. However, the proportion of females in the low V˙O2AT group was
significantly greater than that in the normal V˙O2AT group (24% vs 51%). The
average corrected V˙O2AT in men calculated from the data presented in their paper
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was 11.02 ml/kg/min while in women it was 9.81 ml/kg/min.
In a study by Wilson and co-workers which reported that cardiopulmonary exercise
testing predicted outcome after major elective intra-abdominal surgery, the
proportion of females in the low V˙O2AT group was 51% while it was 28% in the
group with normal AT [Wilson et al. 2010]. There was no data presented on body
mass index in this study. We reported in Chapter 3 that females were more likely
to have a lower V˙O2AT (Table 3.6) and lower V˙O2Peak (Table 3.7). However, all the
results in the present study were controlled for the effect of sex.
The ‘obesity paradox’ would suggest that, in fact, obese patients are not
necessarily at an increased risk of postoperative complications. Several authors
have reported that obesity was not a risk factor for major complications after
pancreaticoduodenectomy [Khan et al. 2010; Tsai et al. 2010; Balentine et al.
2011]. In a large study of 118,707 patients undergoing non-bariatric general
surgery, the authors reported that the risk of death was ‘paradoxically’ low in the
overweight and obese group of patients [Mullen et al. 2009]. The results of the
present study show that V˙O2 as is currently reported for clinical use will also be low
in this very same cohort of patients. This obesity paradox is particularly apparent
in patients with heart failure where in spite of a low V˙O2 (corrected for total body
weight), obese patients have better survival rates. Horwich and co-workers
reported in a study of 2331 patients that body mass index was associated with a
low V˙O2Peak (ml/kg/min) independent of all other factors including age, diabetes,
cardiac disease, New York Heart Association Class of cardiac failure and race
[Horwich et al. 2009].
It is clear from the review presented in Chapter 1 as well as the results presented
in Chapter 2, that cardiopulmonary exercise testing is useful in predicting risk
after major surgery. Cardiopulmonary exercise testing has become ubiquitous in
the preoperative assessment of complex surgical patients. However, the present
study demonstrates that cardiopulmonary exercise test parameters in the
overweight/obese patient must be interpreted with caution, especially when used
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to select patients who may be declined surgery based on these results.
4.4.4 Measuring impact of prehabilitation
Where time to surgery is not critical, prehabilitation has gained an increasingly
important role in optimising patients for surgery. Prehabilitation has been defined
as the ‘process of enhancing functional capacity of the individual to enable him or
her to withstand the stressor of inactivity’ [Topp et al. 2002]. Jones and co-workers
reported an increase in V˙O2Peak by an average 2.4 ml/kg/min when patients were
placed on an aerobic exercise regimen before undergoing surgery for lung cancer
[Jones et al. 2007]. Kim and co-workers also demonstrated a significant
improvement in exercise loads achieved as well as sub-maximal oxygen
consumption in patients who undertook a 4-week exercise program before major
bowel surgery [Kim et al. 2009b]. Moreover, deterioration in aerobic capacity
during prehabilitation was reported to be associated with increased incidence of
postoperative complications [Mayo et al. 2011].
However, other authors have not been able to reproduce these findings. Patient
compliance and difficulties in trying to modify lifestyle prior to surgery were
considered important factors for failure of prehabilitation [Carli et al. 2010;
Dronkers et al. 2010].
Cardiopulmonary exercise testing has been reported to be a useful objective
measure of the impact of prehabilitation in surgical patients. It was used to
demonstrate the decline in V˙O2AT associated with neo-adjuvant chemoradiotherapy
in patients with rectal cancer who did not undertake an exercise program.
However, V˙O2AT improved in the intervention group who undertook a 6 week
exercise program [West et al. 2015].
However, the results presented in this study demonstrate that the success of such
prehabilitation programs must not be determined solely by V˙O2 corrected for total
body weight. Instead, improvement in the absolute values of V˙O2AT and V˙O2Peak
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in conjunction with improvement in other parameters that are not affected by
body composition such as O2Pulse, tidal volume [Jones et al. 2007] or maximal
exercise load [Kim et al. 2009b] may provide more reliable evidence of
improvement in aerobic capacity.
The combination of nutritional assessment and advice, home-based exercise
programs and weight loss may help improve aerobic capacity and eventually
postoperative outcomes. Such preoperative interventions may also be associated
with improvements in body composition with increase in skeletal muscle mass and
reduction in adipose tissue. This may result in apparent improvements in
cardiopulmonary exercise test parameters that are scaled using total body weight
as well as improvements in true aerobic fitness. Further studies are required to
validate the findings presented here as well as to identify optimal scaling methods
for cardiopulmonary exercise test parameters. This will improve the clinical utility
of cardiopulmonary exercise testing in the preoperative risk assessment as well as
optimisation of patients undergoing major surgery.
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5.1 Introduction
The perioperative systemic inflammatory response has a significant role in
determining short-term and long-term outcomes following potentially curative
surgery for a wide variety of cancers. Systemic inflammation both before and after
major surgery has been reported to be associated with significant morbidity.
Elevated preoperative systemic inflammation was associated with increased
complications after colorectal surgery [Moyes et al. 2009; Kubo et al. 2013],
oesophagectomy [Vashist et al. 2010] as well as liver surgery for colorectal
metastases [Neal et al. 2011]. The modified Glasgow Prognostic Score in
particular, which uses the combination of C-reactive protein and serum albumin,
has been reported to be associated with increased incidence of complications
[Moyes et al. 2009; Mohri et al. 2014; Vashist et al. 2010]. Elevated preoperative
CRP levels have also been reported to be associated with increased incidence of
complications including infections and renal dysfunction as well as increased
in-hospital mortality after cardiac surgery [Lorenzo et al. 2012; Mezzomo et al.
2011; Kim et al. 2009a; Biancari et al. 2003; Boeken et al. 1998].
Moreover, an elevated postoperative systemic inflammatory response in the first
few days after surgery was associated with increased incidence of infective
complications after a wide variety of thoraco-abdominal procedures [Singh et al.
2014; Platt et al. 2012; Dutta et al. 2011; Welsch et al. 2008] as well as other types
of surgery [McNeer et al. 2010; Laporta Baez et al. 2011]. The magnitude of this
postoperative inflammatory response has also been reported to be associated with
the severity of the complications [McSorley et al. 2015].
In patients undergoing pancreaticoduodenectomy, preoperative systemic
inflammation may be affected by several factors. These include the presence of
obstructive jaundice with or without cholangitis, preoperative biliary intervention
including endoscopic retrograde cholangio-pancreatography for diagnosis or biliary
drainage and in some patients acute or chronic pancreatitis either due to
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obstruction of the main pancreatic duct or due to other causes. The effect of this
‘priming’ of the immune system on postoperative outcomes is poorly understood in
this cohort of patients.
Chronic inflammation is also a recognised feature of obesity which is increasingly
common in patients undergoing major surgery for pancreatic and other
gastro-intestinal cancers. The impact of obesity, especially visceral obesity, on
complications after pancreaticoduodenectomy remains controversial with some
authors reporting that obesity was associated with increased incidence of
complications [House et al. 2008; Ramsey et al. 2011] while others reporting similar
outcomes in obese and non-obese patients [Khan et al. 2010; Tsai et al. 2010;
Balentine et al. 2011].
More recently, levels of adipocytokines, inflammatory mediators produced
exclusively in adipose tissue, have been reported to be associated with
postoperative surgical site infections after colorectal [Ortega-Deballon et al. 2013;
Matsuda et al. 2009] and gastric cancer surgery [Yamamoto et al. 2013].
Sarcopenia has also been reported to be associated with elevated postoperative
systemic inflammation after colorectal surgery [Reisinger et al. 2015]. This
emphasises the importance of adipose tissue metabolism and body composition in
the preoperative systemic inflammatory status of surgical patients.
To our knowledge, the relationship between the preoperative systemic
inflammatory response and the magnitude of the postoperative systemic
inflammatory response after pancreaticoduodenectomy has not been examined
before. While obstructive jaundice in itself has recently been reported to have no
effect on postoperative complications, the impact of preoperative obstructive
jaundice on postoperative systemic inflammation has not been previously reported.
Moreover, the relationship between comorbidity, body composition and aerobic
capacity as measured by cardiopulmonary exercise testing and postoperative
systemic inflammation has not been studied.
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5.1.1 Aim
The aim of this study was to examine the relationship between patient factors
including preoperative systemic inflammation, obstructive jaundice,
cardiopulmonary exercise test parameters and body composition and the
magnitude of the postoperative systemic inflammation during the first week after a
pancreaticoduodenectomy.
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5.2 Patients and methods
5.2.1 Patients
Patients who underwent elective pancreaticoduodenectomy between January 2008
and December 2012 at the West of Scotland Pancreatic Unit at the Glasgow Royal
Infirmary were included in this study. Patients who underwent only a trial
dissection or palliative surgical bypass for unresectable disease during this period
were excluded.
5.2.2 Preoperative data
Routine preoperative blood tests including full blood count, liver function tests
and serum C-reactive protein were performed in all patients on the day before
surgery. These blood tests were also repeated every day for at least the first
postoperative week. These results were collected from the hospital laboratory
database using an automated MS Access application as outlined in Appendix A.
The modified Glasgow Prognostic Score (mGPS) was calculated as shown in Table
1.7 on page 40 in Chapter 1. Standard thresholds were used to categorise other
biochemical parameters. Obstructive jaundice was defined as serum bilirubin >35
µmol/L while severe obstructive jaundice was defined as serum bilirubin >250
µmol/L.
5.2.3 BMI and body composition
Body Mass Index (BMI) was categorised using the World Health Organisation
thresholds as shown in Table 1.8 on p 52 in Chapter 1. Only one patient had a
BMI less than 18.5 kg/m2 and was excluded from analysis involving BMI. Body
composition was calculated in a subset of these patients using preoperative
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computed tomography of the abdomen. The methodology used in the calculation
of the individual components of body composition including visceral fat,
subcutaneous fat and skeletal muscle is described in detail in Section 4.2.2 on page
104. Continuous data were converted into categorical data using tertiles.
5.2.4 Comorbidity and CPET
The Scottish Index of Multiple Deprivation (SIMD) Quintile Scores were
calculated from the post-code of the patient’s primary residence and dichotomised
into two groups with scores of 1-3 and 4-5 respectively. Lower scores indicated
greater deprivation. The POSSUM Physiology Score was calculated based on 11
physiological parameters (cardiac disease including hypertension, ischaemic heart
disease and heart failure, respiratory disease causing breathlessness on exertion
and COPD, ECG changes, pulse rate, blood pressure, haemoglobin, white cell
count, serum sodium, serum potassium, serum urea and Glasgow Coma Scale) as
described in Table 1.4 on page 18.
In patients who underwent cardiopulmonary exercise testing, V˙O2AT and V˙O2Peak
were compared against postoperative systemic inflammation. V˙O2AT was
dichotomised using a value of 10 ml/kg/min while V˙O2Peak was dichotomised using
a value of 16 ml/kg/min. Cardiopulmonary exercise testing methodology has been
described in Section 1.5.2 on page 23.
5.2.5 Statistics
Continuous variables are reported as median (inter-quartile range).
Non-parametric tests were used to compare postoperative inflammatory markers
(continuous data) with preoperative clinico-pathological characteristics (categorical
data). Mann-Whitney U test was used when two categories were present and
Kruskal-Wallis test was used when more than two categories were present.
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Line-plots were created comparing the trend of inflammatory markers during the
first postoperative week with preoperative systemic inflammation, obstructive
jaundice and V˙O2AT with error bars representing 95% confidence intervals.
SPSS software (Version 22.0; IBM, USA) was used to perform statistical analysis.
Effects were considered significant at α ≤ 0.05.
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5.3 Results
5.3.1 Clinico-pathological characteristics
Pancreaticoduodenectomy was performed in 188 patients (126 male, 67%) during
the study period. Preoperative C-reactive protein was elevated in 70 (37.6%)
patients while just over half the patients had a low preoperative serum albumin
(96, 51.1%). The modified Glasgow Prognostic Score revealed normal preoperative
systemic inflammatory status (mGPS = 0) in 116 (62.4%) patients, mild systemic
inflammation in 16 (8.6%) and severe inflammation in 54 (29.0%) patients.
Obstructive jaundice was present in 44 (23.4%) patients and severe obstructive
jaundice was present in 31 (16.5%) patients. BMI data was available in 167
patients. More than half of these patients were overweight or obese with a BMI >
25 in 87 (52.1%) patients. All the variables necessary for calculation of the
POSSUM Physiology Score, a composite score of comorbidity and preoperative
biochemistry, were available in 180 patients and it was elevated in 87 (48.3%)
patients.
The relationship between preoperative clinico-pathological characteristics and
postoperative C-reactive protein levels is shown in Tables 5.1 and 5.2.
5.3.2 Preoperative vs. postoperative systemic
inflammation
The relationship between preoperative CRP and postoperative systemic
inflammation is depicted graphically in Fig. 5.1a and Fig. 5.1b on page 138. The
median CRP levels on the day of surgery and the first postoperative day (POD)
were significantly higher in patients who had an elevated preoperative CRP.
However, this association was not present after the first postoperative day.
Preoperative hypoalbuminemia on the other hand was associated with lower
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median postoperative CRP levels starting with POD 3. The median difference in
postoperative CRP between patients with or without preoperative
hypoalbuminemia was 30 g/l on POD 3 (p<0.045) and 53 g/l on POD 6 (p=0.002)
with lower CRP levels in patients with hypoalbuminemia. This relationship is
shown in Fig. 5.1b.
The trend in postoperative CRP appeared to differ depending on whether
preoperative CRP and albumin were independently deranged. Fig. 5.2 and Table
5.3 on page 139 show the results of this analysis. When both preoperative CRP
and preoperative albumin were normal, the trend in postoperative CRP is shown
by the solid line (Line 0 in Fig. 5.2). When preoperative CRP was elevated in the
presence of a normal preoperative albumin, postoperative CRP levels were
significantly elevated and remained elevated during the first postoperative week
(Line 1 in Fig. 5.2). However, hypoalbuminemia was associated with lower
postoperative CRP levels regardless of whether preoperative CRP was normal
(Line 2 in Fig. 5.2) or elevated (Line 3 in Fig. 5.2).
5.3.3 Obstructive jaundice vs. postoperative inflammation
Obstructive jaundice was associated with significant differences in the
postoperative systemic inflammatory response. The trends in postoperative CRP
were significantly different between the jaundiced and non-jaundiced patients.
Obstructive jaundice was associated with a significantly lower peak CRP on POD
2 (p=0.001) and this persisted until POD 6 (p=0.005, Table 5.1, 5.2). Median
postoperative CRP had an inverse relationship with severity of preoperative
obstructive jaundice (Fig. 5.1c).
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Figure 5.1: Relationship between preoperative factors and postoperative CRP
in the first week after pancreaticoduodenectomy.
(a) Preop. CRP vs. postop. CRP (b) Preop. Albumin vs. postop. CRP
(c) Preop. Bilirubin vs. postop. CRP
Elevated preoperative CRP was associated with a greater postoperative CRP
on the first postoperative day. Preoperative hypoalbuminemia was associated
with significantly lower postoperative CRP levels during the first postoperative
week after pancreaticoduodenectomy. Preoperative obstructive jaundice was also
associated with a significantly dampened postoperative systemic inflammatory
response.
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Figure 5.2: Relationship between preoperative CRP and postoperative CRP in
the presence or absence of preoperative hypoalbuminemia.
Elevated preoperative CRP in the absence of hypoalbuminemia was associated
with an exaggerated postoperative inflammatory response (line 1). However, pre-
operative hypoalbuminemia resulted in a dampened postoperative inflammatory
response regardless of the preoperative CRP (lines 2,3).
Table 5.3: The relationship between preoperative CRP and postoperative CRP
in the presence or absence of preoperative hypoalbuminemia in patients undergo-
ing pancreaticoduodenectomy.
Preop Albumin ≥ 35 g/l Preop Albumin < 35 g/l
CRP ≤ 10 mg/l CRP > 10 mg/l CRP ≤ 10 mg/l CRP > 10 mg/l p
n 74 16 42 54
Day 0 21 (12-35) 34 (25-72) 14 (10-19) 39 (27-53) <0.001
Day 1 122 (90-147) 164 (130-185) 110 (84-141) 145 (95-186) 0.002
Day 2 215 (155-268) 279 (196-304) 213 (168-257) 200 (152-248) 0.083
Day 3 198 (136-259) 229 (179-309) 174 (124-235) 179 (124-241) 0.056
Day 4 157 (97-238) 194 (128-281) 132 (83-184) 140 (79-216) 0.046
Day 5 129 (78-222) 164 (112-283) 95 (45-155) 102 (58-153) 0.003
Day 6 136 (66-195) 133 (77-226) 80 (38-167) 96 (54-159) 0.025
Day 7 123 (70-180) 127 (72-226) 76 (27-140) 109 (44-154) 0.037
p - Kruskal-Wallis test
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5.3.4 CPET, comorbidity vs. postoperative inflammation
Cardiopulmonary exercise testing was performed in 130 patients. V˙O2AT could not
be estimated in one patient. V˙O2AT was less than 10 ml/kg/min in 52 (40%) of
patients indicating reduced aerobic capacity in these patients. There was no
significant relationship between V˙O2AT, V˙O2Peak and postoperative CRP.
There was no significant, persistent relationship between postoperative CRP and
preoperative SIMD score, body mass index, preoperative haemoglobin levels or the
POSSUM Physiology score.
5.3.5 Body composition vs. postoperative inflammation
Body composition data was available for 90 patients. Visceral adipose tissue area
(cm2) was divided into tertiles as low (n=30, median 57.1 cm2, IQR 29.0-62.4),
moderate (n=30, median 128.9 cm2, IQR 119.0-150.8) and high (n=30, median
241.2 cm2, IQR 221.9-313.1). Subcutaneous adipose tissue area was divided into
tertiles as low (n=30, median 94.1 cm2, IQR 63.2-102.5), moderate (n=30, median
152.5 cm2, IQR 141.3-175.3) and high (n=30, median 253.9 cm2, IQR 203.2-290.3).
Skeletal muscle area was also divided into tertiles as low (n=30, median 96.7 cm2,
IQR 91.9-102.5), moderate (n=30, median 121.7 cm2, IQR 116.4-130.9) and high
(n=30, median 153.0 cm2, IQR 145.3-167.6).
The relationship between body composition and postoperative CRP is shown in
Table 5.4. Postoperative CRP was not related to any of the components of body
composition.
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Table 5.4: The relationship between postoperative CRP and body composition
in patients undergoing pancreaticoduodenectomy.
a. Visceral fat vs. postoperative CRP
Low Moderate High p
Day 0 22 (13-37) 26 (19-38) 30 (24-43) 0.161
Day 1 122 (89-179) 143 (108-165) 121 (80-161) 0.374
Day 2 189 (155-261) 244 (181-269) 200 (152-245) 0.326
Day 3 165 (104-214) 202 (132-287) 192 (136-248) 0.161
Day 4 113 (69-216) 166 (85-239) 157 (129-210) 0.409
Day 5 87 (45-176) 142 (59-200) 115 (95-168) 0.229
Day 6 75 (40-137) 148 (60-170) 146 (73-172) 0.167
Day 7 86 (31-141) 130 (64-174) 123 (66-175) 0.172
b. Subcutaneous fat vs. postoperative CRP
Low Moderate High p
Day 0 31 (19-44) 25 (15-33) 25 (18-42) 0.368
Day 1 132 (106-167) 125 (68-168) 120 (99-153) 0.431
Day 2 216 (155-247) 209 (181-278) 226 (157-268) 0.767
Day 3 156 (132-206) 189 (110-273) 217 (149-266) 0.306
Day 4 132 (88-214) 159 (84-232) 157 (108-216) 0.694
Day 5 105 (56-158) 115 (54-199) 121 (80-197) 0.690
Day 6 91 (40-147) 154 (56-170) 145 (76-174) 0.126
Day 7 95 (29-132) 117 (57-175) 136 (86-189) 0.089
c. Skeletal muscle vs. postoperative CRP
High Moderate Low p
Day 0 27 (18-37) 24 (18-43) 25 (17-44) 0.951
Day 1 108 (78-167) 131 (109-188) 140 (82-156) 0.090
Day 2 210 (155-278) 223 (163-282) 206 (162-245) 0.382
Day 3 203 (149-273) 174 (136-255) 166 (104-241) 0.356
Day 4 163 (117-218) 145 (96-232) 132 (79-180) 0.304
Day 5 138 (80-197) 115 (82-213) 88 (40-163) 0.135
Day 6 156 (84-179) 121 (57-192) 94 (42-147) 0.080
Day 7 130 (77-178) 105 (64-151) 100 (33-165) 0.237
Patients were divided into three equal groups based on each component of body
composition and the median CRP during the first postoperative after pancreatico-
duodenectomy was compared between these groups using the Kruskal-Wallis test.
No relationship was identified between body composition and postoperative CRP
levels. Values are median (inter-quartile range) for postoperative CRP (mg/l).
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5.4 Discussion
The results of the present study demonstrate that preoperative systemic
inflammation is associated with the magnitude of the postoperative systemic
inflammatory response in patients undergoing pancreaticoduodenectomy. The
results also appear to show that preoperative obstructive jaundice is associated
with a dampened systemic inflammatory response as measured by CRP levels.
Taken together, these results appear to suggest that the preoperative inflammatory
status of the patient plays an important role in modulating postoperative systemic
inflammation which may not simply be due to the effect of surgery and its sequelae.
The role of postoperative CRP in predicting complications after surgery has been
well established. A recent meta-analysis of six studies involving 1832 patients
reported that CRP level less than 135 mg/l on the fourth postoperative day had a
high negative predictive value of 89% for infectious complications [Warschkow
et al. 2012]. Postoperative CRP has been shown to predict complications after
pancreaticoduodenectomy by us (chapter 6) as well as other authors [Welsch et al.
2008; Hiyoshi et al. 2013; Kosaka et al. 2014]. The role of preoperative systemic
inflammation as measured by the modified Glasgow Prognostic Score or the
neutrophil-lymphocyte ratio has also been reported to be adversely affect long-term
survival in patients undergoing potentially curative surgery in over a hundred
studies involving a variety of gastrointestinal and non-gastrointestinal cancers.
However, preoperative systemic inflammation as measured by elevated C-reactive
protein or an abnormal modified Glasgow Prognostic Score is increasingly
recognised as an independent risk factor for postoperative infectious complications
[Mohri et al. 2014; Kubo et al. 2013; Moyes et al. 2009].
We hypothesized that preoperative systemic inflammation may adversely affect
postoperative immuno-modulation resulting in an abnormal response in patients
whose immune systems have been ‘primed’ before the surgical insult. This may
affect the healing processes as well as the patient’s ability to clear endotoxins and
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may predispose the patient to infective and other complications. The results of the
present study appear to support this hypothesis.
In this study, raised preoperative CRP in the absence of hypoalbuminemia was
associated with elevated postoperative systemic inflammation. However,
preoperative hypoalbuminemia was associated with significantly lower levels of
postoperative CRP. These apparently opposite effects of preoperative CRP and
albumin on the postoperative systemic inflammatory response is further evidenced
by the fact that the effect of elevated preoperative CRP on postoperative
inflammation is attenuated by the presence of preoperative hypoalbuminemia.
These results appear to suggest when hypoalbuminemia is present as part of
preoperative systemic inflammation, not only is the exaggerated postoperative
response due to elevated CRP lost but the response appears to be dampened.
The impact of hypoalbuminemia on the acute phase response was noted by
Christou and co-workers who performed a delayed type hypersensitivity (DTH)
skin test in addition to measuring acute phase markers including CRP, albumin,
white cell count, haemoglobin and immunoglobulins in 245 patients prior to
undergoing gastrointestinal surgery [Christou et al. 1989]. They noted that
hypoalbuminemia and anergy to the DTH skin test were the only variables
independently associated with postoperative sepsis-related mortality. Moreover,
both low albumin and elevated CRP were significantly associated with cutaneous
anergy. Cutaneous anergy is one of the hallmarks of the compensatory
anti-inflammatory response syndrome (CARS) [Ward et al. 2008].
Preoperative hypoalbuminemia has been reported to be a risk factor for
postoperative complications independent of both inflammation and nutritional
status [Gibbs et al. 1999; Don et al. 2004; Hennessey et al. 2010]. Albumin is a
negative acute phase protein and elevated CRP levels are often associated with low
serum albumin levels [Margarson et al. 1998]. Hypoalbuminemia in patients
scheduled to undergo pancreaticoduodenectomy is likely to be multi-factorial in
origin. Systemic inflammation, obstructive jaundice and the associated complex
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physiological, biochemical and immunological abnormalities, malnutrition, cancer
cachexia, changes in body composition including sarcopenic-obesity may all
contribute to low serum albumin levels. Contrary to our findings,
hypoalbuminemia and poor preoperative nutritional status were found to be
associated with higher postoperative levels of pro-inflammatory cytokines and
CRP in surgical patients [Nakamura et al. 1999]. The association of
hypoalbuminemia with obstructive jaundice may have influenced our findings.
In patients with pancreatic cancer, malignant obstructive jaundice further
complicates the preoperative inflammatory status and the behaviour of the
immune system [Nehe´z et al. 2002]. We reported in Chapter 3 that obstructive
jaundice was associated with elevated preoperative CRP and low serum albumin
on the day before surgery with a linear relationship with severity of jaundice
(Table 3.2 on page 90). Hypoalbuminemia in jaundiced patients persisted after
surgery in the present study. However, the CRP response appears to have reversed
in jaundiced patients. While preoperative CRP was elevated in jaundiced patients,
CRP levels after surgery were significantly lower in jaundiced patients with an
inverse relationship with severity of jaundice.
While preoperative biliary intervention and resolution of jaundice may be offered
as an explanation for the priming of the immune system in the non-jaundiced
patients, this does not explain the initially low preoperative CRP in these patients.
Padillo and co-workers reported that malignant obstructive jaundice was
associated with elevated CRP levels which only improved transiently following
biliary drainage. CRP returned to pre-drainage levels presumably due to bacterial
colonisation of the biliary tree [Padillo et al. 2002; Padillo et al. 2001a]. It would
therefore appear that obstructive jaundice adversely affects the ability to mount an
adequate postoperative inflammatory response and this may be further
compounded by the presence of hypoalbuminemia in these patients.
Immunosuppression and immune dysregulation have been recognised in patients
with obstructive jaundice [Scott-Conner et al. 1994]. Our results are similar to
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those reported by Mackenzie and Woodhouse who studied the CRP response to
bacteraemia in 126 critically ill patients with or without liver dysfunction
[Mackenzie et al. 2006]. Liver dysfunction was defined as serum bilirubin > 20
µmol/l and prothrombin time longer than 18 seconds. The CRP response to
bacteraemia was significantly lower in patients with liver dysfunction than in those
with normal liver function (103 vs. 146 mg/l, p=0.03). These findings have been
corroborated by other authors in patients with cirrhosis [Pieri et al. 2014; Janum
et al. 2011].
Although CRP on POD 0 was significantly different between patients with a
normal V˙O2AT/V˙O2Peak and those with low aerobic capacity, this difference was
not present on other days. The lack of association between aerobic capacity,
POSSUM Physiology Score and postoperative CRP in this study may have been
due to the dominant effect of preoperative systemic inflammation and obstructive
jaundice on the postoperative inflammatory response.
Richards and co-workers reported that elevated preoperative systemic
inflammation was related to low skeletal muscle index [Richards et al. 2012].
Hassen and co-workers reported that fat-free mass and skeletal muscle were
inversely related to the severity of the postoperative inflammatory response
following endo-vascular surgery for abdominal aortic aneurysm [Hassen et al.
2007]. Elevated systemic inflammation has been reported to be related to obesity
as well as sarcopenia. ‘Sarcopenic-obesity’ in patients with pancreatic cancer where
there is relative loss of skeletal muscle with preservation of adipose tissue puts
these patients at particular risk for immune dysfunction [Berg et al. 2005;
Reisinger et al. 2015], post-pancreatectomy complications [Joglekar et al. 2015] and
shorter long-term survival [Tan et al. 2009; Peng et al. 2012]. However, the present
study did not identify any relationship between body composition and
postoperative CRP levels. This may have been due to several reasons including the
effect of preoperative obstructive jaundice, hypoalbuminemia as well as cancer
related inflammation and body composition changes.
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5.4.1 Limitations of the study
The results in this study report the relationship between preoperative
clinico-pathological factors and postoperative systemic inflammation in patients
undergoing pancreaticoduodenectomy. The impact of complications on the
systemic inflammatory response was not studied here but has been reported
separately in Chapter 6. Moreover, it is not clear how the interaction between the
various preoperative factors, especially obstructive jaundice and systemic
inflammation affect postoperative inflammation or which variables are
independently associated with the postoperative inflammatory response.
Postoperative systemic inflammation is likely to be determined by multiple factors
including preoperative factors, intra-operative factors including magnitude of the
surgical insult, blood loss, anaesthetic factors as well as post-operative
complications. Further study of the inter-play between these factors extending
from the preoperative period into the early postoperative period will help elucidate
the complex interaction between preoperative inflammation, aerobic capacity and
obstructive jaundice on postoperative outcomes.
5.4.2 Conclusion
The results presented in this study emphasise the importance of the preoperative
inflammatory status of the patient in influencing postoperative systemic
inflammation. The results also demonstrate the immunosuppressive effects of
obstructive jaundice in patients undergoing pancreaticoduodenectomy.
Chapter 6
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6.1 Introduction
Pancreaticoduodenectomy is associated with significant morbidity in spite of
advances in patient selection, perioperative care and surgical technique. Early
identification of complications can help improve outcomes by better allocation of
critical care resources and aggressive early-rescue strategies [Ferraris VA et al.
2014]. Postoperative pancreatic fistula is one of the most dreaded complications
after a pancreaticoduodenectomy and can lead to a cascade of other complications
including delayed haemorrhage, infected intra-abdominal collections, delayed
gastric emptying, prolonged hospitalisation and in some cases, death. The
International Study Group for Pancreatic Fistula (ISGPF) have not only defined
what constitutes a post-operative pancreatic fistula but have also graded the
severity of this complication based on its impact on the management of the patient
[Bassi et al. 2005a]. However, these definitions are applied after the event and
there are no clear strategies to predict the severity of complications.
Postoperative CRP levels have been shown to predict infective complications after
major surgery including colorectal, oesophago-gastric and pancreatic surgery
[Mustard et al. 1987; Matthiessen et al. 2008; McNeer et al. 2010; Dutta et al.
2011; MacKay et al. 2011; Murakami et al. 2008; Welsch et al. 2008]. It has been
postulated that an unmitigated and exaggerated systemic inflammatory response
in the early postoperative period is followed by a compensatory anti-inflammatory
response that predisposes the patient to sepsis and impaired healing [Bone et al.
1997; Bone 1996].
However, the mechanisms underlying the pathogenesis of post-operative pancreatic
fistula are largely attributed to anatomical factors including soft texture of the
pancreas and small pancreatic duct diameter as well as surgical technique with
increased intra-operative blood loss and pancreatico-jejunostomy rather than
pancreatico-gastrostomy being associated with increased incidence of anastomotic
leakage [Pratt et al. 2008a; Xiong et al. 2014]. The association between the early
postoperative systemic inflammatory response and the severity of postoperative
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pancreatic fistula has not been reported. Moreover, the role postoperative CRP in
predicting infective complications when these occur in association with
postoperative pancreatic fistula has not been studied either.
6.1.1 Aim
The aim of this study was to investigate the association between trends in
postoperative systemic inflammation, postoperative pancreatic fistula and infective
complications in patients undergoing pancreaticoduodenectomy.
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6.2 Patients and methods
6.2.1 Patients
Patients who underwent elective pancreaticoduodenectomy between January 2008
and December 2012 at the West of Scotland Pancreatic Unit at the Glasgow Royal
Infirmary were included in this study. Patients who underwent only a trial
dissection or palliative surgical bypass for unresectable disease during this period
were excluded.
6.2.2 Perioperative care
All patients were given antibiotic prophylaxis at induction and this was continued
for 24 hours after surgery. All patients had general anaesthesia supplemented
either with epidural analgesia or spinal diamorphine and patient-controlled opiate
analgesia for postoperative pain relief. Octreotide (200µg) was administered
subcutaneously three times a day for 5 days in all patients and continued longer in
patients diagnosed with a postoperative pancreatic fistula. Patients were routinely
admitted to the surgical high dependency unit where a standardised regimen was
followed for early mobilisation, chest physiotherapy and early enteral nutrition. All
patients had one or two surgical drain(s) placed at the time of surgery which were
removed at the clinician’s discretion during the postoperative period based on the
presence or absence of postoperative pancreatic fistula or other intra-abdominal
collections. Further details regarding operative technique and postoperative care
are provided in Chapter 1.
6.2.3 Biochemical parameters
Patients had routine measurements of inflammatory markers including C-reactive
protein (CRP) from the day before surgery and every day for at least a week after
Chapter 6. Postoperative CRP and complications 151
surgery. These results were collected from the hospital laboratory database using
an automated MS Access application as outlined in Appendix A.
6.2.4 Complications and severity grading
All complications were discussed at a weekly morbidity meeting and prospectively
recorded in an electronic database. The diagnosis and grading of pancreas-specific
complications including postoperative pancreatic fistula (POPF, Section 1.2.4.1)
were made according to the International Study Group classifications [Bassi et al.
2005a] as shown in Table 1.1 on page 10. A postoperative pancreatic fistula was
defined as drain output of any measurable quantity after the third postoperative
day with amylase content greater than three times the upper limit of the normal
serum amylase value at our laboratory.
All other complications were graded using the Clavien-Dindo classification system
[Clavien et al. 2009; Dindo et al. 2004] as shown in Table 1.3. This allowed grading
of the severity of complications based on the magnitude of intervention(s) required
to treat them. Postoperative mortality was defined as death within 30-days of
surgery or while still in hospital after the operation. Re-intervention in the form of
radiological, endoscopic or surgical procedures was recorded prospectively.
6.2.5 Statistics
Continuous data are presented as median (inter-quartile range, IQR) unless
otherwise specified. Mann-Whitney U test was used to compare the distribution of
postoperative CRP (as a continuous variable) in patients who had a complication
and those who did not. Line plots with error bars depicting 95% confidence
intervals were used to depict the trends in CRP over time across different patient
groups.
Receiver operating characteristic (ROC) analysis [Robertson et al. 1981; Zweig
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et al. 1993] was used to identify the optimum thresholds for postoperative CRP for
predicting infective complications with a preference for thresholds that had a
greater negative predictive value.
Patients were categorised using these thresholds to analyse the relationship
between CRP (as a categorical variable) and re-operation, hospital stay, critical
care stay, number of critical care admissions as well as postoperative mortality
using the Chi-square test.
SPSS software (Version 22.0; IBM, USA) was used to perform statistical analysis.
Effects were considered significant at α ≤ 0.05.
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6.3 Results
6.3.1 POPF, infective complications and other outcomes
Pancreaticoduodenectomy was performed in 188 patients (126 male, 67%) during
the study period. The median age was 63.5 years (IQR 54 - 70 years). 79 (42%)
patients were over the age of 65 years.
Post-operative pancreatic fistula (POPF) as defined by the International Study
Group for Pancreatic Fistula (ISGPF) occurred in 62 (33%) patients. Of these
patients, 19 (10.1%) had a Grade A POPF, 25 (13.3%) had a Grade B POPF and
18 (9.6%) had a Grade C POPF. Significant infective complications of
Clavien-Dindo grade 3 or higher occurred in 84 patients. Infective complications
were more common in patients with age >65 years (35.6% vs. 50.0%, p=0.046)
and V˙O2AT<10 ml/kg/min (28.8% vs. 52.4%, p=0.006). Sex, body mass index,
smoking status, modified Glasgow Prognostic Score, preoperative serum bilirubin
and POSSUM physiology score were not associated with infective complications.
Infective complications were also significantly associated with other complications
including post-operative pancreatic fistula, post-pancreatectomy haemorrhage as
well as length of stay in hospital, critical care stay, number of critical care
admissions, re-operation rates and in-hospital mortality (Table 6.2).
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Table 6.1: The relationship between preoperative clinicopathological charac-
teristics and infective complications in patients undergoing pancreaticoduodenec-
tomy.
Infective complication
CD 0 - 2 CD 3 - 5 p
Age (years) ≤65 67 (64.4%) 42 (50.0%) 0.046
>65 37 (35.6%) 42 (50.0%)
Sex Male 70 (67.3%) 56 (66.7% ) 0.926
Female 34 (32.7%) 28 (33.3%)
BMI (kg/m2) ≤25 48 (50.5%) 37 (46.3%) 0.573
>25 47 (49.5%) 43 (53.8%)
Smoking No 53 (62.4%) 44 (59.5%) 0.709
Yes 32 (37.6%) 30 (40.5%)
mGPS 0 67 (64.4%) 49 (59.8%) 0.570
1 7 (6.7%) 9 (11.0%)
2 30 (28.8%) 24 (29.3%)
Bilirubin (µmol/l) ≤35 66 (63.5%) 47 (56.0%) 0.574
35 - 250 22 (21.2%) 22 (26.2%)
>250 16 (15.4%) 15 (17.9%)
V˙O2AT (ml/kg/min) ≥10 47 (71.2%) 30 (47.6%) 0.006
<10 19(28.8%) 33 (52.4%)
PPS ≤14 56 (56.0%) 37 (46.3%) 0.193
>14 44 (44.0%) 43 (53.8%)
CD - Clavien-Dindo Grade, BMI - Body Mass Index
mGPS - Modified Glasgow Prognostic Score
PPS - POSSUM Physiology Score
p - Chi-square test
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Table 6.2: The relationship between infective complications and other adverse
events in patients undergoing pancreaticoduodenectomy.
Infective complication
CD 0 - 2 CD 3 - 5 p
POPF No 85 (81.7%) 41 (48.8%) <0.001
Grade A 10 (9.6%) 9 (10.7%)
Grade B 7 (6.7%) 18 (21.4%)
Grade C 2 (1.9%) 16 (19.0%)
PPH No 95 (92.2%) 64 (77.1% ) 0.048
Grade A 2 (1.9%) 2 (2.4%)
Grade B 2 (1.9%) 6 (7.2%)
Grade C 4 (3.9%) 11 (13.2%)
Postoperative stay ≤14 days 65 (62.5%) 17 (20.2%) <0.001
>14 days 39 (37.5%) 67 (79.8%)
Critical care stay ≤7 days 84 (80.8%) 34 (40.5%) <0.001
>7 days 20 (19.2%) 50 (59.5%)
Critical care admissions 1 92 (88.5%) 53 (63.1%) <0.001
>1 12 (11.5%) 31 (36.9%)
Reoperation No 99 (95.2%) 64 (76.2%) <0.001
Yes 5 (4.8%) 20 (23.8%)
In-hospital mortality No 103 (99.0%) 76 (90.5%) 0.006
Yes 1 (1.0%) 8 (9.5%)
POPF - Post-operative pancreatic fistula
PPH - Post-pancreatectomy haemorrhage
p - Chi-square test
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6.3.2 Postoperative CRP vs. POPF
Postoperative CRP levels on days 2 through 7 were significantly higher in patients
who developed a postoperative pancreatic fistula (p = 0.002 for CRP on Day 2 and
p<0.001 for CRP on Days 3 through 7, Mann-Whitney U test). These results are
presented in Table 6.3 and Fig. 6.1 on page 157. Fig. 6.1b shows that CRP in the
first postoperative week was not significantly different between postoperative
pancreatic fistulae of ISGPF Grade A, B and C.
However, there is no useful clinical application for the association between CRP in
the early postoperative period and pancreatic fistula as the diagnosis of POPF is
based on the amylase content in surgical drains on the third postoperative day.
Moreover, early postoperative CRP did not predict the severity of the pancreatic
fistula.
6.3.3 Postoperative CRP vs. infective complications
The median CRP levels on or after postoperative day 3 were significantly higher in
patients who developed clinically significant infective complications in the absence
of a POPF (Fig. 6.2a). However, there was no such association between CRP and
infective complications in patients who developed a POPF (Fig. 6.2b).
For instance, the median CRP on Day 4 in patients who did not develop a POPF
and did not have an infective complication was 97 mg/L (IQR 71 - 174) but was
173 mg/L if they had an infective complication. (p<0.001). However, in patients
who had a POPF, the CRP on day 4 was 214 mg/L (IQR 151 - 250) in the absence
of infective complications and 190 mg/L (IQR 137 - 252) in the presence of
infective complications. (p = 0.559)
Therefore, CRP on or after the third postoperative day appears to be useful in
predicting infective complications only in patients who did not develop a POPF
and these results are shown in Table 6.4 and Fig. 6.2 on page 158.
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Figure 6.1: Serum CRP levels in the first week after pancreaticoduodenectomy
in patients with postoperative pancreatic fistula (POPF).
(a) POPF Absent vs. Any Grade (b) POPF ISGPF Grades
Median daily CRP levels in the first postoperative week in 188 patients undergo-
ing pancreaticoduodenectomy were compared between patients who developed a
postoperative pancreatic fistula (POPF) and those who did not develop a POPF.
Figure A shows a significantly raised CRP in the presence of a pancreatic fistula.
However, severity of POPF did not affect CRP levels in the first postoperative
week as shown in Figure B. Error bars represent 95% confidence interval for the
median.
Table 6.3: The relationship between CRP during the first postoperative week
and post-operative pancreatic fistula (POPF) in patients undergoing pancreatico-
duodenectomy.
POPF ISGPS Grades - p
Postop Day No vs. Any Grade No vs. A A vs. B B vs. C
0 0.722 0.582 0.849 0.730
1 0.242 0.331 0.740 0.295
2 0.002 0.161 0.222 0.563
3 <0.001 0.022 0.602 0.530
4 <0.001 0.007 0.906 0.834
5 <0.001 0.035 0.611 0.959
6 <0.001 0.012 0.638 0.781
7 <0.001 0.006 0.235 0.356
p - Mann-Whitney U test
ISGPS - International Study Group for Pancreatic Surgery
POPF - Postoperative Pancreatic Fistula
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Figure 6.2: Relationship between postoperative CRP and clinically significant
infective complications in patients without (A) and with (B) POPF.
(a) Patients with no POPF (b) Patients with POPF
Median CRP was significantly higher in patients who developed infective compli-
cations in the absence of a pancreatic fistula (A). This difference was not seen in
the presence of POPF(B). Error bars - 95% confidence interval for the median.
Table 6.4: The relationship between postoperative CRP and infective compli-
cations grouped by absence/presence of postoperative pancreatic fistula.
POPF Absent POPF Present
Infective Complication Infective Complication
Postop Day No Yes p No Yes p
(n=85) (n=41) (n=19) (n=43)
0 24 25 0.379 27 25 0.629
(12 - 42) (14 - 41) (13 - 44) (16 - 34)
1 122 123 0.667 148 116 0.038
(85 - 156) (87 - 148) (114 - 176 ) (94 - 161)
2 204 218 0.203 242 228 0.919
(136 - 242) (165 - 262) (181 - 279) (186 - 296)
3 157 213 0.011 206 226 0.846
(105 - 211) (150 - 258) (180 - 297) (175 - 281)
4 97 173 <0.001 214 190 0.559
(71 - 174) (118 - 216) (151 - 250) (137 - 252)
5 76 122 <0.001 140 167 0.639
(40 - 129) (87 - 202) (115 - 218) (111 - 222)
6 64 121 <0.001 148 168 0.275
(31 - 133) (87 - 172) (78 - 182) (109 - 224)
7 62 141 <0.001 158 167 0.644
(25 - 106) (90 - 190) (90 - 231) (101 - 226)
Values are median (inter-quartile range; p - Mann-Whitney U test)
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6.3.4 Receiver operating characteristic (ROC) analysis
Receiver operating characteristic (ROC) analysis was undertaken to find the
optimum threshold for the relationship between CRP and infective complications
in patients without POPF. ROC curves were plotted with CRP as a continuous
variable and infective complication as a dichotomous outcome variable for
postoperative days 3 through 7.
The area under curve (AUC) was significantly higher than 0.5 for CRP on days 3
though 7. The optimum thresholds along with the corresponding sensitivity,
specificity, negative predictive value, positive predictive value, 95% confidence
intervals (CI) and p-values are shown in Table 6.5 and the corresponding ROC
curves are shown in Fig. 6.3 on page 160. The thresholds were identified with a
bias towards a higher negative predictive value to allow identification of patients
who did not develop an infective complication.
A CRP level of 125 mg/L on the fourth postoperative day had a sensitivity of 74%
and specificity of 64% with a negative predictive value of 83% for predicting
infective complications (AUC 0.71, 95%CI 0.61 - 0.80, p<0.001). The AUC
improved to 0.80 on day 7 but only with a modest increase in the negative
predictive value to 87%, with corresponding sensitivity, specificity of 65% and 81%
respectively (95%CI 0.72 - 0.88, p<0.001).
The relationship between CRP on the fourth day and other postoperative events is
shown in Table 6.6. There were no deaths in this group of patients who did not
have a POPF.
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Figure 6.3: Receiver operating characteristics analysis of C-reactive protein as
a marker of postoperative infective complications.
(a) Day 3 (b) Day 4 (c) Day 5
(d) Day 6 (e) Day 7
In the 126 patients who did not develop a postoperative pancreatic fistula, C-
reactive protein levels as early as the third and fourth postoperative days had a
high negative predictive value of 0.79 (for Day 3 CRP ≤ 178 mg/l) and 0.83 (for
Day 4 CRP ≤125 mg/l ) respectively for the prediction of infective complications.
Table 6.5: Receiver operating characteristics analysis of C-reactive protein as a
marker of postoperative infective complications in patients who did not develop a
POPF
Day AUC p 95% CI CRP Spec. Sens. NPV PPV
3 0.64 0.011 0.54 - 0.74 178 0.66 0.64 0.79 0.48
4 0.71 <0.001 0.61 - 0.80 125 0.64 0.74 0.83 0.50
5 0.70 <0.001 0.61 - 0.80 107 0.64 0.63 0.78 0.45
6 0.73 <0.001 0.65 - 0.82 92 0.68 0.73 0.84 0.53
7 0.80 <0.001 0.72 - 0.88 87 0.65 0.81 0.87 0.52
AUC - Area under curve, Spec. - Specificity, Sens. - Sensitivity
NPV - Negative Predictive Value, PPV - Positive Predictive Value
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Table 6.6: The relationship between CRP on Day 4 and other postoperative
events in patients with no POPF.
Day 4 CRP (mg/l)
≤125 >125 p
Postoperative stay Days 12 (9 - 16) 15 (13 - 26) <0.001a
(days) ≤14 43 (66.2%) 30 (49.2%) <0.054b
>14 22 (33.8%) 31 (50.8%)
Critical care stay Days 6 (4 - 7) 7 (5 - 10) 0.001a
(days) ≤7 57 (87.7%) 38 (62.3%) 0.001b
>7 8 (12.3%) 23 (37.7%)
Crit. care admissions 1 60 (92.3%) 48 (78.7%) 0.029b
>1 5 (7.7%) 13 (21.3%)
Reoperation No 63 (96.9%) 57 (93.4%) <0.359b
Yes 2 (3.1%) 4 (6.6%)
a - Mann-Whitney U test; b - Chi-square test
In patients who did not develop a postoperative pancreatic fistula (n=126), CRP
≤ 125 mg/l on the fourth postoperative day was associated with shorter stay in
hospital, fewer days in critical care and lower rate of readmission to critical care.
Chapter 6. Postoperative CRP and complications 162
6.4 Discussion
The results of the present study show that the severity of the postoperative
systemic inflammatory response as measured by serial serum CRP levels in the
first week is associated with postoperative complications after
pancreaticoduodenectomy. The results also demonstrate that postoperative CRP
trends are more useful in predicting infective complications in patients who did not
develop a post-operative pancreatic fistula.
While numerous studies have reported on a variety of methods to predict as well as
diagnose POPF, few have reported on the role of CRP in predicting complications
other than POPF.
The introduction of the ISGPF definition for POPF has made the diagnosis of this
complication simple and uniform [Bassi et al. 2005a]. The rate of POPF before the
standardised definition was introduced varied anywhere between 2% and 40%.
However, in the post-ISGPF era, the rate of POPF in published literature has
remained approximately 25% [Knight et al. 2010]. The sole criterion for the
diagnosis of POPF is a drain amylase content on or after the third postoperative
day three times the upper limit of normal for serum amylase in the testing
laboratory [Bassi et al. 2005a] .
In the present study, while CRP was significantly greater in patients with POPF,
this difference did not occur until the second postoperative day and therefore had
no further clinical use in the prediction of this complication. The early rise in CRP
in patients who developed a POPF is expected as the most common risk factors for
POPF are encountered intra-operatively including soft pancreatic texture, small
pancreatic duct size and operative blood loss. Soft pancreatic texture has in fact
been reported to be associated with elevated CRP levels after
pancreaticoduodenectomy [Murakami et al. 2008].
However, the magnitude of increase in CRP during the first postoperative week
was not associated with the severity of POPF. This lack of association appears to
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suggest that the determinants of the severity of POPF may occur later in the
postoperative course and are not related to the magnitude of the initial systemic
inflammatory response.
The presumed cascade of events following a POPF involves accumulation of
amylase rich fluid in the peritoneal cavity around recently dissected tissues and
ligated blood vessels. This can lead to localised collections that can become
secondarily infected, result in erosion of blood vessels resulting in
post-pancreatectomy haemorrhage, result in delayed gastric emptying or
postoperative ileus as well as respiratory complications including sympathetic
pleural effusions or pneumonic consolidation. In fact, most large series report a
close association between POPF and PPH with the latter often following the
former [Choi et al. 2004; Koukoutsis et al. 2006; Tien et al. 2005]. The eventual
outcome in patients with POPF is often determined by the cascade of
complications associated with the POPF itself. In fact, all deaths in this study
were in patients who developed POPF.
However, in patients without a POPF, CRP in the first week after surgery was
associated with infective complications and preceded the clinical manifestation of
complications. The postoperative course of patients who do not develop a POPF is
not dissimilar to that in patients undergoing other major gastrointestinal
resectional surgery such as colorectal or oesophago-gastric surgery. The impact of
the systemic inflammatory response and the compensatory anti-inflammatory
response in these patients is not confounded by the presence of POPF. Our results
show that once the absence of POPF is confirmed by normal drain amylase content
on the third postoperative day, serum CRP on the next (fourth) postoperative day
less than 125 mg/L had a negative predictive value of 83% in excluding an
infective complication.
The results of this study are similar to the findings of Welsch and co-workers who
analysed 688 patients undergoing a variety of pancreatic resections with
pancreaticojejunal anastomosis [Welsch et al. 2008]. They compared 91 patients
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who developed an ’inflammatory postoperative complication’ with a random subset
of 60 consecutive pancreatic resections. They reported that a threshold of 140
mg/L for serum CRP on the fourth postoperative day had the best diagnostic
accuracy for the prediction of inflammatory postoperative complications
(sensitivity 69.5%, specificity 87.1%, positive predictive value 48.7% for an
estimated prevalence of 15%). However, the definitions used for POPF in this
study were different from the ISGPF definition and the authors did not report on
the predictive ability of CRP in the presence or absence of a POPF. Moreover,
Grade A and B POPF were not included in the analysis. Our results clearly
demonstrate that early CRP elevation occurs in all grades of POPF with no
difference between the different grades.
In the present study, preoperative systemic inflammation as measured by the
modified Glasgow Prognostic Score was not associated with infective
complications. A preoperative acute phase response has been reported to be
associated with an exaggerated postoperative systemic inflammatory response and
septic complications [Haupt et al. 1997]. The modified Glasgow Prognostic Score, a
validated measure of preoperative systemic inflammation, has also been reported
to be associated with postoperative infective complications in patients undergoing
curative colorectal resections [Moyes et al. 2009].
The lack of association between the modified Glasgow Prognostic Score and
complications in the present study may have been due to the multiple factors that
are responsible for preoperative systemic inflammation in these patients including
obstructive jaundice, cholangitis, biliary drainage procedures and pancreatitis
consequent to intervention or pancreatic duct obstruction by tumours. These
findings are similar to those reported by Dutta and co-workers who did not find
any relationship between preoperative systemic inflammation and postoperative
complications in patients undergoing oesophago-gastric surgery [Dutta et al. 2011].
The temporal association between CRP and infective complications may reflect the
sensitivity of CRP as a marker of systemic inflammation. This finding is similar to
Chapter 6. Postoperative CRP and complications 165
one of the earliest reports on the role of serial CRP measurements in predicting
septic complications after surgery [Mustard et al. 1987] as well as in several
subsequent reports [Matthiessen et al. 2008; Welsch et al. 2008; Dutta et al. 2011].
This study was not designed to look at inflammatory markers later in the
postoperative period. However, Mustard and co-workers monitored CRP, white
cell count and temperature for 14 days after surgery and found that CRP was the
only reliable marker of septic complications [Mustard et al. 1987].
Several mechanisms have been postulated to explain the association between
postoperative CRP and complications. The most common explanation is that the
CRP rise is consequent to tissue ischaemia, necrosis at the anastomotic site,
bacterial translocation from the gut or bacterial infection of wounds. However, our
findings and that of other authors show that the difference in CRP occurs very
early in the postoperative period before infective complications become clinically
manifest.
More recently, the compensatory anti-inflammatory response with the associated
immunosuppressive effects has been recognised as a possible factor in predisposing
the patient to infective complications and delayed wound healing. Such an
anti-inflammatory response is proportional to the initial systemic inflammatory
response and therefore patients with an exaggerated inflammatory response in the
immediate aftermath of surgery may be at increased risk of developing
complications [Ward et al. 2008].
Mokart and co-workers studied trends in inflammatory cytokine levels in the serum
of 30 patients undergoing major abdominal surgery for cancer [Mokart et al. 2002].
They reported that the levels of anti-inflammatory cytokines IL-10 and IL-1ra were
significantly greater in patients who developed infective complications and were
correlated with IL-6 levels on the first postoperative day. T-cell function is also
depressed after surgical trauma and the degree of suppression is related to the
initial pro-inflammatory response and IL-6 [Faist et al. 1997]. The complex
interactions between the pro and anti-inflammatory processes, neurohormonal
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factors of the stress response, the role of the blood-gut barrier in bacterial
translocation, local factors including tissue ischaemia and damage, the
immunological effects of anaesthesia, blood transfusion and hypothermia remain
the subject of ongoing research [Buttenschoen et al. 2010].
One of the most important strengths of this study is the separate analysis of
infective complications in patients who did not develop a POPF. Other strengths
of this study include the homogeneous cohort of patients all of who underwent a
pancreaticoduodenectomy, the serial measurements of CRP on every day of the
first postoperative week, prospective record of complications and use of the ISGPF
definition for POPF. We did not measure levels of other inflammatory cytokines
routinely in these patients. Future work should be aimed at characterising the
inflammatory cytokine profile after pancreaticoduodenectomy to identify potential
targets for immunomodulation in the perioperative period.
In summary, the advent of enhanced recovery protocols in surgery including
pancreatic surgery requires the early identification of patients not only at increased
risk of complications but also those who are likely to have an uncomplicated
course. This allows early identification of patients who are expected to continue on
the enhanced recovery pathway and allocation of resources to improve the
management of patients who are likely to develop complications. A recent
meta-analysis of seven studies including 1427 patients established the value of
CRP on the third postoperative day in identifying patients who are safe for early
discharge on an enhanced recovery programme [Straatman et al. 2015]. This study
shows that CRP on the third postoperative day is associated with infective
complications in patients undergoing pancreaticoduodenectomy who do not
develop a POPF but not in patients with a POPF.
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7.1 Summary
The overall aim of the thesis was to examine the inter-relationships between
preoperative clinico-pathological characteristics including cardiopulmonary exercise
physiology, obstructive jaundice, body composition and preoperative systemic
inflammation and post-operative complications and the post-surgical systemic
inflammatory response in patients undergoing pancreaticoduodenectomy.
The present work also examined the factors that affect cardiopulmonary exercise
physiology in order to enable a better understanding of the complex
pathophysiology in these patients that is a consequence of the interaction of the
patient’s chronic conditions with the acute derangements brought on by pancreatic
disease, including obstructive jaundice.
This was one of the largest studies involving patients who underwent
cardiopulmonary exercise testing before undergoing pancreaticoduodenectomy in a
tertiary specialist pancreato-biliary unit in the West of Scotland. The results
presented here demonstrate the clinical utility of cardiopulmonary exercise testing
in major pancreatic surgery in the largest cohort of patients in published literature.
The thesis also examined the effect of obstructive jaundice including severe
obstructive jaundice on cardiopulmonary exercise physiology and postoperative
systemic inflammation in this cohort. We are not aware of any other published
reports on this subject.
This work also demonstrated a novel application of the trends in postoperative
CRP in identifying patients at risk of infective complications which is different from
the accepted paradigm for the use of postoperative CRP in published literature.
The results presented here provide the foundations for future work on
prehabilitation, mitigating perioperative risks and improving outcomes after
pancreaticoduodenectomy.
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7.2 Clinical utility of CPET
7.2.1 Risk assessment and predicting complications
The results presented in chapter 2 demonstrated that cardiopulmonary exercise
testing had a role in identifying high risk patients who were more likely to develop
complications, stay longer in hospital and were less likely to receive adjuvant
therapy after pancreaticoduodenectomy. These findings have since been replicated
by other authors examining the role of cardiopulmonary exercise testing in
pancreatic surgery.
Ausania and co-workers evaluated the role of cardiopulmonary exercise testing in
122 patients who underwent a pancreaticoduodenectomy [Ausania et al. 2012b]
Low V˙O2AT (<10.1 ml/kg/min) was the only independent predictor of a
postoperative pancreatic fistula. The incidence of a postoperative pancreatic
fistula was 45% in patients with a low V˙O2AT while it was only 19% in patients
with a normal V˙O2AT (p=0.02). The association between V˙O2AT and postoperative
pancreatic fistula was independent of pancreatic duct size, body mass index,
obstructive jaundice or preoperative biliary drainage. They also reported in a
separate study of 50 patients that complication rates were higher in patients with a
low V˙O2AT undergoing palliative surgical bypass for advanced pancreatic cancer
[Ausania et al. 2012a].
Junejo and co-workers identified elevated V˙E/V˙CO2 to be an independent predictor
of 30-day mortality after pancreaticoduodenectomy in their study that included 64
patients who had undergone cardiopulmonary exercise testing [Junejo et al. 2014b].
However, they also noted that a high V˙E/V˙CO2 was also associated with poor
long-term survival.
The results of our work in chapter 2 as well as that of several others over the past
two decades support the use of cardiopulmonary exercise testing as a clinical risk
assessment tool in patients undergoing major surgery.
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7.2.2 Assessing impact of prehabilitation and neoadjuvant
treatment
Our results also suggest that a better understanding of the determinants of aerobic
capacity as well as the perioperative systemic inflammatory response will enable
clinicians to identify high risk patients and optimise their perioperative care.
In a recent study of 8266 patients undergoing pancreaticoduodenectomy in the
United States, Tzeng and co-workers reported that a third (3033) were of
borderline fitness as a consequence of advanced age (> 80 years), poor performance
status, weight loss > 10%, pulmonary disease, recent myocardial infarction/angina,
stroke history, and/or preoperative sepsis. Major complications (31.3 vs. 26.2%)
and mortality (4.1 vs. 2.3%) were greater in patients with borderline fitness [Tzeng
et al. 2014]. The authors recommended that surgeons identify these patients early,
institute interventions to optimise their comorbidities and enrol these patients for
prehabilitation.
Neoadjuvant treatments were associated with significant reduction in V˙O2AT and
V˙O2Peak in patients with rectal cancer [West et al. 2014] and oesphago-gastric
cancer [Jack et al. 2014]. West and co-workers used prehabilitation to return
aerobic capacity, as measured by cardiopulmonary exercise testing, to baseline
levels in patients with locally advanced rectal cancer undergoing neo-adjuvant
chemoradiotherapy [West et al. 2015]. Neoadjuvant therapy in borderline
resectable pancreatic cancer is the subject of several trials with generally promising
results [Evans et al. 2008; Gillen et al. 2010; Golcher et al. 2015; Kim et al. 2013;
Sahora et al. 2014].
The impact of neoadjuvant treatment on fitness in patients with pancreatic cancer
are likely to be similar or worse to that observed in other cancer patients.
Prehabilitation can play an important role in improving outcomes in these patients
while cardiopulmonary exercise testing serves as an objective clinical tool to
quantify the impact of prehabilitation.
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7.2.3 Assessing impact on long-term survival
There is some evidence that cardiopulmonary exercise testing may predict
long-term survival after pancreaticoduodenectomy for pancreatic cancer [Junejo
et al. 2014b]. Reduced aerobic capacity was also associated with poor survival in
patients with lung cancer [Jones et al. 2010] and reduced long-term survival after
abdominal aortic aneurysm surgery [Tang et al. 2012; Grant et al. 2015].
While an elevated preoperative systemic inflammatory response was associated
with shorter survival in patients with pancreatic cancer, both after potentially
curative surgery [Jamieson et al. 2005; Torre et al. 2012] or palliation for advanced
disease [Glen et al. 2006], the impact of aerobic capacity on long-term survival in
patients with pancreatic cancer is less clear. Some have suggested that comorbidity
was associated with shorter survival in patients with pancreatic cancer
[Dias-Santos et al. 2015]. However, other authors have reported that the relatively
short median survival after pancreatic cancer surgery is not affected by
comorbidity whose effects are more long-term [Kos et al. 2014].
Further studies examining the relationship between aerobic capacity measured
using objective methods and long-term survival are important. Aerobic capacity is
a relatively easy therapeutic target that may have the potential to improve not
only short-term but also long-term outcomes.
7.3 Prehabilitation, improving aerobic capacity
and mitigating risk
In Chapters 3 and 4 we examined the preoperative patient factors that had an
adverse effect on aerobic capacity. A better understanding of the factors that affect
V˙O2 may identify potential therapeutic targets or modifiable risk factors that may
be used to improve patient fitness and mitigate the risks of surgery. We found that
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female sex, high body mass index, anaemia, presence of cancer and elevated CRP
were all associated with either a low V˙O2AT or a low V˙O2Peak.
7.3.1 Obstructive jaundice
In our opinion, the most important observation made in chapter 3 was the lack of
association between obstructive jaundice and cardiopulmonary function. We are
aware of only one other similar study by Junejo and co-workers. They reported
that peripheral oxygen extraction was normal during cardiopulmonary exercise in
patients with malignant obstructive jaundice [Junejo et al. 2014a]. Preoperative
biliary drainage is unlikely to improve aerobic fitness or modify their
cardiopulmonary response to exercise/surgery [Parker et al. 2014].
We also demonstrated the immunosuppressive effects of obstructive jaundice on
the postoperative systemic inflammatory response in chapter 5. To our knowledge,
this is the first detailed study of the postoperative systemic inflammatory response
in jaundiced versus non-jaundiced patients undergoing pancreaticoduodenectomy.
In their, appropriately titled paper ‘The Quandary of Preresection Biliary
Drainage for Pancreatic Cancer’, the authors discuss the complex physiological
effects of obstructive jaundice, its impact on immune function and the differences
between findings in animal studies and humans [Tol et al. 2012]. However, they
also review recent literature where there appears to be overwhelming evidence that
preoperative biliary drainage increases the incidence of postoperative
complications, especially infective complications [Gaag et al. 2010; Arkadopoulos
et al. 2014; Fujii et al. 2015; Furukawa et al. 2015].
In chapter 2 we reported that obstructive jaundice was not associated with
increased incidence of postoperative complications or prolonged hospital stay.
Taken together, our results support the emerging view that preoperative biliary
drainage should no longer be performed routinely in all patients undergoing a
pancreaticoduodenectomy unless specifically indicated such as in cholangitis.
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7.3.2 Systemic inflammation
We reported on the preoperative factors affecting postoperative systemic
inflammation in chapter 5 and the clinical utility of monitoring trends in the early
postoperative systemic inflammatory response in predicting complications in
chapter 6.
Preoperative systemic inflammation is increasingly recognised as playing an
important role in determining not only long-term outcomes but also short-term
outcomes after cancer surgery [Kubo et al. 2013; Mohri et al. 2014; Moyes et al.
2009; Neal et al. 2011; Vashist et al. 2010; Haupt et al. 1997]. While we did not
find an association between elevated preoperative systemic inflammation and
complications in our cohort of patients, we demonstrated in chapter 5 that
preoperative systemic inflammation had a significant impact on the magnitude of
the postoperative inflammatory response. This supports the theory that abnormal
systemic inflammation is a continuum that starts in the preoperative phase and
continues into the postoperative phase.
It would appear that preoperative patient factors affect the postoperative systemic
inflammatory response independent of intra-operative factors or postoperative
complications. The mechanisms underlying the association between pre- and
post-operative systemic inflammation require further study.
7.3.3 Body composition
Overweight and obese patients had significantly lower V˙O2AT and V˙O2Peak in spite
of no significant increase in known cardiac or respiratory comorbidities. We
present a detailed analysis of the relationship between body composition and
preoperative cardiopulmonary exercise testing in chapter 4. This has not been
reported before in surgical patients to the best of our knowledge.
The loss of skeletal muscle mass in patients with pancreatic cancer and spurious
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correlation with obesity due to correction for total body weight may partly explain
the low V˙O2 in these patients. Low aerobic capacity as measured by
cardiopulmonary exercise testing must be interpreted with caution in
overweight/obese patients and in patients with pancreatic cancer. This is
especially true for V˙O2 that has been scaled for total body weight. Further studies
must evaluate other parameters such as O2Pulse or V˙E/V˙CO2 for their ability to
predict postoperative outcomes. The proportion of obese patients undergoing
major surgery is increasing. Moreover, sarcopenia and sarcopenic-obesity are
recognised as important adverse prognostic features in pancreatic cancer [Tan et al.
2009; Peng et al. 2012] and were associated with increased postoperative
complications after pancreaticoduodenectomy [Joglekar et al. 2015; Pausch et al.
2012]. Sarcopenia was also an independent risk factor for an elevated postoperative
systemic inflammatory response in patients with colorectal cancer [Reisinger et al.
2015].
Our results suggest that poor performance at cardiopulmonary exercise testing
may not necessarily be related to only cardiac or pulmonary function. Body
composition appears to affect not only aerobic capacity but also systemic
inflammation. Improvements in body composition in cancer patients are achievable
through nutritional supplementation [Machado et al. 2015] as well as increased
physical activity. Perioperative nutritional supplementation has been reported to
be associated with reduced postoperative complications and improved outcomes
[Kabata et al. 2015; Zhang et al. 2012].
7.3.4 Anaemia
Measures other than exercise may also improve aerobic capacity. Correction of
anaemia was associated with an improvement in V˙O2AT by 0.39 ml/kg/min for
every 1 gm/dl improvement in haemoglobin [Wright et al. 2014]. While anaemia
did not change the effect of aerobic exercise in improving physical performance, the
overall aerobic fitness was significantly lower in anaemic patients than in patients
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with normal haemoglobin [Bellotto et al. 2011]. However, perioperative blood
transfusion in pancreatic cancer patients was associated with poorer long-term
outcomes [Kneuertz et al. 2011; Sutton et al. 2014].
While iron supplementation is associated with correction of anaemia and reduction
in the requirement for blood transfusion, the role of preoperative iron
supplementation in improving outcomes is unclear. Further randomised controlled
trials investigating the short-term and long-term consequences of preoperative iron
supplementation in patients undergoing cancer surgery are required before this
becomes accepted clinical practice [Beris et al. 2008; Hallet et al. 2014].
7.3.5 Aerobic exercise
West and co-workers used prehabilitation to return aerobic capacity to baseline
levels in patients with locally advanced rectal cancer undergoing neo-adjuvant
chemoradiotherapy [West et al. 2015]. Moderate aerobic and resistance exercises
and protein supplementation started 4 weeks before surgery was noted to improve
postoperative functional exercise capacity in patients undergoing colorectal cancer
surgery [Gillis et al. 2014]. Exercise programs as short as 4 weeks in duration have
been reported to improve aerobic capacity by upto 10% measured objectively by
cardiopulmonary exercise testing. This could potentially move approximately 30%
of high risk patients into the low risk category [Dunne et al. 2012].
A recent consensus statement by the ‘Exercise Prehabilitation in Colorectal Cancer
Delphi Study Group’ in the United Kingdom showed agreement between colorectal
surgeons that prehabilitation must form an important part of the preparation of
elective patients for major surgery [Boereboom et al. 2015]. The surgeons also
agreed that improving aerobic capacity is likely to improve outcomes but
recommended that further studies were needed before this became established
clinical practice.
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7.4 Improving outcomes after
pancreaticoduodenectomy
7.4.1 Centralisation and Specialisation
One of the biggest factors in improving both short-term and long-term outcomes
after cancer surgery has been the centralisation of cancer treatment and the
associated specialisation of surgeons.
Birkmeyer and co-workers were the first to report in 1999 that hospital volume was
not only related to postoperative mortality and morbidity but also to long-term
cancer survival in patients undergoing pancreaticoduodenectomy in the United
States [Birkmeyer et al. 1999]. Better overall quality of care, better cancer
operations based on oncological principles, better rates of adjuvant therapy may
have all contributed to better outcomes in high-volume centres. They also reported
in 2003 that operative mortality was inversely related to surgeon volume
emphasising the importance of surgical expertise in improving outcomes
[Birkmeyer et al. 2003]. Gouma and co-workers reported very similar findings in
the Netherlands were morbidity and mortality after pancreaticoduodenectomy
were linked to hospital volume [Gouma et al. 2000].
The importance of multi-disciplinary teams in the administration of complex
perioperative care in these patients by Ho and Heslin who reported that the overall
duration with pancreaticoduodenectomy in a hospital was associated with better
postoperative outcomes [Ho et al. 2003]. This finding stresses the importance of
organisational processes and allied specialists including anaesthetists, intensivists,
diagnostic/interventional radiologists, nurses, physiotherapists and dietitians.
However, in spite of these advances, significant variation in practice remains an
obstacle in improving outcomes after pancreaticoduodenectomy for pancreatic
cancer [Cyr et al. 2015].
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7.4.2 Goal-directed therapy
The results of chapter 2 and the work of Ausania and co-workers [Ausania et al.
2012b] suggest a link between reduced oxygen delivery and increased incidence of
pancreatic fistula. We hypothesised that tissue hypoperfusion may have
contributed to poor healing of the pancreatico-jejunal anastomosis.
Reyad and co-workers performed a randomised trial of the effect of dobutamine
infusion during pancreaticoduodenectomy on splanchnic perfusion, hemodynamics,
and overall postoperative outcome [Reyad et al. 2013]. They reported that
intra-operative dobutamine use was associated with improved global oxygen
delivery as measured by arterial and venous blood gases. Splanchnic perfusion
measured by gastric tonometry also improved. It was interesting to note that the
incidence of anastomotic leak was 30% in the control group, 15% in the group that
received 3µg/kg/min of dobutamine and 5% in the group that received 5µg/kg/min
of dobutamine (p<0.05). The overall complication rate also decreased from 70% in
the control group to 40% and 20% in the dobutamine groups (p< 0.05).
However, the benefit of such goal-directed therapy to improve organ perfusion and
oxygen delivery in improving postoperative outcomes remains unclear [Grocott
et al. 2013; Pearse et al. 2014]. A recent randomised controlled trial evaluated the
role of goal-directed therapy in high-risk patients undergoing major elective
surgery that targeted individualised oxygen delivery [Ackland et al. 2015]. The
study did show that patients whose postoperative oxygen delivery was similar to
their preoperative values had fewer complications. However, oxygen delivery was
not influenced by goal-directed therapy as any beneficial effect of the intervention
was lost with the autonomic nervous system changes that accompanied the
increased intravenous fluids and inotropes in the treatment cohort.
However, the results presented in this thesis support the argument for therapeutic
interventions aimed at improving oxygen delivery and organ perfusion before the
patient reaches the operating room as outlined in section 7.3.
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7.4.3 Early recognition and aggressive management of
complications
Postoperative complications and the associated systemic inflammatory response
are associated with early recurrence and poor-survival after colorectal [Artinyan
et al. 2015; McArdle et al. 2005], gastric [Hayashi et al. 2015; Kubota et al. 2014]
and pancreatic cancer surgery [Aoyama et al. 2015; Kamphues et al. 2012].
Early recognition and aggressive management of complications is therefore
important in mitigating the harmful long-term effects of such adverse events and
the associated inflammation. Several recent studies have demonstrated the value of
monitoring trends in postoperative CRP levels in predicting complications after
pancreaticoduodenectomy [Hiyoshi et al. 2013; Ansorge et al. 2014; Kosaka et al.
2014].
Our approach to interpreting the postoperative systemic inflammatory response
has been different from these studies. We demonstrated in chapter 6 that
postoperative CRP did not predict the severity of a pancreatic fistula and did not
have any clinical utility in the prediction of a POPF (section 6.3.2). However, we
demonstrated a clear role for the use of postoperative CRP in predicting infective
complications in the absence of a POPF. The combination of a low CRP and
absence of POPF reduced the likelihood of any other infective complications and
identified patients who may be suitable for early discharge.
‘Failure to rescue’ after postoperative complications is one of the factors
responsible for the discrepancy between morbidity and mortality in low-volume
versus high-volume centres. Mortality rates in patients undergoing a variety of
complex surgical procedures including pancreatectomy was 2.5 times higher in
low-volume centres than high-volume centres [Ghaferi et al. 2009]. However,
complication rates were similar between these hospitals. Failure to identify and
manage complications aggressively may have resulted in the increased mortality in
the low-volume hospitals. In a recent large study involving nearly 2 million
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surgical patients, Ferraris VA and co-workers studied the outcome of over
two-hundred thousand patients who had complications [Ferraris VA et al. 2014].
They noted that 20% of high-risk patients accounted for 90% of deaths due to
postoperative complications. They also reported that a simple risk-score based on
preoperative characteristics was able to identify these patients. Early recognition
of complications in these high patients and aggressive management will reduce
mortality. These findings are supported by other studies involving emergency
abdominal surgery [Sheetz et al. 2013] and major trauma [Haas et al. 2011]
The results presented in this thesis not only allow identification of high risk
patients before surgery but also help in the early identification of postoperative
complications.
7.5 Future directions
The work done in this thesis raises a number of important clinical questions.
Further studies on the inter-relationships between aerobic fitness, comorbidity,
systemic inflammation at the metabolic level in patients with cancer will allow
better understanding of their impact of postoperative outcomes. Objective
measurement of aerobic fitness and systemic inflammation will allow for
individualised perioperative care that starts at the time of diagnosis and continues
in the postoperative period. Further studies will have to focus on improving
modifiable risk factors such as V˙O2 starting with community/home-based
interventions and continuing with individualised goal-directed therapy during and
after surgery. Aggressive protocol-driven early rescue strategies that include
identification of high risk patients before surgery, early recognition of complications
and multi-disciplinary management may help improve postoperative outcomes and
attenuate the adverse effects of complications on long-term survival. This in
combination with individualised cancer treatments both in the neo-adjuvant and
adjuvant settings will help improve outcomes in patients with pancreatic cancer.
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The following VBA code was written to facilitate collection of laboratory data
from the existing user interface that did not allow easy automation. It forms part
of a Microsoft Access database. Some parts of the code has been removed or
reformatted to be accommodated within the constraints of this thesis.
The RealLink for Windows (RFW, http://www.nps-reality.com/reallink)
application used at Glasgow Royal Infirmary allowed access from VBA via
Dynamic Data Exchange. This was used to collect and parse laboratory data for
preoperative and postoperative blood tests efficiently and without error.
’#########################################################################
’Dynamic Data Exchange with RealLink application
’#########################################################################
Option Compare Database
Function RLChannel () As Long
Dim AppName As String
Dim Topic As String
AppName = "******"
Topic = "******"
DDETerminateAll
On Error GoTo ErrorHandler
RLChannel = DDEInitiate(AppName , Topic)
Exit Function
ErrorHandler:
MsgBox "Error initiating connection to RealLink Error ID: " & _
Err.Description , vbOKOnly , "Error"
End Function
Sub RLSendData(strdata As String , WaitSecs As Integer)
On Error GoTo ErrorHandler
Dim starttime As Double
AppActivate "RealLink NGTBIO", Wait
starttime = Timer
SendKeys strdata , True
starttime = Timer
While Timer < starttime + WaitSecs: Wend
Exit Sub
ErrorHandler:
’Error gets dealt with by procedure calling this function
End Sub
Function RLGetData(ChannelNum As Long) As String
On Error GoTo ErrorHandler
Dim RLItem As String
RLItem = "Table 0,0,80,24,Comma"
RLGetData = DDERequest(ChannelNum , RLItem)
Exit Function
ErrorHandler:
MsgBox "Error capturing data from RealLink : " & _
Err.Description , vbOKOnly , "Error"
End Function
Sub WaitFor(intSeconds As Integer)
Dim starttime As Single
starttime = Timer
While Timer < starttime + intSeconds: Wend
End Sub
Function ChkLabScreen(strLabScreen As String , _
strSurname As String , strLab As String) As Integer
If InStr(1, strLabScreen , strSurname) = 0 Then
ChkLabScreen = ChkLabScreen + 1
If InStr(1, strLabScreen , strLab) Then
ChkLabScreen = ChkLabScreen + 2
End Function
Sub RunRealLink ()
’Wait for application to start then wait 5 seconds
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’Shell runs commands asynchronously
’DDEPoke does not work use windows shell and processID instead
Dim dReturnValue As Single
dReturnValue = Shell ("C:\RFW\RFW.EXE /LC:\RFW\RFWDDE.DLL NGTBIO",_
vbMaximizedFocus)
While dReturnValue < 0: Wend
Call WaitFor (5)
End Sub
Sub Login(LabNum As String , Username As String , Password As String)
’ Login to Biochem/Haem
Dim strSend As String
strSend = "***" & vbCr
Call RLSendData(strSend , 2)
strSend = LabNum & vbCr
Call RLSendData(strSend , 2)
strSend = Username & vbCr
Call RLSendData(strSend , 1)
strSend = Password & vbCr
Call RLSendData(strSend , 1)
End Sub
Sub SearchPatient(Surname As String , HospitalNumber As String , _
Optional EarliestDate As Date , Optional LatestDate As Date)
’Enter patient information and date range(optional)
Dim strSend As String
strSend = ""
Call RLSendData(strSend , 1)
strSend = HospitalNumber & vbCr
Call RLSendData(strSend , 1)
strSend = Left(Surname , 2) & vbCr
Call RLSendData(strSend , 1)
strSend = Format(EarliestDate , "dd.mm.yy") & vbCr
Call RLSendData(strSend , 0) ’Earliest date to search
strSend = Format(LatestDate , "dd.mm.yy") & vbCr
Call RLSendData(strSend , 0) ’Latest date to search
End Sub
’#########################################################
’Parser for results scraped from RealLink screengrab
’#########################################################
Option Compare Database
’Results parsers
Public Sub ParseFBC(strHD As String)
On Error GoTo ErrorHandler
Dim strA() As String ’string to hold rows of data
Dim intRows As Long
Dim intTests As Integer
Dim intPosition As Integer
Dim strTest () As Variant ’name of test eg WBC
Dim strResult (10, 1) As String
’change first dimension if changing number of tests
strTest = Array ("WBC", "Hb", "Hct", "MCV", "Plts", _
"NEUT", "LYMPH", "MONO", "EOS", "BASO")
intTests = UBound(strTest)
strA = Split(strHD , vbCr)
intRows = UBound(strA)
Dim tempRow As String
Dim rowdate As Integer
For rowdate = 0 To 10
tempRow = strA(rowdate)
If InStr(1, tempRow , "Collected ") > 0 Then
Dim strDateTime () As String
Dim strDate As String
Dim strTime As String
strDateTime = Split(tempRow , "Collected ")
strDateTime = Split(strDateTime (1), ",")
If InStr(1, strDateTime (1), "*") > 0 Then
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strDate = Trim(Replace(strDateTime (1), ".", "/"))
End If
If UBound(strDateTime) > 2 Then
strDate = Trim(Replace(strDateTime (1), ".", "/"))
strTime = Trim(strDateTime (2))
End If
End If
Next rowdate
For t = 0 To intTests ’cycle through list of tests strTest
For i = 0 To intRows ’cycle through rows strA
tempRow = strA(i)
tempRow = Replace(tempRow , vbCrLf , "")
tempRow = Replace(tempRow , vbLf , "")
tempRow = Replace(tempRow , vbCr , "")
temptest = strTest(t)
intPosition = InStr(tempRow , temptest)
If intPosition > 0 Then
Dim strTemp () As String
strTemp = Split(tempRow , ",")
For j = 0 To UBound(strTemp)
’cycle through values in a single row strTemp
If Trim(strTemp(j)) = strTest(t) Then
strResult(t, 0) = strTest(t)
If Trim(strTemp(j + 1)) = "+" Or Trim(strTemp(j + 1)) = " " Then
strResult(t, 1) = Trim(strTemp(j + 2))
Else
strResult(t, 1) = Trim(strTemp(j + 1))
End If
End If
Next j
End If
Next i
Next t
’Fill in results into form
Call SaveHaem(strDate , strTime , strResult)
Exit Sub
ErrorHandler:
End Sub
Sub ParseCoag(strCoag As String)
On Error GoTo ErrorHandler
Dim strA() As String ’string to hold rows of data
Dim intRows As Long
Dim intTests As Integer
Dim intPosition As Integer
Dim strTest () As Variant ’name of test eg WBC
Dim strResult (23, 1) As String
’change first dimension if changing number of tests
strTest = Array ("PT", "PT C Ratio", "APTT", "APTT Ratio", "TCT", "TCT Ratio")
intTests = UBound(strTest)
strA = Split(strCoag , vbCr)
intRows = UBound(strA)
Dim tempRow As String
Dim rowdate As Integer
For rowdate = 0 To 10
tempRow = strA(rowdate)
If InStr(1, tempRow , "Collected ") > 0 Then
Dim strDateTime () As String
Dim strDate As String
Dim strTime As String
strDateTime = Split(tempRow , "Collected ")
strDateTime = Split(strDateTime (1), ",")
If InStr(1, strDateTime (1), "*") > 0 Then
strDate = Trim(Replace(strDateTime (1), ".", "/"))
End If
If UBound(strDateTime) > 2 Then
strDate = Trim(Replace(strDateTime (1), ".", "/"))
strTime = Trim(strDateTime (2))
End If
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End If
Next rowdate
For t = 0 To intTests ’cycle through list of tests strTest
For i = 0 To intRows ’cycle through rows strA
tempRow = strA(i)
tempRow = Replace(tempRow , ",+", "")
tempRow = Replace(tempRow , ", ", "")
tempRow = Replace(tempRow , "+,", ",")
tempRow = Replace(tempRow , " ,", ",")
tempRow = Replace(tempRow , "|", ",")
temptest = strTest(t)
intPosition = InStr(tempRow , temptest)
If intPosition > 0 Then
Dim strTemp () As String
strTemp = Split(tempRow , ",")
For j = 0 To UBound(strTemp)
’cycle through values in a single row strTemp
If Trim(strTemp(j)) = strTest(t) Then
strResult(t, 0) = strTest(t)
If Trim(strTemp(j + 1)) = "+" Or Trim(strTemp(j + 1)) = " " _
Or Trim(strTemp(j + 1)) = "" Then
strResult(t, 1) = Trim(strTemp(j + 2))
Else
strResult(t, 1) = Trim(strTemp(j + 1))
End If
End If
Next j
End If
Next i
Next t
’Fill in results into form
Call SaveCoag(strDate , strTime , strResult)
Exit Sub
ErrorHandler:
End Sub
Sub ParseBio(strBD As String)
Dim strSurname As String
Dim strHNum As String
Dim strA() As String ’string to hold rows of data
Dim intRows As Long
Dim intTests As Integer
Dim intPosition As Integer
Dim strTest () As Variant ’name of test eg Sodium
strTest = Array (" Sodium", "Potassium", "Urea", "Creat", "eGFR", "Phos",_
"Mg++", "Chloride", "Bili", "G GT", "A Phos", "ALT", "AST",_
"T Prot", "Alb", "Globulin", "Glucose", "CRP", "Trop I", _
"Calcium", "Ad Cal", "Amylase ")
Dim strResult (21, 1) As String
’change first dimension if changing number of tests
intTests = UBound(strTest)
strBD = Replace(strBD , ". Amylase.", "..")
strBD = Replace(strBD , vbCrLf , "")
strBD = Replace(strBD , vbLf , "")
strBD = Replace(strBD , vbCr , "")
strA = Split(strBD , "|")
Dim strTempDate As String
strTempDate = strA (0)
If InStr(strTempDate , "Collected ") Then
Dim strDateTime () As String
Dim strDate As String
Dim strTime As String
strDateTime = Split(strTempDate , "Collected ")
strDateTime = Split(strDateTime (1), ",")
strDate = strDateTime (1)
strDate = Replace(strDate , ".", "/")
strTime = strDateTime (2)
End If
intRows = UBound(strA)
For t = 0 To intTests ’cycle through list of tests strTest
For i = 0 To intRows ’cycle through rows strA
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tempRow = strA(i)
temptest = strTest(t)
intPosition = InStr(tempRow , temptest)
If intPosition > 0 Then
Dim strTemp () As String
Dim intDots As Integer
’Routine to remove dots word dots
intDots = InStr(strA(i), "..")
If intDots > 0 Then
strTemp = Split(NoDots(strA(i)), ",")
Else
strTemp = Split(strA(i), ",")
End If
’End of Routine to remove dots word dots
For j = 0 To UBound(strTemp)
’cycle through values in a single row strTemp
If Trim(strTemp(j)) = strTest(t) Then
strResult(t, 0) = strTest(t)
If Trim(strTemp(j + 1)) = "+" Or Trim(strTemp(j + 1)) = " " Then
strResult(t, 1) = Trim(strTemp(j + 2))
Else
strResult(t, 1) = Trim(strTemp(j + 1))
End If
End If
Next j
End If
Next i
Next t
’Fill in results into form
Call SaveBio(strDate , strTime , strResult)
End Sub
Function NoDots(strWithDots As String) As String
Dim intDotEndPos As Integer
Dim intDotStartPos As Integer
Dim intRowLen As Integer
intDotEndPos = InStrRev(strWithDots , "..")
’find the first occurrence of .. from the end
intDotStartPos = InStr(strWithDots , "..")
’find the first occurrence of .. from the end
intRowLen = Len(strWithDots)
’get the total length of the string with dots
’get the substring on the right and left of the dots based on above values
NoDots = Left(strWithDots , intDotStartPos) & "," & _
Right(strWithDots , intRowLen intDotEndPos 1)
’Debug.Print NoDots
End Function
’#########################################################
’Code to save results to respective tables
’#########################################################
Option Compare Database
Sub SaveBio(strDate , strTime , strResult)
Dim tf_B As SubForm
Set tf_B = Forms!frm_Demo!frm_Bloods
’create a new record
tf_B.SetFocus
DoCmd.GoToRecord , , acNewRec
tf_B!CHI = Forms!frm_Demo!CHI
tf_B!Surname = Forms!frm_Demo!Surname
tf_B!Date = strDate
tf_B!Time = strTime
intTests = UBound(strResult , 1)
For i = 0 To intTests
Select Case strResult(i, 0)
Case "Potassium"
tf_B!K = strResult(i, 1)
Case "Urea"
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tf_B!Urea = strResult(i, 1)
Case "Creat"
tf_B!Creatine = strResult(i, 1)
’Case "eGFR"
Case "Phos"
tf_B!PO4 = strResult(i, 1)
Case "Mg++"
tf_B!Magnesium = strResult(i, 1)
Case "Chloride"
tf_B!Cl = strResult(i, 1)
Case "Bili"
tf_B!Bilirubin = strResult(i, 1)
Case "G GT"
tf_B!GGT = strResult(i, 1)
Case "A Phos"
tf_B!Al_Phos = strResult(i, 1)
Case "ALT"
tf_B!ALT = strResult(i, 1)
Case "AST"
tf_B!AST = strResult(i, 1)
Case "T Prot"
tf_B!Protein = strResult(i, 1)
Case "Alb"
tf_B!Albumin = strResult(i, 1)
Case "Globulin"
tf_B!Globulin = strResult(i, 1)
Case "Glucose"
tf_B!Glucose = strResult(i, 1)
Case "CRP"
tf_B!CRP = strResult(i, 1)
Case "Trop I"
tf_B!Troponin = strResult(i, 1)
Case "Calcium"
tf_B!Ca = strResult(i, 1)
Case "Ad Cal"
tf_B!Adj_Ca = strResult(i, 1)
Case "Amylase"
tf_B!Amylase = strResult(i, 1)
Case "Sodium"
tf_B!Na = strResult(i, 1)
End Select
Next i
End Sub
Sub SaveCoag(TestDate As String , TestTime As String , Results () As String)
Dim tf_C As SubForm
Set tf_C = Forms!frm_Demo!frm_Coag
’create a new record
tf_C.SetFocus
DoCmd.GoToRecord , , acNewRec
tf_C!CHI = Forms!frm_Demo!CHI
tf_C!Surname = Forms!frm_Demo!Surname
tf_C!Date = TestDate
If TestTime <> "*" And TestTime <> "NK" Then tf_C!Time = TestTime
intTests = UBound(Results , 1)
For i = 0 To intTests
Select Case Results(i, 0)
Case "PT"
tf_C!PT = Results(i, 1)
Case "PT C Ratio"
tf_C![PT C Ratio] = Results(i, 1)
Case "APTT"
tf_C!APTT = Results(i, 1)
Case "APTT Ratio"
tf_C![APTT Ratio] = Results(i, 1)
Case "TCT"
tf_C!TCT = Results(i, 1)
Case "TCT Ratio"
tf_C![TCT Ratio] = Results(i, 1)
End Select
Next i
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End Sub
Sub SaveHaem(TestDate As String , TestTime As String , Results () As String)
Dim tf_H As SubForm
Set tf_H = Forms!frm_Demo!frm_Haematology
’create a new record
tf_H.SetFocus
DoCmd.GoToRecord , , acNewRec
tf_H!CHI = Forms!frm_Demo!CHI
tf_H!Surname = Forms!frm_Demo!Surname
tf_H!Date = TestDate
If TestTime <> "*" Then tf_H!Time = TestTime
intTests = UBound(Results , 1)
For i = 0 To intTests
’frmHaem.strResult(i, 0) = strResult(i, 1)
Select Case Results(i, 0)
Case "WBC"
tf_H!WBC = Results(i, 1)
Case "Plts"
tf_H!Plts = Results(i, 1)
Case "Hb"
tf_H!HB = Results(i, 1)
Case "MCV"
tf_H!MCV = Results(i, 1)
Case "MCHC"
tf_H!MCHC = Results(i, 1)
Case "RDW"
tf_H!RDW = Results(i, 1)
Case "RBC"
tf_H!RBC = Results(i, 1)
Case "NEUT"
tf_H!NEUT = Results(i, 1)
Case "LYMPH"
tf_H!LYMPH = Results(i, 1)
Case "MONO"
tf_H!MONO = Results(i, 1)
Case "EOS"
tf_H!EOS = Results(i, 1)
Case "BASO"
tf_H!BASO = Results(i, 1)
Case "Hct"
tf_H!Hct = Results(i, 1)
Case "MCH"
tf_H!MCH = Results(i, 1)
Case "MPV"
tf_H!MPV = Results(i, 1)
Case "PDW"
tf_H!PDW = Results(i, 1)
Case "PCT"
tf_H!PCT = Results(i, 1)
End Select
Next i
End Sub
’#########################################################
’User interface functions
’#########################################################
Option Compare Database
Private Sub Form_Load ()
Me.RecordSource = "tb_Demo"
End Sub
Private Sub cmbAllPatients_AfterUpdate ()
’ Find the record that matches the control.
Dim rs As Object
Set rs = Me.Recordset.Clone
rs.FindFirst "[IPID] = " & Str(Nz(Me![ cmbAllPatients], 0))
If Not rs.EOF Then Me.Bookmark = rs.Bookmark
End Sub
Private Sub cmbChooseProcedure_AfterUpdate ()
’Filter by operation name
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Dim strSQL As String
Dim strFilter As String
If Me.cmbChooseProcedure = "All" Or IsNull(Me.cmbChooseProcedure) Then
’ If the combo is Null , use the whole table as the RecordSource.
Me.RecordSource = "tb_Demo"
Else
strFilter = Me.cmbChooseProcedure
strSQL = "SELECT tb_Demo .* FROM tb_Demo LEFT JOIN tb_Operation ON _
tb_Demo.IPID = tb_Operation.IPID WHERE ((([ tb_Operation ]![ Primary _
Procedure ]) LIKE ’*" & strFilter & "*’)) ORDER BY _
[tb_Operation ]![ Operation Date ];"
Me.RecordSource = strSQL
End If
End Sub
Private Sub cmbChooseOpDate_AfterUpdate ()
’Filter by operation DATE
Dim strSQL As String
Dim strFilter As Date
If IsNull(Me.cmbChooseOpDate) Then
’ If the combo is Null , use the whole table as the RecordSource.
Me.RecordSource = "tb_Demo"
Else
strFilter = CDate(Me.cmbChooseOpDate)
strSQL = "SELECT tb_Demo .* FROM tb_Demo LEFT JOIN tb_Operation ON _
tb_Demo.IPID = tb_Operation.IPID WHERE _
((([ tb_Operation ]![ Operation Date]) > #" & strFilter & "#))_
ORDER BY [tb_Operation ]![ Operation Date ];"
Me.RecordSource = strSQL
End If
End Sub
Private Sub cmbChooseSpecialty_AfterUpdate ()
’Filter by Specialty
Dim strSQL As String
Dim strFilter As String
strFilter = Me.cmbChooseSpecialty
If strFilter = "All" Or IsNull(Me.cmbChooseSpecialty) Then
’ If the combo is Null , use the whole table as the RecordSource.
Me.RecordSource = "tb_Demo"
Else
strSQL = "SELECT tb_Demo .* FROM tb_Demo LEFT JOIN tb_Event_Admission _
ON tb_Demo.IPID = tb_Event_Admission.IPID WHERE _
((([ tb_Event_Admission ]![ Specialty] _
LIKE ’*" & strFilter & "* ’)));"
Me.RecordSource = strSQL
End If
End Sub
Private Sub cmdNewPatient_Click ()
On Error GoTo Err_cmdNewPatient_Click
DoCmd.DoMenuItem acFormBar , acRecordsMenu , 5, , acMenuVer70
DoCmd.GoToRecord , , acNewRec
Exit Sub
Err_cmdNewPatient_Click:
MsgBox Err.Description
End Sub
Private Sub listCurrentPatients_AfterUpdate ()
’ Find the record that matches the control.
Dim rs As Object
Set rs = Me.Recordset.Clone
rs.FindFirst "[IPID] = " & Str(Nz(Me![ listCurrentPatients], 0))
If Not rs.EOF Then Me.Bookmark = rs.Bookmark
Me.frm_Physiology.Form.Refresh
End Sub
Private Sub cmdSendDetails_Click ()
’checked and works
Dim Surname As String ’Surname from frm_demo
Dim HospitalNum As String ’Hospital number from frm_demo
Dim OpDate As Date ’Date of operation from frm_operation
Dim Edate As Date ’Earliest date of bloods to return
Dim Ldate As Date ’Latest date of bloods to return
On Error GoTo ErrorHandler:
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Surname = Me.Surname
HospitalNum = Me.HospitalNum
OpDate = Me.frm_Operation.Form![ Operation Date]
’Set search date range
Edate = OpDate 10
Ldate = OpDate + 5
If Me.chkResuse = 0 Then ’Is Reuse box not checked then start a new RL session
Call RunRealLink
Select Case Me.frameChooseLab.Value
Case 1
Call Login ("3", "******" , "******")
Case 2
Call Login ("2", "******" , "******")
End Select
End If
Call SearchPatient(Surname , HospitalNum , Edate , Ldate)
Exit Sub
ErrorHandler:
MsgBox "cmdHaem Error" & Err.Description
End Sub
Private Sub cmdImport_Click ()
On Error GoTo ErrorHandler
Dim intRepeat As Integer
KillSwitch = False
If CInt(Me.txtAutoRepeat) > 0 Then
intRepeat = CInt(Me.txtAutoRepeat)
Else
intRepeat = 1
End If
If Me.chkAutoUpdate.Value = 1 Then
For i = 1 To intRepeat
Call ImportData
Me.Refresh
Call cmdLater_Click
If KillSwitch = True Then Exit Sub
Next
End If
ErrorHandler:
Exit Sub
End Sub
Private Sub ImportData ()
Dim LabChannel As Long
LabChannel = RLChannel
’Grab screen text from existing RL window
Dim strResultScreen As String
Call WaitFor (3)
If LabChannel > 0 Then
strResultScreen = RLGetData(LabChannel)
Else
MsgBox "RealLink connection could not be established", vbOKOnly ,_
"Connection Error"
Exit Sub
End If
’Send to either FBC/Coag parser
If InStr(1, strResultScreen , "Press Esc") Then KillSwitch = True
If InStr(1, strResultScreen , ".. FBC ..") Then
Call ParseFBC(strResultScreen)
End If
If InStr(1, strResultScreen , "..C/Screen ..") Then
Call ParseCoag(strResultScreen)
End If
If InStr(1, strResultScreen , "Biochem ") Then
Call ParseBio(strResultScreen)
End If
’Terminate all DDE connections
DDETerminate LabChannel
End Sub
Private Sub cmdEarlier_Click ()
Dim strTemp As String
strTemp = "E" & vbCr
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Call RLSendData(strTemp , 0)
End Sub
Private Sub cmdLater_Click ()
Dim strTemp As String
strTemp = "L" & vbCr
Call RLSendData(strTemp , 0)
End Sub
Private Sub tb_ABG_ALL_subform_Enter ()
Me.Refresh
End Sub
Private Sub tgDemoDupes_Click ()
Select Case Me.tgDemoDupes.Value
Case 1
Me.tgDemoDupes.SetFocus
Me.tgDemoDupes.Caption = "DemoDupes ON"
Me.RecordSource = "qs_DemoDupes"
Case 0
Me.tgDemoDupes.SetFocus
Me.tgDemoDupes.Caption = "DemoDupes OFF"
Me.RecordSource = "tb_Demo"
End Select
End Sub
Private Sub cmdRefresh_Click ()
On Error GoTo Err_cmdRefresh_Click
DoCmd.DoMenuItem acFormBar , acRecordsMenu , 5, , acMenuVer70
Exit_cmdRefresh_Click:
Exit Sub
Err_cmdRefresh_Click:
MsgBox Err.Description
Resume Exit_cmdRefresh_Click
End Sub
’#########################################################
’VBA code to import CPET results into database
’#########################################################
Option Compare Database
Private Sub cmdImport_Click ()
Dim strEmptyline As String
On Error Resume Next
Dim strResult As String
Dim strResult2 As String
Dim strTemp () As String
Dim channel As Long
channel = TermChannel
strResult = TermGetData(channel)
If strResult = "" Then Exit Sub
strResult = Replace(strResult , "qq", "")
’strTemp = Split(strResult , "COMMENT SCREEN ")
’ strResult = strTemp (1)
’strResult = strTemp (0)
strTemp = Split(strResult , vbCrLf)
For j = 0 To UBound(strTemp)
If Trim(strTemp(j)) <> "" Then
Me.txtFull.SetFocus
Me.txtFull.Value = Me.txtFull.Value & Trim(strTemp(j)) & vbCrLf
’Debug.Print Trim(strTemp(j))
End If
Next j
Me.Application.DDEPoke channel , "qvt_term_item", "1"
WaitFor (1)
DDETerminateAll
End Sub
Function TermGetData(ChannelNum As Long) As String
On Error GoTo ErrorHandler
Dim RLItem As String
RLItem = "Table 0,0,80,24,Comma"
TermGetData = DDERequest(ChannelNum , RLItem)
Exit Function
ErrorHandler:
MsgBox "Error capturing data from RealLink : " & _
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Err.Description , vbOKOnly , "Error"
End Function
Function TermChannel () As Long
Dim AppName As String
Dim Topic As String
AppName = "qvt_term"
Topic = "Respiratory"
DDETerminateAll
On Error GoTo ErrorHandler
TermChannel = DDEInitiate(AppName , Topic)
Exit Function
ErrorHandler:
MsgBox "Error initiating connection to Term Error ID: " & _
Err.Description , vbOKOnly , "Error"
End Function
Sub TermSendData(strdata As String , WaitSecs As Integer)
On Error GoTo ErrorHandler
Dim starttime As Double
AppActivate "RealLink NGTBIO", Wait
SendKeys strdata , True
starttime = Timer
While Timer < starttime + WaitSecs: Wend
Exit Sub
ErrorHandler:
’Error gets dealt with by procedure calling this function
End Sub
Private Sub cmdSendPatient_Click ()
Dim channel As Long
Dim strName As String
strName = "ret" & vbCr & "7" & Me.Parent!Surname & " " _
& Me.Parent!Forename & vbCr
channel = TermChannel
Me.Application.DDEPoke channel , "qvt_term_item", strName
DDETerminateAll
End Sub
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The following VBA code was written to facilitate detailed analysis of large volumes
of raw CPET data that would not have been otherwise available from the final
report generated for clinical use. This allowed analysis of all parameters measured
at rest, anaerobic threshold and peak exercise rather than just V˙O2 .
Option Explicit
Sub RenameSortSheets ()
Dim ws As Worksheet
Dim strName () As String
For Each ws In Worksheets
If ws.Range ("$B$1 "). Value ="" Then
Exit Sub
End If
If ws.Name <> "aaa_main" Then
strName=Split(CStr(ws.Range ("$B$1 "). Value), "(")
ws.Name=LCase(strName (0))
ws.Activate
ws.Range ("B4"). Select
ActiveWindow.FreezePanes=True
End If
Next ws
Dim N As Integer
Dim M As Integer
Dim FirstWSToSort As Integer
Dim LastWSToSort As Integer
Dim SortDescending As Boolean
SortDescending=False
If ActiveWindow.SelectedSheets.Count=1 Then
’Change the 1 to the worksheet you want sorted first
FirstWSToSort =1
LastWSToSort=Worksheets.Count
Else
With ActiveWindow.SelectedSheets
For N=2 To .Count
If .Item(N - 1). Index <> .Item(N).Index - 1 Then
MsgBox "You cannot sort non -adjacent sheets"
Exit Sub
End If
Next N
FirstWSToSort =.Item (1). Index
LastWSToSort =.Item(. Count).Index
End With
End If
For M=FirstWSToSort To LastWSToSort
For N=M To LastWSToSort
If SortDescending=True Then
If UCase(Worksheets(N).Name) > UCase(Worksheets(M).Name) Then
Worksheets(N).Move Before := Worksheets(M)
End If
Else
If UCase(Worksheets(N).Name) < UCase(Worksheets(M).Name) Then
Worksheets(N).Move Before := Worksheets(M)
End If
End If
Next N
Next M
Dim x As Integer
x=2
Sheets (" aaa_main "). Range("A:A"). Clear
Sheets (" aaa_main "). Cells(1, 1)=" SheetName"
For Each ws In Worksheets
Sheets (" aaa_main "). Cells(x, 1)=ws.Name
x=x + 1
Next ws
End Sub
Sub GotoSheet ()
If ActiveWindow.ActiveSheet.Name=" aaa_main" Then
Dim selName As String
selName=ActiveWindow.ActiveCell.Value
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Worksheets(selName ). Activate
Else
Worksheets (" aaa_main "). Activate
End If
End Sub
Sub VCO2VO2 ()
Dim ws As Worksheet
For Each ws In Worksheets
Dim x As Integer
x=4
While ws.Cells(x, 2) > 0
If ws.Cells(x, 9) <> "-" And ws.Cells(x, 6) <> "-" Then
ws.Cells(x, 22)= CDbl(ws.Cells(x, 9)) / CDbl(ws.Cells(x, 6))
End If
x=x + 1
Wend
Next ws
End Sub
Sub ClearColumn ()
Dim ws As Worksheet
For Each ws In Worksheets
ws.Range ("AD9 ")=ws.Range("A1")
ws.Range ("A1"). Clear
Next ws
End Sub
Sub DeleteAllCharts ()
Dim ws As Worksheet
Dim chart As ChartObject
For Each ws In Worksheets
For Each chart In ws.ChartObjects
chart.Delete
Next chart
Next ws
End Sub
Sub AddRCValues ()
Dim x As Integer
For x=3 To 88
Sheets(Sheets (" aaa_main "). Cells(x, 1). Value).Range ("AD8 ")=_
Sheets (" aaa_main "). Cells(x, 27). Value
Sheets(Sheets (" aaa_main "). Cells(x, 1). Value).Range ("AD9 ")=_
Sheets (" aaa_main "). Cells(x, 28). Value
Next x
End Sub
Sub CopyLineForSPSS ()
Dim rng As Range
Dim selrow As Integer
Dim selrng As String
selrow=ActiveWindow.ActiveCell.Row
selrng ="AF" & CStr(selrow) & ":BX" & CStr(selrow)
Range(selrng ). Select
Selection.Copy
End Sub
%----------------------------------
Sub ValuesAT ()
Dim r As Integer
r=3 - Selection.Cells(1, 1). Row
ActiveSheet.Range("X29")= Selection.Cells(r, 1)
ActiveSheet.Range("Y29")= Selection.Cells(r, 3)
ActiveSheet.Range("Z29")= Selection.Cells(r, 4)’VE
ActiveSheet.Range("AA29 ")= Selection.Cells(r, 5)’VT
ActiveSheet.Range("AB29 ")= Selection.Cells(r, 6)’VO2
ActiveSheet.Range("AC29 ")= Selection.Cells(r, 7)’VO2/KG
ActiveSheet.Range("AD29 ")= Selection.Cells(r, 8)’VE/VO2
ActiveSheet.Range("AE29 ")= Selection.Cells(r, 9)’VCO2
ActiveSheet.Range("AF29 ")= Selection.Cells(r, 10)’VE/VCO2
ActiveSheet.Range("AG29 ")= Selection.Cells(r, 11)’RER
ActiveSheet.Range("AH29 ")= Selection.Cells(r, 12)’PETO2
ActiveSheet.Range("AI29 ")= Selection.Cells(r, 13)’ PETCO2
ActiveSheet.Range("AJ29 ")= Selection.Cells(r, 14)’ O2PULSE
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ActiveSheet.Range("AK29 ")= Selection.Cells(r, 15)’HR
ActiveSheet.Range("AL29 ")= Selection.Cells(r, 16)’Bf
ActiveSheet.Range("W30 ")="AT"
ActiveSheet.Range("X30")= WorksheetFunction.Average(Selection.Columns (1))’ TIME
ActiveSheet.Range("Y30")= WorksheetFunction.Average(Selection.Columns (3))’ LOAD
ActiveSheet.Range("Z30")= WorksheetFunction.Average(Selection.Columns (4))’VE
ActiveSheet.Range("AA30 ")= WorksheetFunction.Average(Selection.Columns (5))’VT
ActiveSheet.Range("AB30 ")= WorksheetFunction.Average(Selection.Columns (6))’VO2
ActiveSheet.Range("AC30 ")= WorksheetFunction.Average(Selection.Columns (7))’VO2/KG
ActiveSheet.Range("AD30 ")= WorksheetFunction.Average(Selection.Columns (8))’VE/VO2
ActiveSheet.Range("AE30 ")= WorksheetFunction.Average(Selection.Columns (9))’ VCO2
ActiveSheet.Range("AF30 ")= WorksheetFunction.Average(Selection.Columns (10))’VE/VCO2
ActiveSheet.Range("AG30 ")= WorksheetFunction.Average(Selection.Columns (11))’RER
ActiveSheet.Range("AH30 ")= WorksheetFunction.Average(Selection.Columns (12))’ PETO2
ActiveSheet.Range("AI30 ")= WorksheetFunction.Average(Selection.Columns (13))’ PETCO2
ActiveSheet.Range("AJ30 ")= WorksheetFunction.Average(Selection.Columns (14))’ O2PULSE
ActiveSheet.Range("AK30 ")= WorksheetFunction.Average(Selection.Columns (15))’HR
ActiveSheet.Range("AL30 ")= WorksheetFunction.Average(Selection.Columns (16))’Bf
End Sub
Sub ValuesPeak ()
ActiveSheet.Range("W31 ")=" Peak"
ActiveSheet.Range("X31")= WorksheetFunction.Average(Selection.Columns (1))’ TIME
ActiveSheet.Range("Y31")= WorksheetFunction.Max(Selection.Columns (3))’ LOAD
ActiveSheet.Range("Z31")= WorksheetFunction.Max(Selection.Columns (4))’VE
ActiveSheet.Range("AA31 ")= WorksheetFunction.Max(Selection.Columns (5))’VT
ActiveSheet.Range("AB31 ")= WorksheetFunction.Max(Selection.Columns (6))’VO2
ActiveSheet.Range("AC31 ")= WorksheetFunction.Max(Selection.Columns (7))’VO2/KG
ActiveSheet.Range("AD31 ")= WorksheetFunction.Max(Selection.Columns (8))’VE/VO2
ActiveSheet.Range("AE31 ")= WorksheetFunction.Max(Selection.Columns (9))’ VCO2
ActiveSheet.Range("AF31 ")= WorksheetFunction.Max(Selection.Columns (10))’VE/VCO2
ActiveSheet.Range("AG31 ")= WorksheetFunction.Max(Selection.Columns (11))’ RER
ActiveSheet.Range("AH31 ")= WorksheetFunction.Max(Selection.Columns (12))’ PETO2
ActiveSheet.Range("AI31 ")= WorksheetFunction.Max(Selection.Columns (13))’ PETCO2
ActiveSheet.Range("AJ31 ")= WorksheetFunction.Max(Selection.Columns (14))’ O2PULSE
ActiveSheet.Range("AK31 ")= WorksheetFunction.Max(Selection.Columns (15))’HR
ActiveSheet.Range("AL31 ")= WorksheetFunction.Max(Selection.Columns (16))’Bf
End Sub
Sub ValuesOther ()
ActiveSheet.Range("W32 ")=" Other"
ActiveSheet.Range("X32")= WorksheetFunction.Average(Selection.Columns (1))’ TIME
ActiveSheet.Range("Y32")= WorksheetFunction.Average(Selection.Columns (3))’ LOAD
ActiveSheet.Range("Z32")= WorksheetFunction.Average(Selection.Columns (4))’VE
ActiveSheet.Range("AA32 ")= WorksheetFunction.Average(Selection.Columns (5))’VT
ActiveSheet.Range("AB32 ")= WorksheetFunction.Average(Selection.Columns (6))’VO2
ActiveSheet.Range("AC32 ")= WorksheetFunction.Average(Selection.Columns (7))’VO2/KG
ActiveSheet.Range("AD32 ")= WorksheetFunction.Average(Selection.Columns (8))’VE/VO2
ActiveSheet.Range("AE32 ")= WorksheetFunction.Average(Selection.Columns (9))’ VCO2
ActiveSheet.Range("AF32 ")= WorksheetFunction.Average(Selection.Columns (10))’VE/VCO2
ActiveSheet.Range("AG32 ")= WorksheetFunction.Average(Selection.Columns (11))’RER
ActiveSheet.Range("AH32 ")= WorksheetFunction.Average(Selection.Columns (12))’ PETO2
ActiveSheet.Range("AI32 ")= WorksheetFunction.Average(Selection.Columns (13))’ PETCO2
ActiveSheet.Range("AJ32 ")= WorksheetFunction.Average(Selection.Columns (14))’ O2PULSE
ActiveSheet.Range("AK32 ")= WorksheetFunction.Average(Selection.Columns (15))’HR
ActiveSheet.Range("AL32 ")= WorksheetFunction.Average(Selection.Columns (16))’Bf
End Sub
Sub AutomatePeakOtherValues ()
Dim ws As Worksheet
Dim topRow As Integer
Dim bottomRow As Integer
For Each ws In Worksheets
If ws.Name <> "aaa_main" Then
ws.Activate
’Fill other values
Dim rng As Range
Dim fdrng As Range
Set rng=ws.Range("C:C")
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Set fdrng=rng.Find(30, LookIn := xlValues)
If Not fdrng Is Nothing Then
topRow=fdrng(0, 1).Row
bottomRow=fdrng(2, 0).Row
Set rng=ws.Range(topRow & ":" & bottomRow)
rng.Select
Call ValuesOther
End If
’Fill peak values
Dim maxVO2
maxVO2=WorksheetFunction.Max(ws.Range ("G:G"))
Set rng=ws.Range("G:G")
Set fdrng=rng.Find(maxVO2)
If Not fdrng Is Nothing Then
topRow=fdrng(-1, 1).Row
bottomRow=fdrng(3, 0).Row
If ws.Range ("W31 "). Value ="" Then
Set rng=ws.Range(topRow & ":" & bottomRow)
rng.Select
Call ValuesPeak
End If
End If
End If
Next ws
End Sub
Sub ChartResize ()
Range("Y35"). Select
ActiveSheet.ChartObjects (" Chart 1"). Activate
ActiveChart.Axes(xlCategory ). Select
ActiveChart.ChartArea.Select
ActiveSheet.Shapes ("Chart 1"). ScaleWidth 0.5, msoFalse , _
msoScaleFromBottomRight
ActiveSheet.Shapes ("Chart 1"). IncrementLeft 102#
ActiveSheet.Shapes ("Chart 1"). IncrementTop 253.5
End Sub
Sub VECharts ()
Dim ws As Worksheet
For Each ws In Worksheets
With ws.ChartObjects.Add _
(Left :=800 , Top:=725, Width :=400, Height :=225)
.chart.ChartType=xlLine
.chart.SetSourceData Source :=ws.Range("A:A,H:H,J:J") _
, PlotBy := xlColumns
.chart.HasAxis(xlCategory , xlPrimary )=True
.chart.HasAxis(xlValue , xlPrimary )=True
.chart.Axes(xlCategory , xlPrimary ). CategoryType=xlAutomatic
End With
Next ws
End Sub
Sub CopyCPETParametersFromSheetsToMain ()
Dim x As Integer
For x=3 To 99
Dim sheetname As String
Sheets (" aaa_main "). Activate
sheetname=ActiveSheet.Cells(x, 1)
ActiveSheet.Cells(x, 32). Select
Sheets(sheetname ). Select
Range("X30:AL30 "). Select
Selection.Copy
Sheets (" aaa_main "). Select
ActiveSheet.Paste
ActiveSheet.Cells(x, 47). Select
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Sheets(sheetname ). Select
Range("X31:AL31 "). Select
Selection.Copy
Sheets (" aaa_main "). Select
ActiveSheet.Paste
ActiveSheet.Cells(x, 62). Select
Sheets(sheetname ). Select
Range("X32:AL32 "). Select
Selection.Copy
Sheets (" aaa_main "). Select
ActiveSheet.Paste
Next x
End Sub
Sub CopyVEVO2VEVCO2FromSheetsToMain ()
Dim x As Integer
For x=3 To 99
Dim sheetname As String
Sheets (" aaa_main "). Activate
sheetname=ActiveSheet.Cells(x, 1)
ActiveSheet.Cells(x, 79). Select
Sheets(sheetname ). Select
Range("Y22"). Select
Selection.Copy
Sheets (" aaa_main "). Select
ActiveSheet.Paste
ActiveSheet.Cells(x, 80). Select
Sheets(sheetname ). Select
Range("Y23"). Select
Selection.Copy
Sheets (" aaa_main "). Select
ActiveSheet.Paste
Next x
End Sub
Sub FindStartEndTimeofExercise ()
Dim x As Integer
Dim y As Integer
Dim starttime As String
Dim endtime As String
Dim sheetname As String
For x=3 To 99
Sheets (" aaa_main "). Activate
sheetname=ActiveSheet.Cells(x, 1)
Sheets(sheetname ). Select
y=15
While ActiveSheet.Cells(y, 3)=" -"
y=y + 1
Wend
starttime=ActiveSheet.Cells(y, 1)
y=y + 5
While ActiveSheet.Cells(y, 3) > "0"
y=y + 1
Wend
endtime=ActiveSheet.Cells(y - 1, 1)
Sheets (" aaa_main "). Activate
ActiveSheet.Cells(x, 77)= starttime
ActiveSheet.Cells(x, 78)= endtime
Next x
End Sub
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Figure C.1: Breath-by-breath sample data with values averaged every 10 seconds
- Part 1.
Time Load VE Vt
RER
HR Bf
min:sec W l l/min l/l l/min l/l % %
00:10 20 - 13 0.74 0.39 4.6 31.3 0.38 31.9 0.98 111 34 5 75 18 34 97
00:20 18 - 12 0.71 0.35 4.2 30.6 0.34 31.3 0.98 110 34 5 74 16 33 97
00:30 18 - 12 0.78 0.37 4.4 29.7 0.36 30.7 0.97 109 35 5 73 15 33 97
00:40 20 - 12 0.77 0.36 4.4 30.4 0.36 30.9 0.98 110 35 5 73 16 33 97
00:50 17 - 12 0.82 0.35 4.2 31.8 0.36 31.3 1.02 111 34 5 73 15 33 97
01:00 18 - 12 0.84 0.34 4.1 33.2 0.35 32 1.04 113 34 5 74 14 34 97
01:10 17 - 11 0.73 0.29 3.5 34.9 0.31 33.3 1.05 114 33 4 75 15 35 98
01:20 13 - 12 0.71 0.29 3.5 38.3 0.31 36.2 1.06 117 31 4 75 17 35 98
01:30 25 - 14 1.03 0.34 4.1 39.5 0.38 35.9 1.1 119 30 5 73 14 33 98
01:40 12 - 14 1.2 0.36 4.3 36.2 0.4 31.9 1.14 119 31 5 74 11 27 98
01:50 15 - 10 0.95 0.28 3.3 35.7 0.31 31.3 1.14 117 33 4 76 11 30 98
02:00 16 - 10 0.81 0.25 3 37.6 0.28 33.4 1.12 117 33 3 76 13 34 98
02:10 9 - 11 0.76 0.29 3.4 35.6 0.31 32.9 1.08 115 33 4 76 15 34 98
02:20 15 - 12 0.57 0.28 3.4 38.5 0.29 36.9 1.04 116 32 4 78 21 38 97
02:30 22 - 15 0.6 0.41 4.9 33.8 0.4 34.5 0.98 113 33 5 84 25 36 97
02:40 28 - 20 0.75 0.55 6.5 33.1 0.55 32.9 1.01 114 34 6 86 26 34 97
02:50 25 - 19 0.73 0.5 5.9 35.9 0.53 33.7 1.06 117 33 6 88 26 35 97
03:00 27 - 20 1 0.51 6 36.7 0.56 33.2 1.11 117 33 6 87 20 34 98
03:10 22 - 18 0.87 0.43 5.2 38.3 0.49 33.9 1.13 117 33 5 86 21 36 98
03:20 24 - 18 0.82 0.47 5.6 35.1 0.51 32.1 1.09 116 34 5 86 22 34 98
03:30 24 - 17 0.95 0.49 5.8 33.6 0.53 30.6 1.1 115 35 6 87 18 32 98
03:40 27 - 18 0.95 0.49 5.8 34.1 0.53 31.1 1.1 115 35 6 86 19 33 98
03:50 25 - 17 0.94 0.47 5.7 34.2 0.52 31.4 1.09 115 35 6 86 18 33 98
04:00 21 - 16 0.73 0.42 5 35.4 0.45 33 1.07 116 33 5 85 22 35 98
04:10 25 4 18 0.7 0.48 5.7 35.4 0.51 33.3 1.06 116 33 6 85 26 34 98
04:20 21 6 17 0.68 0.44 5.3 34.9 0.46 33.3 1.05 115 34 5 86 25 36 98
04:30 29 9 19 0.92 0.53 6.4 33.7 0.57 31.6 1.07 114 34 6 86 21 33 98
04:40 25 13 19 0.91 0.5 6 35.3 0.56 31.7 1.11 116 34 6 87 21 33 98
04:50 25 16 19 0.94 0.5 6 35.2 0.56 31.8 1.11 115 34 6 88 21 34 98
05:00 35 20 20 1.17 0.5 5.9 38.5 0.56 34.3 1.12 116 34 6 88 17 37 98
05:10 18 23 18 0.98 0.44 5.2 38.9 0.49 34.6 1.12 116 34 5 88 19 37 98
05:20 24 26 16 0.74 0.46 5.5 33.2 0.48 31.6 1.05 113 35 5 89 22 34 98
05:30 26 29 17 0.73 0.52 6.2 30.3 0.5 31.2 0.97 111 35 6 92 23 34 98
05:40 31 32 17 0.82 0.58 6.9 27.9 0.54 29.8 0.94 109 36 6 92 21 32 98
05:50 31 36 18 1 0.63 7.5 27.5 0.59 29.2 0.94 109 36 7 91 19 30 97
06:00 35 40 21 0.98 0.66 7.9 29.8 0.64 30.8 0.97 111 35 7 91 21 32 97
06:10 33 43 21 0.88 0.66 7.9 30.1 0.64 31.1 0.97 111 35 7 92 24 33 98
06:20 37 45 21 1.05 0.69 8.3 29.3 0.67 30.2 0.97 110 36 8 91 20 33 98
06:30 34 49 21 0.96 0.7 8.4 28.5 0.68 29.6 0.96 109 36 8 92 22 32 98
06:40 41 53 23 1.08 0.78 9.4 27.4 0.75 28.5 0.96 108 37 8 92 21 30 98
06:50 42 56 23 1.07 0.8 9.5 27.8 0.77 28.8 0.96 109 37 9 93 22 31 98
07:00 40 59 25 1.25 0.8 9.6 29.5 0.79 30 0.98 110 36 8 94 20 33 97
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Figure C.2: Breath-by-breath sample data with values averaged every 10 seconds
- Part 2.
07:10 39 63 24 1.27 0.75 9 29.9 0.75 29.9 1 110 37 8 94 19 33 97
07:20 40 67 23 0.96 0.78 9.4 28.1 0.76 28.8 0.98 109 37 8 93 24 31 98
07:30 44 70 25 1.11 0.85 10.2 27.5 0.82 28.4 0.97 109 37 9 95 22 31 97
07:40 47 73 25 1.22 0.9 10.8 26.6 0.88 27.4 0.97 108 38 9 97 21 29 97
07:50 46 76 25 1.15 0.88 10.5 27.3 0.86 28 0.97 107 38 9 98 22 32 97
08:00 35 80 24 1.3 0.86 10.3 26.6 0.84 27.4 0.97 106 39 9 100 18 31 97
08:10 56 83 28 1.27 1.01 12 26.4 0.97 27.4 0.97 107 39 10 102 22 30 97
08:20 54 86 31 1.46 1.04 12.5 28.5 1.06 28.1 1.01 109 38 10 103 21 31 97
08:30 52 90 31 1.44 1.02 12.2 28.9 1.07 27.5 1.05 110 39 10 103 22 30 97
08:40 50 93 32 1.58 0.99 11.9 31.4 1.06 29.3 1.07 111 38 10 104 21 33 97
08:50 49 96 30 1.16 0.95 11.4 29.8 1.01 28.2 1.06 111 38 9 105 26 32 98
09:00 56 100 32 1.34 1.09 13 28.2 1.14 26.9 1.05 109 39 10 105 24 30 98
09:10 57 103 33 1.54 1.12 13.3 28.8 1.18 27.2 1.06 110 39 10 107 22 30 97
09:20 63 107 35 1.69 1.14 13.7 29.5 1.24 27.2 1.08 110 39 11 108 21 30 98
09:30 56 109 35 1.5 1.14 13.6 29.7 1.24 27.3 1.09 111 39 11 108 23 30 98
09:40 64 112 36 1.73 1.17 13.9 29.7 1.28 26.9 1.1 111 39 11 110 21 29 98
09:50 55 116 35 1.56 1.14 13.6 29.3 1.24 26.8 1.09 110 40 10 111 22 30 98
10:00 64 120 36 1.64 1.23 14.7 28.7 1.34 26.2 1.09 110 40 11 112 22 29 97
10:10 72 123 43 1.94 1.39 16.5 30.4 1.56 27 1.13 111 39 12 113 22 28 97
10:20 67 126 43 1.65 1.32 15.8 31.4 1.54 26.9 1.17 113 38 12 114 26 28 97
10:30 72 130 42 1.65 1.38 16.5 29.4 1.58 25.7 1.15 112 39 12 116 26 26 98
10:40 68 133 42 1.85 1.35 16.2 30.3 1.57 26.2 1.16 112 39 11 118 23 27 98
10:50 68 136 39 2.08 1.31 15.6 29.3 1.49 25.6 1.14 110 40 11 120 19 26 98
11:00 77 140 44 1.99 1.49 17.8 28.7 1.69 25.3 1.13 111 40 12 120 22 24 98
11:10 79 142 48 1.85 1.53 18.3 30.8 1.81 26 1.18 113 38 13 121 26 25 97
11:20 75 147 47 2.06 1.47 17.6 31 1.75 25.9 1.19 113 39 12 125 23 25 97
11:30 77 150 47 1.96 1.52 18.1 30.2 1.75 26.1 1.15 112 40 12 127 24 26 98
11:40 81 153 51 1.92 1.59 19 31.3 1.9 26.3 1.19 114 38 12 128 27 24 97
11:50 83 156 54 2.02 1.59 18.9 32.9 1.95 26.8 1.23 116 38 12 130 27 24 97
12:00 90 159 61 2.56 1.78 21.2 33.8 2.22 27 1.25 116 37 14 132 24 22 97
12:10 104 163 71 2.65 2 23.8 34.9 2.57 27.1 1.29 119 35 15 134 27 18 97
12:20 98 166 75 2.36 1.95 23.3 37.6 2.55 28.7 1.31 121 34 14 136 32 21 97
12:30 95 169 74 2.13 1.85 22.1 39.3 2.46 29.5 1.33 122 33 13 138 35 23 98
12:40 91 172 73 2.16 1.77 21.2 39.9 2.36 30 1.33 121 34 13 139 34 25 97
12:50 89 - 72 2.15 1.71 20.4 41 2.32 30.1 1.36 122 33 12 140 33 24 98
13:00 81 - 71 2.05 1.58 18.9 43.9 2.23 31.1 1.41 124 32 11 138 35 25 98
13:10 68 - 55 1.91 1.29 15.5 40.9 1.88 28.2 1.45 123 34 10 136 29 20 98
13:20 72 - 56 2.11 1.45 17.3 37.7 2.05 26.6 1.41 122 36 11 130 27 19 98
13:30 65 - 65 1.89 1.28 15.3 49.5 1.97 32.1 1.54 127 31 10 125 34 26 97
13:40 46 - 46 1.69 0.95 11.4 46.6 1.5 29.6 1.57 126 32 8 119 27 23 95
13:50 49 - 50 1.51 0.89 10.6 54.6 1.42 34.1 1.6 128 28 8 117 33 25 96
14:00 36 - 48 1.53 0.74 8.8 63.1 1.24 37.5 1.68 129 29 6 115 32 33 96
14:10 40 - 43 1.22 0.78 9.4 53 1.25 33.3 1.59 127 31 7 110 35 29 97
14:20 39 - 43 1.15 0.77 9.2 52.4 1.18 34.2 1.53 127 30 7 107 37 31 97
14:30 36 - 39 1.14 0.71 8.4 52.6 1.07 34.7 1.52 127 30 7 105 34 31 98
14:40 34 - 39 0.99 0.67 8 54.5 1.02 35.7 1.52 127 29 6 104 39 32 97
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